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“It is structure that we look for whenever we try to understand anything. All science is built upon 
this search; we investigate how the cell is built of reticular material, cytoplasm, chromosomes; how 
crystals aggregate; how atoms are fastened together; how electrons constitute a chemical bond 
between atoms. We like to understand, and to explain, observed facts in terms of structure.” 
- Linus Pauling 
 
 
“Everything that living things do can be understood in terms of the jigglings and wigglings of 
atoms.” 
- Richard Feynman 
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For a large part its history, structural biology has relied on X-ray crystallography as 
the primary means of accessing the atomic structures of proteins and other 
molecules. 140,000 crystal structures currently populate the Protein Data Bank, each 
representing a single snapshot of the cellular landscape. To what extent are these 
conformations representative of each protein’s biochemical capabilities? What 
percentage of the proteome’s conformational space has been mapped? While these 
questions remain far too large and impossible for any one PhD student to answer, 
this thesis demonstrates several ways in which the conformational dynamics of 
proteins and complexes can be tackled through combining computational 
modelling with the powerful analytical capabilities of mass spectrometry (MS).  
The structural characterisation of large dynamic molecules remains one of the major 
challenges in biology due to the lack of techniques capable of capturing their 
motions. In Chapter 2 of this thesis, we model the conformational dynamics of large 
flexible Immunoglobulin G (IgG) antibodies using a workflow integrating ion mobility 
(IM)-MS, modelling and molecular dynamics simulations. This workflow provides the 
means of leveraging experimental IM-MS measurements with atomistic models. 
Next, the use of hydrogen deuterium exchange (HDX)-MS for protein 
characterisation has gained traction over the recent years due to its ability to capture 
dynamic aspects of protein behaviour. Advances in HDX-capable instrumentation 
has been paralleled by developments into software that facilitates its analysis. 
Chapter 3 documents the development of Deuteros, a software designed for rapid 
statistical analysis and visualisation of HDX-MS data, including recent upgrades to 
its code and analytical facilities. Finally, in Chapter 4, the structural dynamics of a 
large multi-subunit enzyme known as the Constitutive Photomorphogenesis 9 
Signalosome (CSN) is examined using the synergy of structural MS and cryo-electron 
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microscopy density maps. Integration of these techniques provided a method of 
exposing the multifaceted dimensions of the CSN and revealed its stepwise 
activation cascade. The work comprising Chapters 2, 3 and 4 have each been 
published in Angewandte Chemie, Bioinformatics and Nature Communications 
respectively. Overall, the research presented in this thesis has not only contributed 
important biological insights into the conformational dynamics of IgG and the CSN 
but has also demonstrated the utility of using integrative approaches for the 
characterisation of dynamic macromolecules. 
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QTOF Quadrupole-Time-of-flight 
RBX RING box 
RFU Relative fractional uptake 
RING Really interesting new gene 
RMSD Root mean square deviation 
RMSF Root mean square fluctuation 
RNA Ribonucleic acid 
RRT Rapidly-exploring random tree 
RT Retention time 
SASA Solvent accessible surface area 
SAXS Small angle x-ray scattering 
SD Standard deviation 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SOCS Suppressor of cytokine signalling 
SPOP Speckle-type POZ 
SR Substrate receptor 
SUMO Small Ubiquitin-like Modifier 
SUPREX Stability of unpurified proteins from rates of H/D exchange 
SVM Support vector machine 
TCEP Tris(2-carboxyethyl)phosphine 
TLR Toll-like receptor 
TM Trajectory method 
TOF Time-of-Flight 
TRAF Tumour necrosis factor receptor-associated factor 
TTR Transthyretin 
TWIMS Travelling wave ion mobility spectrometry 
UB Ubiquitin 
UBL Ubiquitin-like protein 
UI User interface 
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UPLC Ultra-performance liquid chromatography 
UPS Ubiquitin-proteasome system 
UV Ultraviolet 
VBC von Hippel Lindau-Elongin B-Elongin C 
VHL von Hippel Lindau-Elongin B-Elongin C 
VMD Visual molecular dynamics 
WHA Winged-Helix A 










Chapter 1: Structural Mass Spectrometry for Modelling of 
Protein Complexes 
 
1.1 Introduction to structural mass spectrometry 
Proteins are diverse cellular machines that are capable of performing complex 
functions by virtue of their intricate structures. The intimate relationship between 
protein structure and function, can be studied through various biophysical and 
biochemical techniques that provide a method of interrogating their mechanical 
features, and inform on how it is that they fulfil their biological roles. While structural 
information can be accessible through techniques such as X-ray crystallography and 
nuclear magnetic resonance (NMR) spectroscopy, these experiments are typically 
time consuming to perform, may have limitations in protein size and complexity, 
and produce models which are ambiguous in interpretation. X-ray crystal structures 
are such an example, whereby protein structures are stabilized in a solid lattice and 
often in a highly artificial and non-biologically relevant media. Although 
crystallographic structures offer unprecedented resolution into the intrinsic 
framework of proteins, further abnormalities in crystal contacts or crystal twinning, 
may complicate interpretations. Notwithstanding, the progressive shift in the focus 
of structural biology in the direction of protein conformational dynamics and 
interaction networks, means that new tools must be developed to fulfil new criteria 
in structural research.  
Mass spectrometry is one of the most powerful analytical techniques. Its accuracy 
and sensitivity to detect atomic composition, from single atoms to intact viruses, 
megadaltons in mass, is unrivalled by other techniques. Hyphenation of MS with 
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other analytical methods such as ion mobility (IM), chemical cross-linking (XL) and 
hydrogen deuterium exchange (HDX) has evolved the MS technique into an 
attractive and practical toolkit for the study of biological molecules. While the 
resolutions of each of these techniques are lesser to that of crystallography, they 
each offer an alternative perspective on the molecular structure, composition and 
conformational behaviour of the system of study. Uniting data from these 
techniques along with existing crystallographic structures or other models, into 
streamlined computational workflows, has the potential to yield a more complete 
representation of a protein’s dynamic capabilities. The following sections of this 
chapter will outline the principles of various concepts and MS techniques used 
throughout the work presented in Chapters 2, 3 and 4.  
  
  




1.2 Overview of electrospray ionisation mass spectrometry 
The analysis of biomolecules such as proteins and their complexes can be 
performed using mass spectrometry. At its core, the mass spectrometer consists of 
several components including an inlet, ion source, a mass analyser and a detector. 
At the inlet, a sample of protein must be subjected to ionisation in order to generate 
protein ions that can be detected via MS. One such method is via electrospray 
ionisation (ESI). ESI is a soft ionisation method which involves the gradual transfer 
of protein ions from an aqueous to gas environment (Figure 1.1).  
 
Figure 1.1. Analyte ionisation through ESI. Electrospray of an analyte sample from a capillary 
needle results in a spray of charged droplets containing analyte molecules. Desolvation of 
charged droplets results in charge accumulation, Coulombic repulsion and fission into smaller 
progeny droplets. Desolvation continues until only dry analyte ions remain and enter the mass 
spectrometer.  
To achieve ESI, a potential difference is set up between a capillary holding the 
protein sample of interest (set to low microlitre min-1 flow rate) and an opposing 
counter electrode, establishing an electric field that draws the charged solvent from 
the capillary and towards the counter electrode. Charge accumulation at the 
capillary tip eventually causes instability of the solvent surface, leading to the 
formation of a Taylor cone which disperses the solvent into a fine plume of droplets 
roughly several microns in diameter1. Each droplet inherits a number of charges 
from the initial dispersion and are held together by the surface tension of the solvent. 
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The charge  that a droplet can hold in relation to its diameter  depends on the 
electrical permittivity of the surrounding environment  and surface tension , given 
by the Rayleigh limit2 (1.1). 
 (1.1) 
As droplets evaporate and decrease in size, the charge per unit volume increases 
until the Rayleigh limit is reached and Coulombic repulsion exceeds the surface 
tension of the droplet. This leads to droplet fission or ejection of charge from the 
surface of the droplet3 (Figure 1.1). Desolvation continues until at some point, 
protein ions are generated (Figure 1.1). How ESI produces protein ions from 
desolvation is less certain, however for folded proteins, it is widely thought to occur 
under the framework of the charge residue model (CRM)4. The CRM envisions that 
protein ions are produced via gradual and complete desolvation of droplets. Under 
this mechanism, droplet desolvation continues until only single proteins are housed 
within each droplet. Evaporation of the final solvation shell is accompanied by the 
transfer of droplet charges to charge carriers on the surface of the protein2,4,5. 
Whether charge arises via protonation of basic (His, Lys, Arg) or neutralisation of 
acidic (Asp, Glu) residues is also a subject of discussion6. Several studies have further 
supported the notion that desolvation of proteins occurs under the CRM3,7. 
Following desolvation, dry protein ions enter the mass spectrometer and can be 
subject to different separation and fragmentation techniques to derive quantitative 
measurements on their molecular features. For example, the mass of an ion can be 
determined via m/z measurements using mass analysers such as quadrupole and 
time-of-flight (TOF) analysers. Features such as molecular shape can be quantified 
through ion mobility MS via measurements of collision cross-section using a 
collision cell.  
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1.3 Native mass spectrometry 
Coupling ESI together with MS provides a method of studying macromolecules in a 
manner that presumably does not disrupt their three-dimensional structures. ESI of 
biological macromolecules under non-denaturing conditions is commonly referred 
to as "native MS". The exact suitability of the word "native" however, is controversial 
since MS techniques are undeniably performed in the gas phase8. It is widely 
accepted that the conditions of native MS are at least non-denaturing and ample 
examples of structural retention after transfer into the gas phase can be seen in 
native MS studies of proteins and their interactions with other proteins, small 
molecules, nucleic acids and lipids9-12. 
 
 
Figure 1.2. Example of a native MS spectra for a multi-subunit complex. Data shown is for the 
CRL2 complex (unpublished data).  
MS is a separation technique - a protein sample subjected to native MS generates a 
mass spectrum that provides a readout of structural and compositional features. 
Since proteins and other macromolecules possess multiple charge carrying sites, 
ionisation via ESI produces a statistical distribution of multiply charged ions (Figure 
1.2). Samples containing multiple molecules will produce multiple distributions of 
peaks (Figure 1.2). Each distribution corresponds to a single molecular population 
with mass , while each constituent peak  corresponds to one of its observed 
charge states , and thus manifests as a distribution of m/z values. The highest m/z 
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peak of a distribution corresponds to the lowest charge state  and the charge of 
each subsequent adjacent peak is given by . For two adjacent peaks  






𝑚+ (𝑧 + 1)𝐻+
𝑧
(1.2) 
where  is the mass of a proton at 1.008 Da. Since both  and  are unknown, 
calculating these values from  and  involves solving a pair of simultaneous 
equations.  and  can be made equal by rearranging for  (1.3): 
  (1.3) 







Substituting the spectral m/z values for  and  calculates  of  which can be re-
substituted into (1.2) to derive the  of . In practice, mass calculations via the 
above methods can be performed in an automated manner using MS software such 
as MassLynx (Waters Corp.). While mass is no doubt the most important parameter 
assessed by native MS, Hall & Robinson have demonstrated that the average 
observed charge state of a distribution can additionally be used to predict the 
corresponding solvent accessible surface area (SASA) of a molecule in good 
agreement with calculated SASA from crystal structures (Figure 1.3)13. 
 




Figure 1.3. Relationship between charge from native MS and SASA. (a) Empirical relationship 
between the average observed charge state  and SASA. Adapted from Hall & Robinson, 
2012 13. (b) SASA is defined as the surface area accessible by a water molecule (modelled by a 
spherical probe of radius 1.4 Å).  
 
1.4 Ion mobility mass spectrometry 
Using native MS, populations of ions are separated via differences in their m/z. 
Hyphenation of native MS with ion mobility (IM-MS) provides a method of further 
separating ions of the same m/z, based on their shape14,15. The quantitative 
measurement derived from IM-MS is the collision cross-section (CCS) - a 
physicochemical feature of the ion's size, shape and charge16. Differences between 
the conformations of ions of the same m/z manifest as differences in their CCS, 
allowing subpopulations of molecular shapes to be distinguished between. The 
earliest methods of IM-MS utilised linear drift tubes (DT) in which analyte ions are 
propagated through an inert gas (typically He or N2) filled chamber of pressure , by 
a weak electric field  (Figure 1.4).  




Figure 1.4. Ion mobility allows further separation of ions of same m/z according to their molecular 
shape. (a) Example of native spectra indicating presence of a single population of ions. (b) Inert 
gas molecules (grey spheres) continuously collide with analyte ions (red and blue spheres) which 
are propelled through the collision cell via an electric field ( ). Any differences between the 
mobility of the ions, such as their CCS, lead to differences between the time taken for the ions to 
cross the collision cell. (c) The corresponding mobility spectra from (b) distinguishes between 
two separate distributions of molecular shapes. 
Sub-populations of ions with a more compact profile between two populations of 
otherwise identical ions, will have greater mobility  and thus traverse through the 
chamber quicker due to fewer collisions with the buffer gas compared to a more 
elongated conformation.  is defined as the ratio between the steady state velocity 
of the ion , and the applied electric field (1.5). In turn, the velocity is the ratio 











As  is dependent on the number of collisions experienced by the ion and is 
propagated by the electric field, it is proportional to  and inversely proportional to 
both  and the number of gas particles in the chamber  and is affected by the 













where  is the reduced mass of the ion and gas pair,  is the Boltzmann constant, 
 is the absolute charge of the ion and  is the elementary charge. To ensure the 
consistency of CCS measurements across laboratories,  is corrected to standard 
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pressure  (100,000 Pa) and temperature  (275.15 K) and reported as reduced 
mobility 17.  is also corrected to the Loschmidt's constant  (1.8). 






















In summary, for a simple linear drift tube system, the time taken for an ion to traverse 
the collision chamber  is used in (1.5) to calculate the mobility of the 
corresponding ion.  is corrected for measurement-specific parameters such as , 
 and  in (1.7) and then used to calculate CCS in (1.8).  
In commercial instruments such as the Synapt G2-Si (Waters Corporation) with 
which some data shown in this thesis were acquired using, IM-MS measurements are 
performed using travelling wave or "T-wave" IM-MS (TWIMS). Unlike the drift tube 
technique which measures  of an ion in a linear trajectory, TWIMS employs a 
periodic travelling wave of specific wave height and velocity, which increases the 
separation of ions but does not allow CCS to be determined directly from  (Figure 
1.5). Instead, the  of calibrant proteins which have had their CCS measured via drift 
tube, is used to calibrate the  of the analyte to derive its equivalent CCS (Figure 1.5). 
To derive CCS using TWIMS, the time of arrival at the end of the collision chamber  
is measured for each charge state of multiple calibrants. Which calibrants are used, 
depends on the analyte of interest and should be selected such that analyte mass is 
between that of the calibrant masses18. Automated calibration can be performed 
using software such as PULSAR18. The  of each calibrant is plot against its expected 
drift tube measured CCS,  allowing a calibration curve to be generated and 
applied to the analyte data.  




Figure 1.5. Separation of ions using TWIMS. (a) The separation of ions can be improved in IM-MS 
by applying a travelling wave of specific wave height and velocity. (b) Example calibration curve 
generated from TWIMS measured  of avidin, concanavalin A and glutamate dehydrogenase 
and plotting against literature CCS values determined via drift tube measurements ( ; 
unpublished data courtesy of Z. Ahdash). The approximate molecular weight of each calibrant is 
shown as well as the  of the fitting. Individual datapoints for each calibrant represents an 
alternative charge state.  
 
1.5 Methods of calculating theoretical CCS 
Experimental measurements of CCS can be compared with theoretical values 
calculated from atomistic or coarse-grained models of proteins and constitutes the 
basis of molecular modelling using data from IM-MS. Many methods have been 
conceived in order to calculate theoretical CCS from models. These can be 
subdivided into two groups: methods that perform scattering calculations to derive 
CCS, including the exact hard sphere scattering (EHSS) and trajectory method (TM), 
and those that approximate CCS through non-scattering calculations such as 
projection approximation (PA) and projected superposition approximation (PSA). 
The features of each method will be briefly described below. 
The earliest examples of comparisons between experimental and theoretical CCS 
can be found from almost a century ago by Mack, who in 1925, envisioned that 
model CCS could be approximated through averaging an object's projected area 
over all rotational angles19. The method of calculating model CCS based on its 
projected area were later encapsulated in the projection approximation (PA) 
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method. Measurements of PA along with EHSS and TM can be performed using 
software such as MOBCAL by Mesleh et al.20. Measurements of CCS via PA (CCSPA) 
takes into account the size of the buffer gas used, but not any explicit interactions 
between protein and gas particles since scattering is not modelled using PA. The 
projected area is calculated for a number of different orientations of the molecule 
however non-globular topologies which present surfaces for multiple scattering 
events are typically under-represented, leading to underestimation of the true 
CCS14,21. However as demonstrated by Benesch and Ruotolo, an empirical scaling 
factor of 1.14 can be applied to yield CCS that is in good agreement with 
experimental equivalents22. Calculations of CCS via PA are among the fastest of all 
methods (Table 1.1). Recent upgrades to the PA calculation method by Marklund et 
al. in the software IMPACT, has made it possible to derive CCSPA for all biological 
assemblies in the protein data bank (~300,000 models) in approximately 5 hours23, 
making PA a highly viable CCS determination method when a large number of 
models must be accounted for.  
Limitations in the PA to account for some macromolecular shapes such as concave 
surfaces, are further remedied by the PSA method which includes size and shape 
effects, allowing more representative CCS values to be calculated for non-globular 
shapes such as channels, cavities and pores24. PSA approximates long range 
interactions via application of statistical probabilities to take into account 
temperature and distance-dependence of scattering events. As a result, calculations 
with PSA are much longer than those of PA14. 
Table 1.1. Methods of calculating CCS from models. 
Method Typical computing timescale 
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More rigorous calculations of CCS can be made through EHSS and TM methods, both 
of which calculate CCS as a momentum transfer integral, taking into account the 
sum of individual collision events. The most accurate calculations of CCS are derived 
from the TM which performs repeated scattering simulations of the model of interest 
colliding with gas particles while taking into account both short- and long-range 
interactions20. TM integrates the momentum-transferring collision events over all 
scattering orientations simulated and uses molecular mechanics to simulate a 
realistic trajectory of the gas molecule20,25. The high number of calculations 
performed for both short- and long-range interactions means that the TM is very 
computationally expensive. TM for protein molecules can take several hours to 
compute, indicating that the accessibility of CCSTM is severely limited by the number 
of models or system size. A more simplistic method of modelling the scattering 
trajectories is offered by the EHSS method, which speeds up calculation times but 
at the cost of ignoring long range interactions between gas and model particles26. 
A new and unique approach to calculating CCS of models emerged in 2016 from 
Zhou et al. who used a support vector machine (SVM) to predict the model CCS of 
small molecules based on 14 molecular features, including mass, formal charge, 
physiological charge and solubility16. SVMs are a subset of artificial neutral networks 
(a branch of machine learning) which can be trained to partition data based on a set 
of descriptive parameters (in this case the molecular features) and an expected 
result (the CCS). A hyperplane is constructed through the datapoints and used in 
regression analysis to derive a relationship between the input descriptive 
parameters and output expected CCS. Zhou et al. applies their SVM to the human 
metabolome database of 35,000 compounds and show accurate CCS derivation for 
90% of the compounds16. CCS via machine learning has so far only been applied to 
small molecules and no algorithms have been trained for protein complexes. 
However, the application of machine learning in the field of structural mass 
spectrometry is an interesting method of empirically modelling relationships 
between different structural and chemical features of molecules.  




1.6 Collapse of protein structures in the gas phase 
As seen previously, a combination of native and IM-MS can distinguish between sub-
populations and sub-conformations of protein structures through differences in 
their m/z and CCS. Whether these structures resemble their solution counterparts is 
a vigorously discussed topic and highly relevant when considering the possible 
implications of misinterpreted structural information. The consensus that ESI 
produces proteins that remain folded upon transfer into the gas phase, is supported 
by a number of observations including: (1) protein spectra following native MS do 
not resemble those of unfolded proteins which are able to carry much more charge, 
and thus suggest compact gas phase topologies; (2) native MS charge states 
correlate with calculated SASA from protein models, further supporting (1); (3) non-
covalent interactions between protein-protein or protein-ligand are preserved in the 
gas phase, suggesting that the gas phase topology resembles that of the solution 
phase; (4) experimental CCS of most proteins can be well correlated with theoretical 
values calculated from crystal structures. Point (4) is especially interesting and 
worthy of further discussion since a number of proteins and nucleic acids have been 
observed, whereby their experimental CCS can be up to 60% lower than that of the 
theoretically calculated value (Table 1.2, Figure 1.6).  
Jurneczko and Barran review the CCS of number of proteins shown in Figure 1.7, and 
observed that for all examples, experimental CCS is consistently lower than that of 
the theoretical value21. Ewing et al. further report that theoretical CCS calculated via 
TM, although being one of the more rigorous models of collision events, typically 
results in a +5% CCS difference compared to experimental values27. To explain these 
differences, Jurneczko and Barran rationalise that protein-solvent interactions are 
important for structural stability in the solution environment, and so protein 
structures "collapse" during transfer into the gas phase as evaporate to dryness21.  




Figure 1.6. Differences between theoretical and experimental CCS found in the literature. (a) Plot 
of theoretical and experimental CCS for 20 molecules. Points closest to the origin have not been 
labelled for clarity. Dashed line represents exact match between experimental and theoretical 
values. (b) Percentage CCS difference between datapoints in (a) are shown, along with five 
example protein structures. Datapoints correspond to those displayed in Table 1.2. 
Abbreviations: Haemoglobin4: haemoglobin tetramer; USP5com and USP5ex: compact and 
extended USP5; BPTI: bovine pancreatic trypsin inhibitor. IgG1a values from Devine et al. 2017 28. 
IgG1b values from Pacholarz et al. 2014 29. 
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Table 1.2. Reported experimental and theoretical CCS values 
Protein MW (Da) PDB Method CCSexp CCSThr Method % 
Melittina 2846 1MLT DT 544 574 TM 5.2 
β-defensin 2a 4328 1LFD3 DT 598 669 TM 10.6 
BPTIa 6512 6PTI DT 770 891 TM 13.6 
Ubiquitina 8565 1UBQ DT 1004 1055 TM 4.8 
β2-microglobulina 11860 1LDS TWIMS 1142 1459 TM 21.7 
Cytochrome Ca 12355 1HRC DT 1217 1310 TM 7.1 
α-lactalbumina 14178 1HFX TWIMS 1342 1523 TM 11.9 
Lysozymea 14305 1DPX DT 1300 1468 TM 11.4 
Calmodulin (apo)a 16700 1CFD DT 1526 2029 TM 24.8 
Myoglobina 17566 1VXG TWIMS 1314 1725 TM 23.8 
Haemoglobina 64447 1GZX DT 3051 4181 TM 27.0 
USP5b 93792 3IHP TWIMS 5200c 6340 TMd 18.0 
   TWIMS 6600c 7400 TMd 10.8 
IgG1e 150000f 1IGY TWIMS 6820 10100 PSAg 32.5 
I275e 52235h N/Ai TWIMS 3980 6310 PSAg 36.9 
POTRA (BamA)e 90552j 5D0O TWIMS 3510 4530 PSAg 22.5 
SasGe 178527 N/Ai TWIMS 5770 13780 PSAg 58.1 
RNA (seq 1)e 11217 2PCV TWIMS 1021 1445 PSAg 29.3 
RNA (seq 2)e 11219 2DRB TWIMS 1016 1146 PSAg 11.3 
IgG1k 150000f 1IGY DT 6100 10084 TM 39.5 
                                                        
a Values from Jurneczko & Barran, 2011 ref 21 
b Values from Scott, Layfield and Oldham, 2015 ref 30 
c compact and extended conformations of USP5 
d Approximate TM-like value via  
e Values from Devine et al., 2017 ref 28 
f Exact mass not given 
g Approximate PSA-like value via  
h Mass from Brockwell et al. 2002 ref 31 
i Modelled by authors, no model deposited 
j Mass from UniProt (AN: P0A940) 
k Values from Pacholarz et al., 2014 ref 29 




Figure 1.7. Comparison of theoretical and experimental CCS for proteins. (a) The experimental 
CCS of melittin, β-defensin 2, bovine pancreatic trypsin inhibitor (BPTI), ubiquitin, β2-
microglobulin, cytochrome C, α-lactalbumin, lysozyme, apo conformation of calmodulin and 
myoglobin are shown along with theoretical CCS calculated via TM. (b) Crystal structures used to 
derive values in (a). Adapted from Jurneczko and Barran, 2011 21. 
A model of the timeline following desolvation was described by Breuker and 
McLafferty who used molecular dynamics (MD) simulations of cytochrome C by 
Steinberg et al. to propose that desolvation eventually leads to the loss of protein 
structure over millisecond timescales32. In this model, charged protein side chains 
collapse within picoseconds of complete desolvation, forming a stabilising salt-
bridge network that encapsulates the surface of the protein32. Devoid of its solution 
environment, loss of the hydrophobic effect follows, eventually leading to a loss of 
salt-bridges and unfolding of cytochrome C over the next few milliseconds32. 
However, drift time measurements of ubiquitin by Koeniger, Merenbloom and 
Clemmer, demonstrated that the gas phase conformation of ubiquitin does not 
change or unfold over the 10-20 ms timescale of the experiment33, indicating that 
stability should be discussed on a per-protein basis.  
Further attempts to model gas phase conformations of proteins, as well as the 
desolvation process have provided valuable insights into the relationship between 
protein topologies and gas phase collapse. Methods of simulating these events 
through molecular dynamics will be discussed later. Gas phase collapse typically 
occurs in proteins with non-globular topologies, particularly those with domains 
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connected by flexible linkers28. Compact gas phase structures of extended and 
elongated proteins such as the IgG1 antibody, and two rope-like proteins known as 
I(27)5 and SasG, have been simulated. However, the post-MD theoretical CCS values 
of these simulations typically still exceed that of the experimental CCS28,29. On the 
other hand, gas phase simulations of proteins with fewer flexible linkers such as the 
USP5 deubiquitinase and the POTRA domains of the BamA complex, have yielded 
structures highly matching experimental CCS28,30. The observation that not all 
simulations may be able to produce agreeable models, suggests that either the 
simulation method or the initial starting conformations of proteins, typically found 
from crystal structures, may be limited in their ability to represent the solution 
ensemble and may lead to structure being trapped in non-representative 
conformations. Modelling successes of proteins with fewer degrees of freedom such 
as USP5 and POTRA, support this notion further and indicate a correlation between 
the in-solution conformational space of a protein, and its degree of gas phase 
collapse. The methods of performing gas phase simulations on protein structures 
will be explored in the following section. 
  




1.7 Principles of molecular dynamics simulations  
The motions of proteins in the form of their dynamic interactions with itself, or atoms 
in the surrounding environment are an essential feature of its conformational and 
biochemical space. MD simulations provides a method of simulating the motions of 
proteins and their associated mechanical events as a function of time34. The 
availability of high-performance computing power, graphical processing units and 
developments into accurate parameterisation of MD forcefields have led to the 
ability to simulate increasingly complex and diverse biological systems to even 
millisecond timescales35. Several variants of MD simulations exist, including classical 
and quantum mechanical methods. MD performed for macromolecular motions are 
typically referred to as "classical MD" - differentiating them from simulations such as 
enzymatic reactions which require quantum mechanical methods that are able to 
model the breaking and forming of covalent bonds to high accuracy.  
In classical MD simulations, the trajectory of each atom is calculated through 
integrating Newton's second law over small timeframes, typically femtoseconds. 
Each calculation step of the trajectory involves calculating the force acting upon 
each atom according to its environment. The atom's position is then updated, and 
the process repeated. The physical characteristics of atoms during MD are 
represented in a forcefield that is applied globally to all atoms. These include the 
atomic mass, partial charge, van der Waals radii, and inter-atomic bond lengths and 
angles. One of the most widely used MD forcefields for the simulation of biological 
molecules is the CHARMMl forcefield developed by Martin Karplus and colleagues36. 
Many flavours of the CHARMM forcefield have been developed, each specialising in 
simulations of a particular type such as the CHARMM27 for protein-nucleic acid 
                                                        
l CHARMM: Chemistry at Harvard Macromolecular Mechanics  
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interactions37,38. In the CHARMM forcefield, the energy  for a set of protein atoms  
is calculated using an additive six-term function (1.9): 
 
𝐸(𝑹) = ∑ 𝑘𝑏(𝑏 − 𝑏0)
2
𝑏𝑜𝑛𝑑𝑠
+ ∑ 𝑘𝜃(𝜃 − 𝜃0)
2
𝑎𝑛𝑔𝑙𝑒𝑠





















Each of the six terms describe different bonded (terms 1-5) and non-bonded (term 
6) interactions (Figure 1.8). The first term in (1.9) calculates the potential energy 
contribution of bond displacements  from an ideal bond length , where  is the 
bond force constant. Both  and  are parameterised for each bond type (e.g. C-C, 
C-H, N-H). In the second term, oscillations around bond angles are also modelled via 
a harmonic potential, and  is the corresponding angle force constant for the 
particular set of atoms.  
 
Figure 1.8. Bond characteristics. (a) Definitions of bond lengths , angles  and dihedrals  for a 
set of four bonded atoms. (b) Improper dihedrals (out-of-plane) are measured as the angle 
between planes  and  and given as . (c-d) van der Waals and electrostatic 
interactions between atoms  distance apart.  
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Dihedrals of a set of four atoms are assumed to be periodic and taken as the sum of 
cosine functions where  is the multiplicity,  is the dihedral angle and  is the phase 
shift.  is the corresponding atom-specific dihedral force constant for the set of four 
atoms that comprise the dihedral angle. Out-of-plane or "improper" dihedrals are 
modelled similar to terms 1 and 2 as harmonic potentials of the angle between two 
atom planes shown in Figure 1.8. The 5th term known as the Urey-Bradley potential, 
is specific to the CHARMM forcefields and introduces a virtual bond between two 
atoms involved in an angle and restrains the distance between them , based on 
idealised values  and an atom-specific force constant . Finally, contributions 
from non-bonded interactions are taken as the sum of van der Waals and 
electrostatic bonds and calculated for atom pairs separated by no more than three 
bonds (1.10): 
 𝐸𝑛𝑜𝑛𝑏𝑜𝑛𝑑𝑒𝑑 = 𝐸𝑣𝑑𝑤 + 𝐸𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑠𝑡𝑎𝑡𝑖𝑐 (1.10) 














van der Waals interactions are modelled using a Lennard-Jones potential where 
 is the atom type-dependent distance at which the potential energy is zero,  
is the distance between atoms  and  and  is the dielectric constant for the 
surrounding media (1.11). The electrostatic energy term is represented by a 
Coulomb potential taking into account the product of atom charges ,  and 
distance between them  (1.11). 
1.8 Molecular dynamics of proteins in the gas phase 
MD simulations that aim to elucidate functional aspects of proteins are typically 
performed in a solution environment that mimics its native aqueous environment. 
The behaviour of water molecules and protein solvation effects are handled by a 
number of different water models39. MD simulations are also commonly combined 
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with structural MS studies in order to leverage MS observations with atomistic 
representations of the system of study. This has led to fruitful discoveries including 
contributions into the understanding of how DNA is repaired by the HerA-NurA 
complex which was performed during this PhD but is not shown in this thesis9. 
Marklund and Benesch provide an excellent review of synergy between MD and MS40.  
MD simulations of proteins in a vacuum environment are commonly performed and 
used in conjunction with IM-MS. However, due to the lack of forcefields developed 
for proteins in the gas phase, those for solution environments are typically used in 
their stead, leading to controversy regarding the validity of the resulting structures. 
The effectiveness of performing gas phase simulations with solution forcefields has 
been described by Konermann et al.41. Konermann and colleagues rationalise that 
there are multiple criteria that a forcefield developed for the gas phase must take 
into account, primarily a reasonable representation of the atoms at the protein-
vacuum interface and also at the protein interior which would likely be better 
represented by condensed-phase forcefields41. Notwithstanding the lack an ideal 
gas phase forcefield, Konermann et al. point out that so far, gas phase simulations 
have yielded "surprisingly good" descriptions of proteins in the gas phase but 
conclude that all simulations should be judged on their ability to provide new 
insights into the system of study.  
Current methods of performing gas phase MD of proteins can be divided into those 
that include the timeline of desolvation and those that do not (Figure 1.9). To model 
the ESI process, the group of Lars Konermann developed a trajectory stitching 
method and demonstrated its utility in simulating the desolvation of ubiquitin, 
cytochrome C and holo-myoglobin using the CHARMM36 forcefield developed for 
proteins in solution42. In these simulations, water droplets each containing a single 
molecule of protein is simulated over a period of >100 ns and droplet charges are 
modelled through an excess number of Na+ (Figure 1.9a). Water molecules evaporate 
from the droplet, accompanied by ejection of charge, as envisioned under the 
framework of ESI. Inspecting the time evolution of the droplet charge also indicated 
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that Na+ ejection occurred as the droplet charge approached the Rayleigh limit41. To 
lessen the computational cost, the simulation is periodically stopped, water 
molecules distanced greater than 150 Å from the protein centre-of-mass are 
removed, and the simulation continued. Eventually, each simulation results in a dry 
 protein ion with a theoretical CCS in good agreement with 
experimental measurements42. The agreeability of McAllister's simulations to 
capture key events of the ESI process using the CHARMM36 forcefield, supports 
Konnerman's rationale that solution forcefields although not ideal, may be equally 
valid for gas phase simulations.  
 
Figure 1.9. Methods of protein gas phase MD. (a) Simulating protein desolvation involves placing 
a protein of interest in a water droplet. Charges are contributed by excess ions such as Na+. After 
a short period of simulation, all atoms exceeding 150 Å from the protein centre-of-mass are 
removed and repeated until the protein is dry. (b) Proteins can be directly subjected to gas phase 
MD. This involves pre-charging the protein through distributing charges across the surface of the 
protein, typically to basic residues. All other residues are assumed to be neutral. The protein is 
simulated until convergence. (c) Similar to (b), an initial distribution of static charges are 
distributed across the protein surface. After a short period of simulation, an optimal migration 
path for each charge is calculated. Charges are moved to the new residues if more energetically 
favoured. Another short simulation takes place and the process is repeated until convergence. 
Charges are further allowed to migrate from acidic residues, allowing salt-bridges to be formed. 




There are equally examples where proteins have been subjected directly to gas 
phase MD and these constitute the majority of reports found in literature28-30. Unlike 
desolvation simulations which model droplet charge and protein ionisation using 
mobile Na+, direct gas phase protein simulations first perform pre-charging of the 
protein prior to simulation (Figure 1.9b)41. Typically, all residue side chains are 
neutralised such that the net protein charge is zero. A set number of charges (those 
seen from ESI) are distributed via protonation of either a randomised or calculated 
distribution of basic residues such as His, Arg and Lys. Another limitation manifests 
in this step as not all forcefields contain parameters for protonated residues. In these 
simulations, a limitation of MD engines such as GROMACS or NAMD to handle mobile 
charges, means that the initial charge setup is fixed over the course of the simulation. 
As a consequence, the initial charge set up may heavily bias the resulting trajectory. 
Meyer et al. rationalise that charging a small protein such as lysozyme to 5+, with 19 
basic Arg, Lys, His and N-termini sites, results in more than 11,000 possible 
combinations to consider43. A mobile proton algorithm was developed by 
Konermann and colleagues to circumvent these major simplifications in the pre-
charging method44. The mobile proton method uses the OPLS forcefield designed 
for solution simulations. In essence, the algorithm first performs a pre-simulation 
sampling of thousands of charge distributions and determines the most 
energetically stable selection of chargeable sites including this time Asp, Glu, N and 
C-terminal sites41. In a manner similar to that of the trajectory stitching method, the 
algorithm performs short stretches of simulations followed by re-calculation and re-
distribution of charges (Figure 1.9c). As a result of mobile charges and inclusion of 
both acidic and terminal residues, salt bridges are abundantly formed during mobile 
proton simulations44. Both simulations using the trajectory stitching desolvation and 
mobile proton methods are detailed in a protocol paper by Konermann et al.41. 
These new methodologies will no doubt lead to an increasingly accurate and 
informative number of gas phase simulations in the future.  
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1.9 Chemical cross-linking mass spectrometry 
Synonymous to the utility of MD in providing access to the dynamics of protein 
structures, their conformational dynamics and interaction space can be captured 
experimentally through chemical cross-linking (XL)-MS. XL-MS provides proximity 
data, and thus when applied to proteins and their complexes, can be used to 
determine changes in protein conformations, the proximity of regions within multi-
subunit complexes and also determine interaction networks in proteome-wide 
studies45. XL-MS combines together the structural specificity of small chemical 
modifiers with the analytical sensitivity of MS. These chemical modifiers, known as 
cross-linkers, are bifunctional molecules that feature two reactive groups separated 
by a linker or spacer of defined length. The reactive groups of a cross-linker are 
specially designed such that they react with particular functional groups of proteins 
or other proximal interacting molecules such as nucleic acids or lipids46,47.  
A typical XL-MS workflow involves first incubating the system of interest with cross-
linker molecules (Figure 1.10a-b). There are several types of cross-linking 
experiments, each with a range of cross-linkers including amine-to-amine, zero-
length and photo-activated cross-linkers (Figure 1.11). Cross-linkers can further be 
homo- or hetero-bifunctional, giving rise to a diverse palette of chemical specificities 
(Figure 1.11c)45. Amine-to-amine cross-linkers, such as the commonly used 
bis(sulfosuccinimidyl) suberate or BS3, is a homo-bifunctional molecule with two N-
hydroxysuccinimide (NHS) esters separated by an 8-carbon long spacer for a total 
length of 11 Å. When exposed to proteins, the NHS groups of BS3 react with amine 
groups of Lys and the N-termini, although they have also been shown to have limited 
reactivity for hydroxy groups of Ser, Thr and Tyr48.  
 




Figure 1.10. Example of the XL-MS workflow. (a-b) Protein complexes in an aqueous environment 
are incubated with cross-linker reagents which tether together pairs of residues within a defined 
distance. (c) An optional step involves the fractionation and isolation of specific MW species via 
SDS-PAGE. (d) Cross-linked proteins are digested to the peptide level using various enzymes (e.g. 
trypsin). Four types peptides can be generated: non-cross-linked peptides, type 0 mono-links in 
which one reactive group of the peptide has not reacted, type 1 cross-links where both groups 
are found tethered to the same peptide, and type 2 cross-links where both groups are found on 
different peptides. (e) The cross-linked peptide mixture is subjected to LC-MS/MS and database 
search for cross-link identification. (f-g) Tables of cross-linked residues are generated and can be 
visualised either graphically or via projection onto existing or modelled structures of the system. 
Steps (c) and (g) are optionally performed. 
 
Carbodiimides, condense together carboxylate and amine groups of proteins, 
forming zero-length linkages. Other cross-linkers such as diazirines are photo-
activatable49. Under long wave UV irradiation (330-370 nm), diazirines form reactive 
carbene intermediates which have non-selective reactivity for solvent accessible 
surfaces of the protein45. Incorporation of diazirine-modified photo-activatable 
amino acids such as photo-lysine have even enabled the capturing of protein-
protein interactions directly from within cells50. In the case of a bifunctional cross-
linker such as BS3, the reactive groups engage with amine groups of the protein, 
stabilising its structure via a network of covalent linkages (Figure 1.11a).  




Figure 1.11. Cross-linker chemistries. (a) Amine-to-amine cross-linking using BS3. (i) BS3 consists 
of two amine-reactive NHS groups separated by an 8-carbon spacer. (ii) Cross-linked lysine side 
chains using BS3. (b) Carboxylate and amine groups of proteins can be zero-length cross-linked 
using carbodiimides. (c) Hetero-bifunctional cross-linkers such as NHS-diazirine are bi-specific. 
NHS reacts with amine groups while the diazirine upon UV irradiation, generates a reactive 
carbene species that non-specifically reacts with proximal chemical groups.  
 
A major benefit of XL-MS is that cross-linking events take place in solution, allowing 
structural and conformational information to be captured from proteins while in an 
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environment that is most representative of its conformational dynamics. Since 
cross-linking takes place in solution, the data acquired from XL-MS are ensemble 
measurements that represents all sub-populations and sub-conformations of 
protein states present within the sample. This presents multiple sources of 
heterogeneity such as alternative conformations of proteins, partial complexes or 
unfolded species which will equally be quantified. Thus, incubation conditions such 
as the buffer used, pH, salt concentrations, sample purity and viability (i.e. folded or 
unfolded) must be controlled for, to ensure that measurements are representative 
of the intended system state. 
The next step involves digesting cross-linked proteins to the peptide level in order to 
later identify them via proteomics. Since XL-MS protocols operate on the peptide 
level, there is no limit on the size and complexity of the system that can be studied45. 
Digestion typically utilises trypsin which is a highly specific and aggressive protease 
that preferentially cleaves at the C-terminus of Arg and Lys51. However, the majority 
of protein cross-linking, involves linkages between Lys and thus the effectiveness of 
tryptic digestion is hindered by the presence of cross-linkers52. Combinations of 
secondary enzymes able to cleave at alternative sites such as N-terminal of Asp have 
been used in conjunction with trypsin to improve the yield of observable peptides53. 
Samples can be subjected to digestion via two commonly employed methods: in-
gel digestion, which first subjects cross-linked samples to sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) prior to digestion54 (Figure 1.10c), or 
in-solution digestion, in which trypsin and/or other enzymes are added directly to 
the cross-linked sample. In-gel digestion is particularly complementary to studies of 
protein complexes in which unwanted partial complexes or oligomeric states may 
be present alongside the complex of interest. Separation of these species via SDS-
PAGE allows bands corresponding to the wanted complex to be isolated through 
physically excising the band followed by treatment with trypsin. However, the 
recovery of cross-linked peptides following in-gel digestion is typically poor relative 
to in-solution methods55. 
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The digestion of cross-linked proteins leads to the generation of four categories of 
peptides based on their cross-linking features (Figure 1.10d). The nomenclature of 
these categories follows suggestions by Schilling et al. and are: 1) non-cross-linked 
peptides; 2) Type 0 or mono-links where only one reactive group has attached to a 
peptide; 3) Type 1 intra-peptide cross-links and 4) Type 2 inter-peptide cross-links56. 
Each peptide type reveals structural information regarding the state of the initial 
captured protein57. For example, Type 0 cross-links are akin to covalent labels which 
provide information regarding regional accessibility, but also the availability of 
second cross-link acceptor sites in the immediate vicinity of the initial tether point.  
In the next step, the identity of each peptide in the mixture must be determined. In 
XL-MS experiments, cross-linked peptides constitute a minority of the total number 
of peptides in the mixture and thus a number of procedures have been developed 
to 'enrich' for cross-linked peptides, improving their observation52. A ubiquitously 
applied method in most XL-MS workflows, involves first subjecting the peptide 
mixture to LC for separation via differences in their retention time, leading to higher 
concentrations of cross-linked peptides being detected53. Separated peptides enter 
the MS and are next subject to fragmentation via MS/MS. Peptide identification 
through MS/MS forms the basis of proteomic techniques and involves the 
acquisition of both the mass and fragmentation spectra of each peptide (Figure 
1.10e). The mass of each intact peptide and its resulting fragment ions are input into 
a database search to identify and score the peptide against a list of possible 
candidates from a known sequence57. The spectra acquired from cross-linked 
peptides are more complex than those encountered from standard proteomics 
experiments due to the presence of the cross-linker and any attached peptides. The 
exact site of cross-linking can be determined when fragment ions upstream and 
downstream of the cross-link site can be identified57. Fragmentation of peptides can 
be performed through a number of different methods which result in specific 
peptide fragmentation patterns (Figure 1.12)57. The ability to predict the expected 
fragment ions based on the fragmentation method used, aids in identification of the 
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peptide since only a subset of potential fragments can be generated. Collision-
induced dissociation (CID) involves accelerating ions into helium, argon or diatomic 
nitrogen, leading to kinetic fragmentation at the peptide bond58, generating an N-
terminal and C-terminal fragment, referred to as b and y-ions respectively. Other 
methods such as electron-transfer dissociation (ETD) utilises chemical reagents 
which transfer electrons to peptide ions, causing fragmentation at N-Cα bonds59 and 
leads to generation of c and z-ions57.  
 
Figure 1.12. Nomenclature of fragment ions produced from fragmentation of the peptide 
backbone. Fragmentation of peptides at different bonds generates pairs of fragments. N-terminal 
fragments are known as a, b or c-ions and C-terminal fragments as x, y and z-ions respectively. 
The number of residues within the fragment is represented by the subscript.  
Cross-links identified from XL-MS are exported in tabulated formats by database 
software such as pLink (Figure 1.10f)60. Data tables exported from pLink includes a 
breakdown of all cross-links identified between a set of supplied sequences which 
reflect known proteins within the initial cross-linked sample. This breakdown 
includes which proteins the cross-link was observed between, the exact sequence 
and residue numbers, the number of identified spectra, observed peptide charge 
states and precursor mass, as well as a confidence score of the peptide assignment. 
The resulting data tables from XL-MS experiments can be visualised through a 
number of different methods. One of these is the commonly used circular plot 
format produced by the XVis webserver61, in which residue-scale bars corresponding 
STRUCTURAL MASS SPECTROMETRY FOR MODELLING OF PROTEIN COMPLEXES 
 
 48 
to proteins are arranged in a circular ring and each connection represents a cross-
link between two proteins at specific residues (Figure 1.10g, right). Two-dimensional 
representations of cross-linking data are particularly useful when considering 
proteins without solved structures. If structures or models are available, cross-links 
can be directly projected onto these models using molecular graphics software such 
as visual molecular dynamics (VMD)62 or PyMOL63 (Figure 1.10g, left).  
Cross-links determined from a dynamic protein, contains information regarding its 
conformational space. Cross-links from multi-subunit protein complexes, capture 
the relative orientations and positions of individual proteins, including any 
variations in their dynamics. The utility of XL-MS in studies of protein structure and 
function, rely on its integration with computational methods that aim to build 
accurate models through using the observed cross-links to guide their generation. 
This restraint-based modelling approach is not only limited to cross-links from XL-
MS but can also take advantage of any complementary data that can be modelled, 
including models from X-ray crystallography or density maps from cryo-electron 
microscopy. The use of cross-linking data for protein complex modelling will be 
demonstrated in Chapter 4 of this thesis. 
 
1.10 Hydrogen-deuterium exchange mass spectrometry 
1.10.1 Principles of hydrogen-deuterium exchange 
Hydrogen deuterium exchange (HDX)-MS is a structural MS technique which has 
garnered attention for its ability to assess protein-protein and protein-ligand 
interactions, protein folding, and the associated dynamics of these processes, all 
while within a suitable "native" solution environment64,65. The labile amide 
hydrogens of the protein backbone undergoes exchange with the surrounding 
deuterium, forming the basis of HDX. Whether or not HDX occurs, depends on both 
structural and physiochemical factors. The intimate relationship between protein 
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structure and dynamics thus means that HDX is sensitive to changes in both the 
former and latter. Exchange of hydrogen for deuterium ("on/in-exchange"), leads to 
measurable increases in mass, that can be detected via MS. The combination of HDX 
with bottom-up proteolytic fragmentation strategies, alleviates restrictions on the 
upper limits of protein size, commonly suffered by other techniques favoured for the 
dynamic characterisation such as NMR. Further combination of MS allows the 
localisation of HDX to the peptide-level, providing a read out of the conformational 
state of the system. 
HDX is an isotopic labelling method that involves the exchange of hydrogens in a 
protein of interest, with deuterium within a deuterium-rich labelling buffer.  
Hydrogens in N-H, O-H and S-H groups will naturally exchange with the deuterium 
through acid or base catalysis. However, differences in the exchange rates of each of 
these chemical groups means that only N-H exchange events are captured by MS. 
Thus, HDX measurements are concerned with only the exchange of amide 
hydrogens of the protein backbone.  
All residues with the exception of proline and the N-terminal residue feature 
backbone amide hydrogens that can undergo HDX. The probability of exchange is 
dependent on structural factors including solvent accessibility and hydrogen 
bonding status – both of which are intimately related to the secondary structure of 
the protein. Backbone amide groups are directly involved in the majority of α-helical 
and β-sheet folds and thus hydrogens of these structures are less likely to exchange 
(Figure 1.13). Conversely, the fastest exchange occurs in non-hydrogen bonded 
solvent accessible regions such as those found in flexible or disordered loops.  




Figure 1.13. Hydrogen bonding and solvent accessibility of α-helical and β-sheet structures. (a) 
Representative α-helix and β-hairpin of ubiquitin (1UBQ). Backbone shown as lines, amide 
hydrogens as spheres. Teal and white indicate hydrogen bonded (yellow dashes) and non-
bonded hydrogens respectively. Red, blue and grey are oxygen, nitrogen and carbon respectively. 
Side chains hidden for clarity. (b) Surface view of (a) showing surface accessibility of each atom 




Figure 1.14. Effect of pH and temperature on HDX chemical exchange rate. Chemical rate 
constant  as a function of (a) pH and (b) temperature. The pH at which is at a minimum 
is marked by . Adapted from Bai et al. 1993 66. 
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The rate of exchange of an amide when unhindered by accessibility or hydrogen 
bonding is represented by the chemical rate constantm , which is in turn affected 
by a number of physiochemical factors such as the chemistry of the flanking side 
chains, temperature and pH65. The side chains of residues adjacent to amide groups 
affect  either through sterically reducing solvent accessibility (in the case of large 
non-polar side chains) or through the inductive effect which facilitates exchange by 
promoting nucleophilic attack of the amide hydrogen in base catalysis.  
Using a poly-DL-alanine model peptide, Bai et al. demonstrated that  is 
dependent on both pH and temperature66. Plotting  as a function of pH generates 
a characteristic V-shaped curve that has a  minima at a pH of approximately 2.5 
( ) (Figure 1.14a). At , the rates of acid and base catalysis are equal, thus 
when pH is greater than , exchange via base catalysis is dominant. Likewise, 
when pH is lower than , exchange occurs via acid catalysis64. The half-life of 
exchange for poly-DL-alanine at physiological pH, equates to approximately 1 
second, while at , increases to 25 minutes64. Similarly,  rapidly increases as 
a function of temperature  and is the lowest at 0˚C (Figure 1.14b).  
All proteins within their native environments exhibit conformational and thermal 
fluctuations which lead to transient changes in their structure, commonly thought 
of as their “breathing motions” 65. As part of these motions, individual regions or the 
entire protein may temporarily become more solvent accessible or hydrogen bonds 
may be transiently broken, allowing HDX to take place. The rate of opening and 
closing transitions are each associated with the rate constants  and  and thus 




                                                        
m Also referred to as the intrinsic rate constant 
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Under this mechanism, two exchange regimes have been observed. The first, EX1, 
occurs when  is faster than , that is, the opening of amides is long enough such 
that exchange can occur (1.13)64. In EX1, isotopic exchange rate  is therefore 
equal to  . The opposite is observed in EX2 kinetics whereby multiple rounds of 
opening and closing occur before exchange takes place (1.14). Under EX2,  is 
equal to the ratio between open and close rates represented by the equilibrium 







Under physiological conditions, the majority of exchange occurs under the EX2 
regime65. The opening and closing motions exhibited by a protein while within a 
native environment, is a feature of its conformational dynamics. Each EX2 exchange 
event relates to a particular conformation of its solution ensemble that permits 
exchange to take place at the particular amide hydrogen. Therefore, understanding 
the relationship between the HDX and the underlying conformational dynamics of 
proteins, is paramount to making full use of the structural information available from 
HDX-MS. 
1.10.2 The HDX-MS workflow 
Advances in the understanding of HDX and its utility as a conformational reporter of 
proteins has led to the emergence of several different HDX-MS methods, such as 
those that can derive binding affinities (e.g. PLIMSTEX n ) and monitor protein 
                                                        
n PLIMSTEX: Protein-ligand interactions by mass spectrometry, titration and HDX 
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unfolding events (e.g. SUPREXo). PLIMSTEX experiments incorporate ligand titration 
methods into the HDX workflow in order to generate binding curves from which 
affinity values can be mathematically extracted67. SUPREX on the other hand 
performs HDX in the presence of varying concentrations of denaturants and so 
captures conformational information along the protein’s unfolding pathway67. The 
most commonly applied HDX-MS routine, however, remains the use of HDX in time-
resolved experiments for monitoring binding events and changes in protein 
conformation. The following section will outline various key steps of the HDX-MS 
workflow. 
 
Figure 1.15. Workflow of HDX-MS kinetics experiments. (a) A protein of interest is incubated in 
deuterium-containing buffer for a series of timepoints. A non-deuterated t0 timepoint is also 
processed to provide a reference mass. (b) Exchange is quenched by increasing the acidity of the 
mixture and dropping its temperature to 0˚C. (c) The deuterated protein is digested to the 
peptide level and input into an LC-MS/MS workflow to acquire m/z and fragmentation spectra for 
each peptide. The identity of each t0 peptide is determined through a database search. (d) The 
mass of each peptide at different t is compared to t0 to determine the mass shift as a result of 
deuterium uptake. (e) Deuterium uptake as a function of time can be displayed for each peptide 
in kinetics plots. (f) Deuterium uptake for all peptides can be displayed via a number of different 
global plots.  
 
                                                        
o SUPREX: Stability of unpurified proteins from rates of HDX 
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In time-resolved HDX-MS experiments, a protein of interest is exposed to a 
deuterium-rich buffer at physiological pH, for a series of deuteration timepoints 
(Figure 1.15a). A non-deuterated sample is set up in parallel and subjected to the 
same workflow to serve as a reference state representing deuteration at . Under 
physiological pH, the half-life of exchange as demonstrated earlier by Bai et al. is 
approximately on the order of seconds66. The timepoints selected are typically 
spaced out such that they sample the level of deuteration from seconds to hours or 
even days. Long timepoints serve the utility of representing the fully deuterated state 
and can also be used for back-exchange correction, explained later n this thesis. The 
effect of temperature and pH on the intrinsic exchange rate of amides can be taken 
advantage of in order to halt exchange. To prevent further exchange, a quench buffer 
is injected into the labelling solution in order to rapidly drop the mixture to a pH of 
2 and 4˚C (Figure 1.15b). Under these conditions, the half-life of exchange increases 
to between approximately tens of minutes to hours68. While exchange is slowed 
under quench conditions, a degree of “back-exchange” (in which N-D is exchanged 
with N-H) can occur, leading to a loss of the deuteration signal69. The degree of back-
exchange is both dependent on the residue and on the post-labelling experimental 
set up. Quench conditions also typically include the addition of chaotropic agents 
such as urea or guanidine hydrochloride and reducing agents such as dithiothreitol 
(DTT) which promotes protein unfolding and reduction of any disulphide bonds 
which may prevent efficient digestion in the next step. 
Following quench, the protein mixture is subjected to an LC method which performs 
digestion to the peptide level and separation prior to ESI (Figure 1.15c). Digestion 
involves injection of the quenched sample into a chromatographic column 
containing a matrix of immobilised proteases. To minimize back exchange, it is 
necessary to maintain quench conditions during digestion and thus the protease 
employed must be active under these conditions. Another criteria of the protease is 
that its digestion must be non-specific since the spatial resolution of HDX relies on 
overlapping peptides. A commonly used enzyme for this purpose is pepsin, however 
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greater enzymatic efficiency has been observed from alternative enzymes including 
nepenthesin from the Nepenthes genus70 and the use of multiple chained enzymatic 
columns has also been explored71. Elution from the enzymatic column proceeds 
with injection into a trapping column and reverse phase UPLC for peptide 
separation, followed by ESI into the MS. Within the mass spectrometer, peptides are 
subjected to MS/MS in a similar manner as that described for the XL-MS workflow. 
The m/z and fragmentation spectra for each peptide is collected and can be 
analysed in the next stage. 
1.10.3 Data processing and experimental types 
Data processing methods following spectral acquisition depend on the 
instrumentation used, and a number of different software have been developed for 
the purpose of streamlining HDX-MS data processing. For the Waters Synapt line of 
HDX-MS instruments, data processing is performed in two stages: first, a proteomics 
database search using the ProteinLynx Global Server (PLGS) which identifies and 
generates a list of observed peptides based on m/z and fragmentation spectra; 
second, peptide mass assignment using DynamX which provides facilities for 
automated and manual evaluation of  spectra. The role of data processing software 
such as PLGS and DynamX is to allow extraction of peptide mass information 
following deuteration as a function of time (Figure 1.15d). The mass of each 
deuterated peptide is compared with the mass of the non-deuterated reference in 
order to determine the mass shift associated with deuteration. HDX-MS data 
processing software will be covered in much greater detail in Chapter 3: of this thesis. 






Chapter 2: Developing a workflow for modelling protein 
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A mass-spectrometry-based modelling workflow for 
accurate prediction of IgG antibody conformations in 
the gas phase 
 
2.1 Abstract 
Immunoglobulins are biomolecules involved in defence against foreign substances. 
Flexibility is key to their functional properties in relation to antigen binding and 
receptor interactions. Here we develop an integrative strategy combining ion 
mobility mass spectrometry (IM-MS) with molecular modelling to study the 
conformational dynamics of human IgG antibodies. Predictive models of all four 
human IgG subclasses were assembled and their dynamics sampled in the transition 
from extended to collapsed state during IM-MS. Our data imply that this collapse of 
IgG antibodies is related to their intrinsic structural features, including Fab arm 
flexibility, collapse towards the Fc region, and the length of their hinge regions. The 
workflow presented here provides for the first time an accurate structural 
representation in good agreement with the observed collision cross section for these 
flexible IgG molecules. These results have implications for studying other non-
globular flexible proteins. 
  






Immunoglobulins (Ig), or antibodies, are the proteins responsible for mediating an 
extensive network of immunological responses. The past decades have seen a 
steady increase of interest in developing Igs as biotherapeutic agents for the 
treatment of various diseases, including cancer and autoimmune disorders72-74. 
While the architectures of Igs are relatively conserved, they exhibit dramatic 
differences in their dynamics and mode of interactions with antigens and cognate 
receptors75,76. These differences stem from intrinsic features in their structures such 
as binding site specificity and hinge flexibility (Figure 2.1a)77. 
 
Figure 2.1. Schematics and workflow for modelling antibody flexibility. (a) Schematic 
representation of human IgG1-4 subclasses. (b) Representative structure of IgG1, denoting hinge 
substructure and modes of Fab movement stemming from the upper hinge. (c) Integrative 
workflow generating and comparing the calculated CCS values of initial, post-sampling and gas 
phase MD models with experimental CCS values. 
There are five isotypes or classes of Igs, the most abundant of which in humans is Ig 
gamma (IgG), comprising approximately 75% of all human antibodies in serum78. IgG 
is by far the most commonly exploited isotype for biotherapeutics73, including, 
bispecific antibodies79,80 and antibody-drug conjugates (ADCs)81-83. In 2017, 10 new 
antibody therapeutics were approved, all of which were IgG based84. There are four 
subclasses of human IgG, named IgG1-4 (Figure 2.1a). While IgG1, 2 and 4 are similar 
in topology, overall length and hinge length, IgG3 has a markedly longer hinge, 




producing a molecule much longer than the other subclasses85,86. IgG molecules 
exhibit a high degree of heterogeneity due to their extensive glycosylation, and also 
sequence variability in their antigen binding regions. All IgG molecules consist of two 
heavy chains and two light chains that are covalently linked via disulphide bridges 
in a characteristic "Y" shaped topology (Figure 2.1b). A central hinge separates two 
Fab "arms" from the Fc "stem" of the IgG molecule. This hinge plays a pivotal role in 
providing IgG molecules with flexibility, allowing relative Fab-Fab and Fab-Fc 
movements87. The hinge and Fc region play an important role in binding immune 
effector proteins including, the Fc gamma receptors (FcγR), neonatal Fc receptor 
(FcRn) and complement component C1q86 (Supplementary Figure 6.1). The ability 
for all IgG subclasses except IgG4 to trigger the complement cascade via C1q88, for 
example, illustrates that the intrinsic structure and dynamics of these molecules 
have functional consequences for each of the IgG subclasses. 
Native mass spectrometry (MS) has recently emerged as a powerful method for 
interrogating proteins and their complexes, providing valuable information about 
their stoichiometry and topology9,89-95. Native MS can be hyphenated with IM; the 
resulting ion mobility (IM)-MS method offers an extra dimension enabling shape 
information on the investigated proteins. IM-MS allows for derivation of topological 
information of proteins through calculating their collisional cross section (CCS). CCS 
is described as the rotationally-averaged cross section of a molecule and is 
calculated based on the overall size and molecular architecture15. The 
experimentally measured CCS can be compared to theoretical CCS calculated from 
structural models derived by molecular dynamics (MD) simulations or other 
modelling techniques23,96, enabling structures to be assigned back to experimental 
observations97.  
Native MS mainly uses electrospray ionisation (ESI) for the purpose of creating 
multiply charged protein ions98. The response of folded proteins entering the gas 
phase through ESI is most commonly described through the charged residue model 
(CRM)2,5,99. The CRM envisions gradual droplet desolvation leading to production of 




a dry protein ion. While the behaviour of a globular protein transferring into the gas 
phase of a mass spectrometer can be rationalised under the CRM framework, here 
we pose the following question: do these same rules apply to non-globular and 
flexible proteins? Early studies which compared the experimental CCS of antibodies 
to those calculated from their crystal structures, observed a >30% discrepancy 
between these CCS values28,29, suggesting collapse of the protein in the gas phase. 
Such collapse is experienced by non-globular molecules that are intrinsically flexible 
or disordered in solution and are capable of conformational change21,30,100,101. Whilst 
others have explored simulating such collapsing structures100, these call for 
computationally complicated methods such as "trajectory stitching"42 or including 
mobile proton algorithms44,102, which may be impractical for large molecules. Here, 
we have developed an integrative IM-MS-based strategy which enables the 
prediction of the structure and dynamics of IgG molecules in the gas phase 
including, for the first time, capturing and simulating the dynamics of human IgG3 
(Figure 2.1a-c). In the first step, homology models of the antibodies were built and 
subsequently subjected to Fab arm sampling allowing representation of their 
intrinsic flexibility as a conformational ensemble. Simultaneously, we subjected 
IgG1-4 to IM-MS experiments and derived their corresponding CCS values. The most 
compact conformations were taken forward for vacuum MD simulations in order to 
model the gas phase structure of IgG molecules.  
  





2.3 Materials and Methods 
2.3.1 Sample Preparation 
IgG1, IgG2, IgG3 and IgG4 (kappa from human myeloma plasma) were purchased 
from Sigma-Aldrich at a concentration of 1 mg mL-1. Lyophilised intact mAb mass 
check standard was purchased from Waters. Herceptin was purchased from the 
Churchill Hospital Pharmacy, University of Oxford. The proteins were buffer 
exchanged into 150 mM ammonium acetate pH 7 using Micro Bio-Spin columns 
(Bio-Rad) prior to running on the mass spectrometer. Transthyretin (TTR; 56 kDa), 
alcohol dehydrogenase (ADH; 148 kDa) and glutamate dehydrogenase (GDH; 336 
kDa) were used as CCS calibrants and were buffer exchanged using the same 
procedure as above. The glycans were removed for the deglycosylation experiments 
with PNGase F (New England BioLabs) for 4 hours at 37 °C. 
2.3.2 Ion Mobility 
A commercial qTOF-TWIMS instrument (Synapt G2-Si, Waters) was used with a nano-
ESI source. The instrument was run with positive polarity in sensitivity mode and 
calibrated with caesium iodide. Capillaries were pulled in-house with a 
Flaming/Brown P-97 micropipette puller (Sutter Instruments) and coated with Au:Pd 
(80:20) using a sputter coater (Quorum Q150RS). The following mass spectrometer 
settings were used: capillary voltage 1.3-1.8 kV, sample cone 50 V, source 
temperature 45 °C, trap pressure 3.6x10-2 mbar, drift tube pressure 2.6 mbar, TOF 
pressure 1.0x10-6 mbar, IM-MS wave height 40 V, m/z range 500-12000, cone gas 0 L 
hr-1. Nitrogen was used as the ion mobility gas and drift times were collected at IM-
MS wave velocities of 550, 600 and 640 ms-1.  
The resulting data was processed using MassLynx V4.1 (Waters Corp. Manchester, 
UK) and PULSAR18 which contains literature values for the CCS calibrants103. CCSexp of 




TTR, ADH and GDH were used to generate calibration curves (for each T-wave 
velocity) to which the IgG1-4 data points were fitted (R2 = 0.985-0.989). Final CCSexp 
for each IgG1-4 were taken from the lowest charge state species. All CCSexp values 
were converted to CCSHe in PULSAR. 
2.3.3 High-Resolution Native Mass Spectrometry 
A Thermo Q-Exactive mass spectrometer (Thermo Fisher Scientific) modified for 
detection of high molecular weight ions was used for IgG1 glycosylation analysis. 
Data was obtained in positive ion mode with an acquisition window of 1000 to 15000 
m/z. Ions were desolvated in the HCD cell with 100 V. Additional settings were as 
follows: capillary voltage = 0.8-1.0 kV; source temperature = 60°C; max injection time 
= 100 ms; S-lens RF = 150; resolution = 17500. Spectra were obtained with 10 
microscans, averaged over 50 scans. Data was processed using XCalibur 2.1 software 
(Thermo Fisher Scientific, Germany) and glycoforms were assigned manually. 
2.3.4 Generating initial models of IgG1, IgG2 and IgG4 
All homology modelling was performed using MODELLER104. IgG1 (UniProt 
accession: P01834 and P01857) was modelled using PDBs 1HZH (human) and 1IGY 
(mouse) as template. The Fab of 1HZH (chains B and D) missing covalent connection 
to the rest of the molecule, was extracted and aligned to the Fab of 1IGY in order to 
recover an extended solution-like conformation of IgG1. The structure of IgG2 (AN: 
P01834 and P01859) was modelled using PDB 1IGT (mouse; whole molecule), 4L4J 
(human; Fc) and 2QSC (human; Fabs). Two additional disulphides were inserted into 
the hinge to generate a representative model of human IgG2. 200 models of each 
IgG1 and IgG2 were generated and evaluated based on their discrete optimised 
protein energy (DOPE) score105. Missing residues of the human IgG4 crystal structure 
were re-generated automatically in MODELLER using PDB 5DK3 (human) as 
template. Glycans structures were not modelled into any of the IgG molecules for 
two reasons. Firstly, each IgG exhibits numerous glycoforms which dramatically 




increases the number of starting models of our study, both for the Fab arm sampling 
and gas phase simulation sections. Secondly, deglycosylation of IgG molecules 
results in no significant difference in experimental CCS. These observations have led 
us to believe that the added complexity of including glycan structures does not offer 
significant benefits to our modelling workflow. 
2.3.5 Homology modelling of IgG3 
For IgG3 which lacks most structural representation, we acquired fragments of the 
structure from PDBs 4HAF (human; Fc) and, 4HDI and 1CLZ (mouse; Fab) and 
manually built the hinge structure using 11 CYS-CYS pairs interspersed with six tri-
proline helices. All other hinge residues were automatically added with MODELLER. 
Glycans were not modelled for IgG3, as described in the homology modelling 
procedure of IgG1, 2 and 4. The IgG3 model was then subjected to 100 ns of explicit 
solvent molecular dynamics simulation in GROMACS 5.1.3106 with the CHARMM27 
(modified CHARMM22 for proteins) forcefield107. The atomistic homology model of 
IgG3 was added to a triclinic simulation box (178 x 169 x 252 Å) with an edge buffer 
of 10 Å to account for flexibility and prevent interactions with periodic images. 
Disulphide bonds were manually checked to ensure correct bonding. 243,611 TIP3 
waters and 2 chloride counterions were added to neutralise the system charge. We 
then performed energy minimisation using a steepest-descent algorithm, followed 
by equilibration in isochoric-isothermal (300 K, τ = 0.1 ps) and isobaric-isothermal 
(1.0 bar, τ = 2.0 ps) ensembles for 1 ns each. Equilibration employed the "V-rescale" 
modified Berendsen thermostat and Parrinello-Rahman barostats. The LINCS 
algorithm was employed to restrain bonds. Finally, production simulation of the 
system was continued for 100 ns at constant temperature and pressure. For non-
covalent interactions, we utilised particle mesh Ewald (PME) with a grid spacing of 
0.16 nm for long-range electrostatic interactions, and the Verlet cut-off scheme for 
Van der Waal calculations. The RMSD evolution of the simulation was monitored and 
reviewed after 100 ns of simulation to ensure appropriate convergence of the IgG3 




structure. To extract a single representative model of IgG3, we clustered models 
from the final 50 ns of the simulation and identified centroid model of the major 
conformation.  
2.3.6 Fab arm conformational sampling 
For conformational sampling of each of the IgG1-4 Fab arms, we first identified the 
selection of residues which constituted their upper hinges. For each IgG heavy chain, 
these were, IgG1: D446-T450, IgG2: E437-K439, IgG3: E219-T230, IgG4: E437-P443. The 
conformational space of each upper hinge and its Fab were then sampled using a 
rapidly exploring random tree (RRT) algorithm available from the Integrative 
Modelling Platform (IMP)108. This procedure sets the disulphide top-most disulphide 
of each hinge as the tree root and randomly tests availability for each node 
(connected atom) to rotate to a new position which is also permissible by the 
residue's torsional space. Conformations which do not result in steric clashing or 
overlap are exported as a structure within the ensemble. Both Fab arms are sampled 
simultaneously with 10,000 models being generated in total for each IgG1-4.  
2.3.7 Gas phase molecular dynamics simulations of IgG1-4 
Each of the lowest CCS conformations of IgG1-4, including two models selected from 
the pool of lowest 50 CCS models, were subjected to gas phase molecular dynamics 
simulations using GROMACS 5.1.3106. Since there is no method of determining the 
experimental charge sites, we pre-charged our IgG models using a localised charge 
model. This model reflects the lowest observed experimental charge state (21+ for 
IgG1, IgG2 and IgG4, 22+ for IgG3). Charges were applied to a randomly selected 
distribution of basic (lysine, histidine and arginine) residues which were found within 
5 Å residue depth of the protein surface, using a combination of the DEPTH server109 
and in-house scripts. Pre-charging was repeated where charges were placed too 
close to each other or prevented the structure from collapsing. We also did not 
consider acidic residues or neutral salt bridges due to there being no method of 




accounting for these interactions experimentally. All acidic residues (aspartate and 
glutamate) remained neutral for our gas phase simulations. Simulations were 
performed using the OPLS forcefield due to the availability of protonated arginine 
topologies. All disulphide bonds were manually checked to ensure correct bonding. 
Energy minimisation was performed for 50,000 iterations using a steepest descent 
minimiser, followed by position restraints for all bonds for 500 ps. Simulations were 
carried out at a temperature of 300 K and regulated using the Berendsen thermostat 
(τ = 0.1 ps). Pressure coupling and periodic boundary conditions were switched off 
due to the in vacuo nature of the simulations. A cut-off scheme of infinite distance 
was used for coulombic and van der Waals interactions. Each model was 
equilibrated briefly at the correct temperature for 1 ns and then for a further 10 ns to 
produce the collapsed topologies. RMSD, radius of gyration and CCS was monitored 
throughout all simulations. 
2.3.8 Gas phase simulations of IgG4 for charge states 22-25+ 
All simulations were carried out as detailed above. Each simulation begins from an 
identical pre-collapsed model of IgG4 (produced by Fab arm sampling). 22, 23, 24 
and 25 charge sites were selected randomly using in house scripts. The charge site 
distributions are different between each simulation. Each simulation was performed 
for a total of 10 ns, and the average CCS and CCS variation over the last 1 ns of 
simulation time was calculated.  
2.3.9 CCS Calculation of Computational Models 
All CCS for IgG structures were calculated as CCSHe using IMPACT software23. CCS were 
calculated through scaling the projection approximation (PA) from IMPACT, by a 
factor of 1.14 to account for PA underestimation. PA measurements from IMPACT 
have been calibrated to values calculated from the trajectory method, with a root 
mean square relative error of less than 1%23. This linear scaling factor of PA has 
shown success with approximating the experimental CCS of large protein 




complexes22. While other direct CCS approximation methods such as exact hard 
sphere scattering (EHSS)26, trajectory method (TM)110 and projection superposition 
approximation (PSA)111 are available, the magnitude of models generated in our 
study (minimum of 50,000), required a high throughput calculation method such as 
IMPACT23. 
  






Due to the flexible nature of IgG molecules, there are currently only four intact IgG 
crystal structures available: IgG1 (human: 1HZH, mouse: 1IGY)112,113, IgG2 (mouse: 
1IGT)114 and most recently, IgG4 (human: 5DK3)115. We modelled human IgG1, 2 and 
4 using the available crystal structures, followed by generation of any missing 
residues. IgG3, however, presented a greater challenge due to its complex hinge 
structure and lack of crystallographic representation. The absence of an IgG3 intact 
crystal structure is likely due to its greater flexibility. We thus built a homology model 
of human IgG3 and subjected it to 100 ns of explicit solvent simulation to model its 
average solution state conformation (Supplementary Figure 6.3). This average 
conformation exhibits a hinge length of approximately 70 Å between the Fab and Fc 
regions, with the fully extended length of the hinge at approximately 110 Å 
(Supplementary Figure 6.4). This is in agreement with an earlier electron microscopy 
study by Roux et al. who observed a distance of 80 ±23 Å between the Fabs and Fc in 
solution, and an estimated 100-110 Å for the length of the extended hinge77, as well 
as with other hydrodynamic and solution X-ray scattering studies116,117. 
 
  




Table 2.1. Experimental and model CCS values for IgG1-4 
Subclass IgG1 IgG2 IgG3 IgG4 
Theoretical mass (kDa)a 150 150 170 150 
Experimental mass (Da)b 149,328 (±89) 154,297 (±42) 162,123 (±4) 155,758 (±62) 
Experimental chargec 21+ 21+ 22+ 21+ 
Overall hinge lengthd 12 12 62 12 
No. hinge disulphides 2 4 11 2 
Upper hinge residues sampled 5 3 12 7 
Initial model CCS (Å2)e 9532 9747 10958 9512 
Fab arm sampling CCS (Å2)f 8756 8597 9170 8484 
ΔCCS of sampling (Å2)g 1102 929 1329 1080 
Collapsed model CCS (Å2)h     
Model 1 7226 (±176) 7396 (±201) 7284 (±173) 7017 (±204) 
Model 2 6988 (±196) 7197 (±184) 7176 (±197) 6766 (±268) 
Model 3 7142 (±176) 7309 (±213) 7588 (±202) 6644 (±179) 
Experimental CCS (Å2)i 6827 (±81) 7030 (±113) 7173 (±68) 7024 (±97) 
Deglycosylated CCS (Å2)j 6851 (±61) 7087 (±56) 7202 (±43) 7095 (±51) 
Net solution chargek 20+ 2- 2+ 2+ 
                                                        
a Approximate mass of glycosylated protein given sequence variability in Fc and Fab regions. 
b Experimentally observed glycosylated mass via MS (± standard deviation). 
c Lowest observed experimental charge for glycosylated proteins. 
d Fc to Fab distances (UniProt: IgG1 P01857, IgG2 P01859, IgG3 P01860, IgG4 P01861). 
e  calculated via IMPACT for starting models. 
f Lowest CCSmodel generated from Fab arm sampling. 
g CCSmodel range of ensemble from Fab arm sampling. 
h CCSmodel for triplicate models after 10 ns of gas phase simulation (± denotes range over final nanosecond). 
i Average CCS for lowest charge over T-waves 550, 600 and 640 ms-1 (±SD) for glycosylated proteins. 
j Average CCS for lowest charge over T-waves 550, 600, and 640 ms-1 (±SD) for deglycosylated proteins. 
k Net solution charge of each IgG molecule as determined via the Protparam webserver. 




We next subjected all four of the human IgG subclasses to IM-MS allowing us to 
quantify their topology through their experimental CCS values (Figure 2.2a, 
Supplementary Figure 6.5-Supplementary Figure 6.6, Table 2.1). Consistent with 
previous studies of human IgG1-428,29, we observed an approximately 30% difference 
between the experimental CCS (CCSexp) and model CCS (CCSmodel; Table 2.1), 
suggesting significant structural collapse. Despite the much longer length of IgG3 
compared to IgG1, 2 and 4, all IgG antibody are equally able to collapse producing a 
CCS of approximately 7000 Å2. We further deglycosylated all antibodies and 
subjected them to IM-MS (Supplementary Figure 6.7-Supplementary Figure 6.8) – 
the resulting CCS showed no significant difference compared to their glycosylated 
counterparts (<1%) (Supplementary Figure 6.9). To further exclude the possibility 
that glycoform heterogeneity influences IgG gas phase conformations, we 
characterised the glycans bound to two additional monoclonal antibodies, 
Herceptin and Waters mAb, and compared their glycoforms to Sigma IgG1 
(Supplementary Figure 6.10). While we identified different N-linked glycans bound 
to the IgG molecules, their corresponding CCS values were found to be within 1%, 
indicating no significant changes in their conformations. 





Figure 2.2. Modelling the conformational flexibility of antibodies. (a) Representative mobilogram 
and native mass spectrum (i) and CCS distributions for 21-23+ charge states of IgG2 (ii). (b) Space 
occupied by IgG1-4 Fabs following upper hinge flexibility sampling. Each sphere represents one 
model for each IgG Fab heavy chain (teal and purple). Light chains are shown as blue. Initial 
models are shown as surface representations. (c) Overlay of experimental CCS distribution with 
triplicate simulated collapse models. Experimental error is represented by the ±6% dotted lines. 
Purple error bars represent the CCS range over the last 1 ns of gas phase simulation. 
The ability of significant compaction is likely provided by IgG hinges imparting the 
steric freedom necessary for the Fab and Fc domains to contort into a compact 
structure. While collapse of IgG structures and other flexible molecules in the gas 
phase have been widely observed, simulating their collapsed structures remains a 




challenge. Previous studies beginning gas phase simulations directly from crystal 
structures of IgG molecules, show >20% discrepancy from their CCSexp values28,29. 
Thus, we hypothesise that IgG molecules may experience pre-collapse prior to 
transfer into the gas phase. 
With the aim of developing a methodology able to simulate the collapse of IgG 
molecules, we designed an in silico workflow for pairing experimental data with 
computational models (Figure 2.1c). In the first step of our modelling workflow, we 
subject each of the four initial IgG models to Fab arm conformational sampling using 
a rapidly exploring random tree algorithm. This sampling technique produces 
randomly varied Fab conformations given the degrees of freedom allowed by the 
antibody’s flexible upper hinge residues. Specifically, the conformations of residues 
between the most N-terminal hinge disulphide bond and the Fab domains are 
explored. Sampling in this way produces a model ensemble of conformations of IgG 
structures which mimic their flexibility in a solution environment. 
Through Fab arm sampling, we generated 10,000 conformations for each IgG and 
calculated the model variation over each ensemble (Figure 2.2b, Table 2.1, 
Supplementary Figure 6.11-Supplementary Figure 6.12). The CCS variation in each 
of the IgG ensembles correlated well with previously reported Fab flexibility (IgG3 > 
IgG1 > IgG4 > IgG2)77,118 and upper hinge lengths. Closer inspection of the 
conformational space occupied by each Fab arm revealed that Fabs of IgG1, 2 and 4 
are restricted to their own hemispheres (Figure 2.2b). The Fabs of IgG3 however, 
share a high degree of overlapping space indicative of their enhanced flexibility 
provided by the longer upper hinge region (Figure 2.2b). 
Our sampling strategy identified conformations of IgG1 which are highly similar to 
those modelled through solution-based small angle X-ray scattering (SAXS)119. A 
recent study also highlighted the ability of Fab arm sampling and clustering analysis 
to deliver solution-relevant antibody conformations120. Within our IgG2 ensemble, 
movement of Fab arms are more confined due to the presence of two extra 




disulphide bonds located in the upper hinge compared to the other short IgG 
molecules (IgG1 and IgG4) (Table 2.1). While Fabs of IgG1, IgG3 and IgG4 are able to 
flex away from their Fc, exposing potential receptor binding sites (Supplementary 
Figure 6.1), this dynamic behaviour is not shared to such a degree by IgG2. It is 
interesting to speculate that this modelling observation may offer insight into why 
experimentally, IgG2 exhibits reduced affinity to some FcγR receptors compared to 
IgG1, 3 and 486,121. 
While Fab arm sampling provides a powerful method of exploring the 
conformational space, it is important to note that this is a pseudo-simulation and 
does not take the energetic landscape of the molecule into account. To provide 
structures relevant to the gas phase environment, we subjected models from each 
ensemble to molecular dynamics (MD) in vacuo (Supplementary Figure 6.13-
Supplementary Figure 6.16). We performed simulations in triplicate by selecting the 
lowest CCS and two low CCS models from each Fab arm sampling ensemble. Each 
model was pre-charged with the lowest observed experimental charge state (Table 
2.1). The models were then simulated in vacuo for 10 ns. All CCSmodel calculated for 
the final simulation frame for each IgG were within approximately 6% of the CCSexp 
values, with the closest match being IgG3 showing 0.1% CCS difference. For each set 
of three simulations, the CCS difference between independent simulations were 
3.8% for IgG1, 1.9% for IgG2, 4.3% for IgG3 and 4.9% for IgG4. We additionally carried 
out simulations of IgG4 for charge states 22-25+ which show agreement with 
experimental values (Supplementary Figure 6.17). To the best of our knowledge, this 
is the first time that the dynamic structures of substantially collapsed IgG molecules 
have been modelled with this level of agreement with experimental values.  
Overlaying the CCSmodel of our collapsed models with the experimental CCS 
distribution showed that each individual simulation occupies a narrow CCS range, 
indicating that collapsed structures are relatively inflexible in the gas phase (Figure 
2.2c). We hypothesise that IgG flexibility in solution leads to a diverse population of 
rigid collapsed structures in the gas phase, resulting in the observed experimental 




CCS distribution. The results of each step of our modelling workflow has been 
summarised in Figure 2.3.  
 
 
Figure 2.3. Summary of experimental and model CCS for IgG1-4. CCS was calculated for each 
stage of the modelling workflow. The reduction in CCS between modelling stages is shown by 
percentages. Error bars for the experimental data points (green) represent the standard deviation 
of measurement. Error bars for simulated collapse models (red) show CCS range over the last 1 
ns of simulation. 
  





2.5 Discussion and Conclusions 
Overall, our modelling workflow has generated collapsed models of IgG1-4 which 
closely match experimental CCS values. The steps undertaken aim to simulate the 
collapse of these molecules in the gas phase whilst staying in line with the current 
consensus of the CRM of folded proteins undergoing ESI. The timeline emerging 
from our workflow envisions that IgG molecules, being flexible in their solution 
environments, are coerced into semi-collapsed conformations by their shrinking 
droplets. This theory is supported by an MD study which saw gradual desolvation of 
ubiquitin, cytochrome c and holo-myoglobin >100 ns trajectories42. While IgG semi-
collapsed conformations are accessible through Fab arm sampling, this procedure 
provides two additional benefits. Firstly, computational timescales can be cut 
significantly as the IgG has already collapsed to mimic a state in which nearly all of 
the solvent molecules have already evaporated from the protein. As a result, our gas 
phase MD simulations converge after a much shorter period of time. Secondly, 
charges cannot be mis-assigned to surfaces of the protein which later form the 
collapsed interfaces (which would prevent collapse). Therefore, we speculate that 
CRM charge transfer occurs concurrently or after partial collapse resulting in charge 
migration from solvent to exposed protein surfaces. This hypothetical model has 
been summarised in Figure 2.4.  
In summary, probing the conformational dynamics of antibodies by IM-MS has led 
to several interesting conclusions due to their intrinsic flexibility. Firstly, the flexibility 
of IgG molecules can be represented through Fab arm sampling and allow 
inferences to be made about their solution dynamics. Building on these solution-
relevant conformations, we theorized that IgG molecules undergo partial collapse in 
solution which eventually leads to their collapsed topologies in the mass 
spectrometer. The ability to model these collapsed structures accurately has 
provided insight into the experimental CCS distribution of these flexible molecules.  




Overall this study highlights the need for a predictive model when interpreting gas 
phase data as non-globular proteins are unlikely to retain their native structures. A 
combination of high throughput IM-MS and molecular modelling may therefore 
provide complementary structural and dynamical information to other biologically 
relevant techniques such as hydrogen deuterium exchange mass spectrometry. 
Such approaches may facilitate invaluable data interpretation which might not be 
possible without structural representations. Ultimately, we anticipate that this 
workflow will be applicable to other flexible proteins currently eluding solution or 
gas phase structural and dynamical characterization. 
 
 
Figure 2.4. Proposed collapse pathway of IgG during ESI. (a) IgG molecules exhibit full flexibility 
in solution. (b) Nanospray ESI produces charged droplets in which IgG molecules retain partial 
flexibility depending on droplet size. (c) Gradual evaporation of droplets coerces flexible IgG 
molecules into more compact topologies. Solvent charges migrate to protein surfaces as they 
become exposed through desolvation (CRM). (d) Dry protein ions are inflexible in vacuum and 
represent a distribution of compact conformations. 
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Chapter 3: Deuteros 2.0: improved software for rapid 




The work presented in this chapter relates to the following article: 
Lau, A. M. C., Ahdash, Z., Martens, C., Politis, A. (2019). Deuteros: software for rapid 
analysis and visualisation of data from differential hydrogen deuterium exchange-mass 
spectrometry. Bioinformatics, btz022, https://doi.org/10.1093/bioinformatics/btz022. 
In early 2019, the first iteration of our Deuteros software was published. Since then, 
the code of Deuteros has been significantly reworked and upgraded in a second 
iteration - Deuteros 2.0. The 2.0 version of Deuteros constitutes a major change in 
both the code, interface and robustness of the data handling methods performed by 
the software. In this chapter, the workflow of Deuteros 2.0 will be described. The 
publication of the original Deuteros can be found in the Appendix. Data of the CSN-
CRL2 complexes can be found in Chapter 4: of this thesis.  
Author contributions 
As first author of the above article, I conceptualised, designed and developed all 
code for Deuteros and Deuteros 2.0. I also led the writing of the manuscript, 
generated all figures, maintain the GitHub repository and coordinated the 
submission of the Deuteros article to Bioinformatics. Miss Zainab Ahdash and Dr 
Chloe Martens either aided in workflow design or contributed data for testing 
purposes. Dr Argyris Politis assisted with software suggestions.   
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3.1.1 The HDX-MS Pipeline 
HDX-MS data analysis begins where acquisition ends. Although data analysis can be 
performed manually, this is a time-consuming process and many pieces of software 
have been developed over the last several decades to streamline this process. Each 
software employs unique algorithms which intake data from HDX-MS and provide 
an output that can be interpreted for biological importance. While each software is 
different in design and their handle of the data, the typical stages of analysis are: 1) 
identification of peptides - generation of a peptide list, 2) extraction of isotopic 
envelopes belonging to each peptide and measurement of masses, 3) data 
visualisation (Figure 3.1).  
 
Figure 3.1. From machine to biology: typical steps of HDX-MS. 
 
The first stage involves the generation of a list of peptides for the protein of study. In 
some HDX-MS workflows, such as that for Waters instrumentation, this list can be 
generated through identification of experimentally observed peptides from LC-
MS/MS, using proteomics platforms such as the Waters ProteinLynx Global Server 
(PLGS). For data collected with other setups or vendors such as the Thermo 
Scientific line of Orbitrap instruments, all-in-one data processing packages such as 
HDX Workbench122 will perform the proteomics database search step within their 
automated pipeline. Other methods have also been developed which do not require 
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pre-established peptide lists such as AUTOHD and HEXICON123,124. These software 
instead use in silico digestion algorithms to generate a list of all possible peptides.  
In the second stage, the clusters of isotopic envelopes belonging to each peptide 
identified in stage one is extracted and the corresponding mass determined. The 
mass of each deuterated peptide is also calculated. Similar to stage one, there are 
various methods of performing this step. Stage three represents a diverse range of 
different stylisations and representations that have been adopted for visualisation 
of HDX-MS data. These range from linear coverage maps that display the peptide 
coverage of the experiment, to two dimensional graphs that display the kinetics of 
each peptide. An optional fourth step is that statistical analysis can be applied to the 
peptide data to yield groups of peptides that behave in the same manner. A range of 
statistical approaches have been adopted for the treatment of HDX-MS peptide data, 
both in the context of single-state and differential comparisons. Conclusions can 
then be drawn about these peptide regions in the context of the biological system. 
In some software specialised for visualisation such as Deuteros, statistically treated 
peptide data can be visualised on molecular structures to further facilitate the 
interpretation of structural changes as a result of an environmental or 
conformational difference.  
3.1.2 Software for HDX-MS data analysis 
Since the advent of HDX-MS, the main bottleneck of the technique was in the speed 
that data could be collected for a set of biological samples. Since then, the 
commercialization of HDX-MS instrumentation and other efforts in enhancing 
automation for HDX, has shifted the rate-limiting step towards data analysis122,123,125. 
In short, data analysis for HDX-MS involves the extraction of peptide-sequence 
specific information from a set of raw MS files. This requires first identifying the 
sequence identity of a peptide, locating its relevant spectra and evaluating the 
peptide isotopic envelopes in order to determine the mass of the peptide. This is 
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repeated for all peptides at all timepoints, for all experimental conditions and 
replicates. Reviewing the peptide mass in the context of the deuterium labelling, 
provides a kinetic assessment of the peptide's behaviour in the folded protein. While 
these steps appear to be straightforward, in practice, data processing for HDX-MS is 
a laborious stage of the workflow, requiring significant manual effort from users to 
extract information from the raw data.  
The typical peptide yield from an HDX-MS experiment is in the order of 102 peptides. 
Considering multiple labelling timepoints, measurement replicates and 
experimental conditions, the number of peptides quickly grows to unmanageable 
levels. For an example of how the number of peptides increases, consider the 14-
subunit, ~500 kDa CSN-CRL2~N8 complex of which we recently characterized 
through HDX-MS. On average, 50 peptides per subunit may be expected from the 
complex. Taking into account four timepoints, technical replicates of  and in a 
differential comparison, results in 16,800 assignments across the dataset. It is 
unsurprising that without assistance from data processing software, HDX-MS of large 
or compositionally heterogeneous systems may be entirely impossible to tackle 
using this method. As a consequence, the last 20 years has seen the development of 
a wide variety of computational methods that can assist with data processing. These 
tools fulfil a myriad of niches, ranging from data processing of raw MS files, statistical 
analysis and data visualisation. These software can be broadly classified as doing 
one or more of the following: a) data extraction, b) statistical analysis, c) data 
visualisation. The release dates, publications and category of each software or 
related methodology is listed below in Table 3.1. The following sections will explore 
some concepts seen across HDX-MS software.  
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Table 3.1. Software for HDX-MS data analysis 
Year of 
Release 
Software Name Developer & Publication Category 
2001 AUTOHD Palmblad et al. 2001 124 Data extraction 
 DXMS Woods & Hamuro, 2001 126 with 
Sierra Analytics (Modesto, US) 
Data extraction 
2006 HX-Express Weis & Engen, 2006 127 Data extraction 
2007 The Deuterator Pascal et al. 2007 128 Data extraction 
2008 TOF2H Nikamanon et al. 2008 129 Data extraction 
2009 HD Desktop Pascal et al. 2009 130 All-in-one 
 Hydra Slysz et al. 2009 125 Data extraction 
2010 MSTools Kavan et al. 2010 131 Data visualisation 
 HeXicon Lou et al. 2010 123 Data extraction 
2011 HDX-analyzer Liu et al. 2011 132 Data extraction and 
statistics 
 ExMS Kan et al. 2011 133 Data extraction 
 DynamX Waters Corporation (Milford, 
US) 
All-in-one 
2012 HDXFinder Miller et al. 2012 134 Data extraction 
 HDX Workbench Pascal et al. 2012 122 All-in-one 
2014 MS Studio Rey et al. 2014 135 All-in-one 
 HeXicon 2 Lindner et al. 2014 136 Data extraction and 
visualisation 
 HDExaminer Sierra Analytics (Modesto, US) All-in-one 
2016 MEMHDX Hourdel et al. 2016 137 Statistics and 
visualisation 
2019 Deuteros Lau et al. 2019 138 Statistics and 
visualisation 
 HDX-Viewer Bouyssie et al. 2019 139 Data visualisation 
DEUTEROS 2.0: IMPROVED SOFTWARE FOR RAPID ANALYSIS AND VISUALISATION OF DATA FROM 
HYDROGEN DEUTERIUM EXCHANGE-MASS SPECTROMETRY 
 
 81 
3.1.3 Methods for determining peptide mass 
The extraction of HDX-MS data consists of the steps necessary to identify the isotopic 
envelope or distribution belonging to a particular peptide, and from this 
distribution, extract features that allow interpretations to be made. The isotopic 
envelope is the "information unit" of HDX-MS data and numerous useful parameters 
can be calculated, such as the mass of the peptide, amount of deuterium 
incorporation and the distribution width. There are two primary methods for 
determining the mass of a peptide from HDX-MS files. These will be explored in the 
following sections. The width of the isotopic envelope is a useful feature that can be 
used as a diagnosis of dynamics within the EX1 or EX2 exchange regimes. It is worth 
mentioning that most if not all of the software listed in Table 3.1 assume that 
residues within each peptide follow EX2 dynamics.  
Determining peptide mass can be done through one of two types of methods: I) via 
determination of the distribution centroid m/z; or II) by fitting a theoretical isotopic 
envelope to the measured data. Using the centroid m/z method, the distribution 
centroid is calculated as the intensity-weighted average of the peaks belonging to 
the isotopic envelope. This, however, typically assumes EX2 exchange (unimodal) 
unless measures are set up to detect the distribution shape. In contrast, the isotopic 
envelope fitting methods first generate a theoretical distribution based on a known 
peptide composition identified earlier through the proteomics stage of the HDX-MS 
workflow. The theoretical distribution is then fitted and minimised to the measured 
distribution via linear regression. The fitting adjusts a component that accounts for 
the shift in mass and change in distribution shape, allowing the level of deuterium 
incorporation to be calculated. Since the shape of the isotopic distribution is an 
important factor for the goodness of fit, this method requires the distribution to be 
resolvable.  
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3.1.4 AUTOHD: mass determination through isotopic envelope fitting method 
The necessity of computational assistance in data processing is visible in the 
timeline of publications detailing software developments for HDX-MS. In 2001, the 
HDX-MS community saw the release of the first data extraction software: AUTOHD 
and DXMS. DXMS, developed by Virgil Woods in collaboration with Sierra Analytics 
(Modesto, US), was offered as a commercial solution126. The early collaboration 
between Woods and Sierra Analytics, would later develop into the HDExaminer all-
in-one platform. AUTOHD developed by Palmblad et al. was the first to apply the 
theoretical fitting method in an automated manner for HDX-MS124. AUTOHD is a 
command-line based software that employs a Fourier deconvolution method for 
generating theoretical isotopic envelopes. The deconvolution method was unique 
in that it recognised that the isotopic envelope of a peptide, can be generated 
through convolution of the individual isotopic envelopes of the constituent 
elements of the peptide. In other words, if the identity of a peptide is known, its 
isotopic envelope is a summary of all of its constituent elements. Calculating the 
isotopic envelope of peptide , involves taking the elementwise product of the 
Fourier transformed ( ) isotopic envelopes for each H, C, N, O and S elements, 
(denoted as  for each element and  is the number of element ) and then the 
inverse Fourier transform ( ) to recover a convoluted distribution for  (3.1): 
  (3.1) 
The most interesting feature of AUTOHD compared to its modern counterparts such 
as Waters DynamX, is that peptide mass determination using this method is 
performed independent of the undeuterated control124. Palmblad et al. recognised 
that in HDX, hydrogens can be divided into two categories: I) those that undergo 
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exchange too quickly or too slowly (i.e. hydrogens of side chains); or II) those that 
undergo measurable HDX (i.e. backbone hydrogens). Since group I hydrogens are 
either in equilibrium with deuterium in the surrounding labelling buffer, or do not 
exchange, their contribution to the calculated isotopic envelope can be accounted 
for through a  term or, are already accounted for by . In 
contrast, the contribution of group II hydrogens - those with measurable deuterium 




Using this method, AUTOHD first generates a list of all possible peptide sequences 
given the experimental enzymatic setup. Using (3.2), a theoretical isotopic envelope 
is generated for each candidate peptide. Through a series of steps, isotopic clusters 
are identified and fitted with the theoretical envelope of each candidate peptide. 
The best fitting theoretical envelope is selected and minimised against the 
measured envelope to derive the level of deuterium incorporation. While this 
method is powerful in its ability to determine the level of deuterium incorporation 
without the need of a reference mass, it is worth noting that this method works well 
for protein sequences in the low molecular weight range (~15 kDa). The accuracy of 
AUTOHD quickly decreases as a function of molecular weight, presumably due to 
the dramatic increase in number of theoretical candidate peptides generated for 
longer sequences124.  
3.1.5 HX-Express: mass determination through the centroid m/z method 
HX-Express was released in 2006 by David Weis and John Engen127. Rather than a 
standalone software package or command-line scripts, HX-Express is a collection of 
macros implemented in Microsoft Excel. HX-Express calculated peptide mass using 
the centroid  method and additionally automated the calculation of the 
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distribution width. Compared to AUTOHD which is executed via the command-line, 
the implementation of HX-Express in Microsoft Excel, while simple, was highly 
accessible to researchers due to both the common occurrence of Microsoft Excel 
and lack of specialised skills necessary to use the program. HX-Express provides 
three notable functions: 1) isotopic peak identification, 2) peak width determination 
and 3) centroid calculation. The algorithm of HX-Express takes as input, spectral 
data and other search parameters used to then search for isotopic clusters within an 
 range. The peak boundaries of a distribution are then determined and peak 
intensities  and  of each member peak , are used to calculate the intensity-
weighted average  using (3.3). Peak widths are calculated at specified 
percentage intensities of the distribution's height (e.g. 20% or 50%) and can be used 




3.1.6 The Pascal series of HDX-MS software 
In 2007, the HDX community would see the beginning of a line of programs that were 
eventually capable of performing data extraction, statistical analysis and data 
visualisation. These were 'The Deuterator', HD Desktop and HDX Workbench 
developed by Bruce Pascal et al. in the lab of Patrick R. Griffin. In 'The Deuterator', 
Pascal et al. emphasised the importance of providing easy access to data 
processing, both by implementing their program as a web-based application and its 
ability to accept input files in the common XML format from a range of high- and low-
resolution MS instrumentation128. 'The Deuterator' uses both centroid  and 
theoretical isotopic envelope fitting methods for determining peptide mass allowing 
for robust high throughput data analysis. A significant drawback, however, was that 
no facilities post-extraction for data analysis, visualisation or any statistical analysis 
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were possible, meaning additional downstream software were still necessary for 
users to gain an understanding of their data. These areas of disadvantage were 
resolved when Pascal et al. released HD Desktop two years later in 2009, as the 
successor to 'The Deuterator' (albeit with a less catchy name)130. The theme of 
software accessibility was also inherited, implementing HD Desktop as an online 
web server and allowing data input from multiple instrumental sources. HD Desktop 
also represents a significant improvement on 'The Deuterator', with means of 
performing a myriad of data visualisation operations. Both single-state and multi-
state experimental setups were possible, as were statistical analysis of the ensemble 
data. Finally, the output data could be represented on molecular structures through 
the use of Jmola.  
HD Desktop was the answer of Pascal et al. to provide an all-in-one automated 
solution for data processing. The implementation of HD Desktop as a web server, 
increases accessibility to the software as it requires no local installation or any other 
software dependencies. Uploading data to a remote server, however, may be off-
putting to some users who wish for their data to remain confidential. Pascal et al. 
addresses this issue with HDX Workbench, the third and latest iteration of their 
software line122. Released in 2012, HDX Workbench builds on the authors' five years 
of experience in handling and developing HDX-MS software. Pascal et al. rationalise 
that due to advances both in processing methods and computational power, there 
is no longer a need for data analysis to be performed using specialised servers122. As 
such, rather than being implemented as a web server, HDX Workbench is now 
installed either on a local computer or server, allowing greater file sharing capability 
between small groups of users. Another significant change is that raw files can be 
directly input into HDX Workbench as the MSFileReader library from Thermo 
Scientific is included. This, however, also reflects that at the time of release, only the 
                                                        
a http://www.jmol.org/ 
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Thermo Scientific line of MS instrumentation is supported. The typical workflow for 
data analysis using HDX Workbench is shown in Figure 3.2. 
 
Figure 3.2. Data processing workflow of HDX Workbench. Adapted from Pascal et al. 2012 122. 
 
The hallmark of HDX Workbench is in its ability to analyse, organise and visualise 
large sets of HDX-MS data, directly from the raw input files. Data can be visualised in 
one of several styles, including coverage and heat maps which provide an overview 
of experimental coverage and deuteration levels of the entire dataset. The 
'Experiment Comparison Tool' is an interface that displays HDX information as a 
function of experimental conditions and provides statistical assistance of datasets. 
Comparisons can be made between both sets of replicate data and between 
experimental conditions. For comparing replicate data, Pascal et al. employ analysis 
of variance (ANOVA) analysis to determine if the mean deuterium uptake over the 
replicate sets are significantly different. If a difference is found, a t-test is applied to 
quantify the significance through its P-value. Comparisons of experimental states 
instead employ a t-test for determining statistical significance. Results can then be 
visualised using a number of different tools including projection onto 3D model 
structures. The processed data is also archived for the user and can be reviewed at 
a later stage without the need for the software. Overall, the software line developed 
by Pascal et al. are a well thought out series of programs that addresses many 
bottlenecks and inconveniences of HDX-MS data analysis. 
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3.1.7 MS Studio 
In 2014, the Schreimer group released MS Studio as another alternative data analysis 
package for HDX-MS135. Like the Pascal et al. software, MS Studio was a reimagined 
and redesigned all-in-one package stemming from another software that the 
Schreimer group released in 2009 - Hydra125. While Hydra was specialised designed 
to perform for statistical analysis specifically from HDX-MS, the MS Studio has 
expanded to perform data analysis for an umbrella of different MS labelling 
techniques. The inputs and outputs of HDX Workbench and MS Studio are similar - 
the user provides raw data files directly to the software, isotopic clusters are 
automatically identified, extracted and analysed, deuterium uptake determined, 
and data visualised. Masses are determined via the centroid m/z method; however, 
the studio also possesses an advanced interface that allows users to manually 
curate the isotopic envelope and select peaks that belong to the distribution. MS 
Studio employs t-tests and P-value filtering to identify peptides which show 
statistically significant differences in differential HDX-MS. The peptide ensemble and 
the statistical significance of each peptide is visualised via a specialised plot, named 
the 'Woods' plot as homage to the late Virgil Woods who was one of the first pioneers 
of automated HDX-MS. The Woods plot displays the residue number against 
ΔDeuterium uptake for each peptide, where the length of each peptide corresponds 
to the length of the bar. A statistical filter can then be applied to the data to identify 
significant peptides. Those with positive ΔDeuterium uptake, i.e. become 
'deprotected' or 'destabilised' as a result of a change in the environment, are 
coloured red, while the opposite is coloured blue. This style of identifying potentially 
interesting peptides through applying statistical methods to peptide ensembles was 
also demonstrated by Houde, Berkowitz and Engen earlier in 2011140. Houde et al. 
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utilised a similar 'mirror' plot which was analogous to the Woods plot but used a 
numerically ordered peptide index in place of residue number (Figure 3.3). Applying 
a global statistical filter to the data, provided a convenient method of quickly 
identifying peptides of potential interest.  
A major feature of the studio is its integration with HADDOCK which allows for the 
modelling of protein-protein and protein-ligand interfaces using the statistically 
relevant peptide data from HDX-MS135. This feature makes MS Studio unique in the 
all-in-one category of software since it is the only one that includes model building 
activities. MS Studio identifies a set of residues statistically determined via HDX-MS 
to be involved in interactions between proteins and other proteins or their ligands. 
These residues are passed to the HADDOCK server which performs the in silico 
docking. One HADDOCK run is performed for each residue identified and the results 
are clustered to identify possible conformations of the interaction.  
3.1.8 DynamX 
Packaged alongside its line of Synapt QTOF HDX-MS instrumentation, the Waters 
Corporation (Milford, US) released the DynamX software as an all-in-one to 
complement data analysis from HDX-MS. DynamX is the only software in the all-in-
one category to be developed and released by an MS vendor, and is designed to be 
used together with another Waters developed software. A major limitation of 
DynamX is that it is vendor specific to only Waters instruments. The ProteinLynx 
Global Server (PLGS) is a proteomics platform used to identify peptides from LC-
MS/MS data and unpacking this data for input into DynamX. In the first step of data 
analysis, 'ion-accounting' files containing a list of peptides identified through PLGS 
are input into DynamX along with the raw HDX-MS files for both undeuterated and 
deuterated reference files.  
 
DEUTEROS 2.0: IMPROVED SOFTWARE FOR RAPID ANALYSIS AND VISUALISATION OF DATA FROM 




Figure 3.3. Representation styles for differential HDX-MS from DynamX software. (a) Butterfly plot 
from Waters DynamX. States A and B are shown on the top and bottom halves of the plot, 
mirrored along . Each point on the plot is a single peptide. Orange, teal and black 
represent different timepoints. The grey trace along  represents the ‘error band’ from 
DynamX. (b) Difference plot from Waters DynamX. Data shown is identical to (a). The grey bars 
represent the sum of differences over all timepoints. Both plots have been edited using Adobe 
Illustrator to increase legibility.  
The peptide ensemble is then filtered for reproducibility and used to populate a list 
of peptides in the software's main interface. For each peptide, DynamX identifies an 
m/z range that the isotopic envelope can be found in. The software offers a 
streamlined interface for the manual curation of peak assignments, allowing users 
to check and amend incorrect assignments if necessary. There are no statistics 
available. Post assignment, the data can be visualised in several methods, including 
kinetic plots for individual peptides, coverage and heat maps and 'butterfly' and 
'difference' plots (Figure 3.3). The software also provides the option to output 
peptide uptake data to molecular structures using PyMOL. The name 'butterfly' 
derives from the appearance of the plot being similar to the symmetric wing profile 
of a butterfly when two plots are simultaneously shown as in the multi-state format. 
The difference plot is a condensed plot format that calculates the difference 
between peptides shown in the butterfly plot. A useful feature of these plots is their 
inclusion of replicate standard deviation within the plots in the form of a grey 
silhouette along y=0. 
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MEMHDX developed by Hourdel et al. in 2016, is a standalone software for analysis 
of differential HDX-MS137. While MEMHDX is not an all-in-one software, its features are 
heavily geared towards statistical analysis. Unique to MEMHDX, is that Hourdel et al., 
acknowledge that the currently seen statistical methods in HDX-MS data are only 
carried out at certain acquisition timepoints rather than holistically. MEMHDX uses a 
'Mixed-Effects Model' in which variation over replicate datasets are treated as 
random effects, while also account for time dependency of the measurements. The 
focus of MEMHDX is on differential comparison of experimental states. For each 
peptide comparison, MEMHDX calculates two P-values: P-value of the 'magnitude of 
ΔDeuterium uptake' and P-value of the change in dynamics. The P-values of each 
peptide comparison used to cluster peptides into groups showing similar uptake 
kinetics. Results are displayed in a 'Logit plot' which plots the P-value of ΔDeuterium 
uptake against the P-value of change in dynamics (Figure 3.4). Interestingly, 
MEMHDX determines peptide dynamics to be in one of four categories for each 
differential comparison: those that experience upon ligand binding 1) increased 
dynamics, 2) decreased dynamics, 3) no change in dynamics and 4) increased 
dynamics in both states. These groups of peptides are coloured in red, blue, grey 
and green in the Logit plot respectively.  
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Figure 3.4. Example of outputs styles from differential HDX-MS using MEMHDX. Data shown are 
for the comparison of the apo CyaA toxin and when bound to a ligand. (A) Logit plot displaying 
P-value of change in dynamics against P-value of magnitude of ΔDeuterium uptake is shown for 
peptide comparison. Colours indicate clusters of peptides that exhibit similar behaviour. 
Red/blue peptides show increased dynamics in the holo or apo states respectively. Grey/green 
are peptides which show dynamics in either both states and no dynamics respectively. (B) Global 
visualisation plot allows users to visualise the kinetics of deuterium uptake. Top and middle 
panel show the relative fractional uptake of peptides in apo and holo states. Bottom panel shows 
a differential comparison of the two. (C) Structural representation of results. Cyan and red 
colouration indicate regions of dynamics and no dynamics upon binding of the ligand. Taken 
from MEMHDX website at http://memhdx.c3bi.pasteur.fr/). 
3.1.10 Next steps in HDX-MS data analysis 
As seen in the above sections, many software have been developed for the analysis 
HDX-MS data. These software range from those that perform single steps in the data 
analysis workflow, such as extraction of isotopic envelopes (e.g. AUTOHD), or 
statistics (e.g. MEMHDX), while others aim for true automation of the workflow 
through all-in-one packages (e.g. HDX Workbench, MS Studio, DynamX). The 
flexibility of recent all-in-one software to support vendor or instrumentation-
independent data processing, has also vastly improved the accessibility of HDX-MS 
to researchers. These advances in software developments have led some in the 
community to believe that data analysis is no longer the bottleneck of the 
technique122. Downstream to data analysis, however, is the issue of data 
interpretation and whether or not this is meaningful. Although data can be acquired 
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and processed in a semi-high throughput manner, the appropriate interpretation of 
HDX-MS data is still paramount to gaining correct biological insights into the system 
of study. The increase in acquisition and processing efficiency has also been 
accompanied by an increase in the complexity of systems being studied, such as 
membrane protein systems141,142, intrinsically disordered proteins143 and 
macromolecular complexes135,144,145. The current statistical methods employed in 
HDX-MS are also used only as data filters for qualitatively clustering peptides into 
categories (e.g. deprotected, protected or no change), meaning that both the rate of 
change and magnitude of deuterium uptake difference are effectively ignored once 
the filtering threshold is crossed. In other words, current methods lack the ability to 
fully extract the information that HDX-MS offers. 
In summary, although current software developed over the last few decades have 
been indispensable for streamlining HDX-MS data analysis, future software must be 
able to provide accurate and meaningful methods of interpreting HDX results in the 
context of protein dynamics. This should be done in relation to both single-state and 
differential modes of HDX-MS. In the following sections of this thesis, we will 
showcase the development of our HDX-MS visualisation software Deuteros, as well 
as the significant increases in software features following the first publication of the 
software. 
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3.2 Aims & Objectives 
In this chapter, we aim to develop a data analysis and visualisation software that is 
capable of supporting interpretation of HDX-MS data. While this role is already 
served by many existing software, we find that there are incompatibilities between 
these, such as HDX Workbench, and Waters-based HDX-MS instrumentation (Synapt 
G2-Si with DynamX). Moreover, our in-house HDX-MS setup relies on the use of PLGS 
for peptide identification and DynamX for mass assignment, effectively dismissing 
the use of other all-in-one solutions such as MS Studio. A combination of these 
circumstances means that the simplest way of supplementing our current set up 
without drastically redesigning our HDX-MS workflow, is the addition of statistical 
analysis and visualisation steps downstream of mass assignment.  
Taking into account these several points, the data analysis software Deuteros was 
developed specifically to address the following aims: 
1. To provide an easy to use platform for statistical analysis and visualisation of 
HDX-MS data 
2. To provide a method of extracting meaningful information from HDX-MS data in 
the context of structural interpretations 
3. To develop a foundation software that can be dynamically adjusted to the 
needs of the evolving HDX-MS field 
4. To keep user interaction to a minimum where unnecessary 
5. Free to use, offline and accessible on most computers 
 
To meet these aims, the following objectives must be completed:  
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Objective 1: Develop a function for reading the output of DynamX with minimal 
manual edited needed 
There are several data output formats offered by DynamX - these will be outlined in 
greater detail in section 3.3. As mentioned before, software such as MEMHDX require 
a degree of manual editing of the DynamX output file prior to data analysis. To 
improve accessibility to data analysis, we will avoid the need for any manual 
intervention through two actions: 1) the output of DynamX will be directly parsed 
into Deuteros. Any data that is not needed, will be simply ignored, rather than 
require they be manually removed. 2) Any required manual labelling, such as the 
number of replicates, will be performed programmatically in Deuteros, rather than 
by the user. Meeting this objective will significantly improve the speed and 
accessibility to data visualisation features offered by the software.  
 
Objective 2: Develop methods of data visualisation, including 2D and 3D 
representations  
There are three categories of visualisation styles:  
1. Simple 2D maps, e.g. coverage and redundancy maps, etc. 
2. Complex 2D maps, e.g. deuterium uptake plots, Butterfly plot, Difference plot, 
Woods plot, Logit plot, etc.  
3. Visualisation on 3D structures, e.g. projection of deuterium uptake on PDB 
structures.  
We will begin by implementing simple 2D maps that show peptide coverage and 
redundancy as these are typically the first types of data visualised. Other complex 2D 
maps such as the Woods plot should be added to provide facilities for performing 
differential HDX-MS analysis. Woods plots can also take advantage of established 
statistical methods for determining the significance of differential uptake140. In turn, 
peptides identified as showing statistically significant deuterium uptake differences 
can be mapped onto protein models using PyMOL.  
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Objective 3: Include the latest recommendations from the HDX-MS community 
Deuteros should include recommended practices detailed in the recent HDX 
community guideline paper146. This involves including automated methods for back 
exchange correction, as well increasing transparency on the quality of HDX-MS 
datasets.  
 
Objective 4: Design an accessible and simple to use graphical user interface 
To meet this objective, we have opted to develop Deuteros using the application 
development suites of MATLAB. There are several reasons for using MATLAB. Firstly, 
the author's programming experience is primarily in the MATLAB language, meaning 
that a simple application can be crafted quickly. MATLAB provides facilities to 
streamline development of the graphical user interfaces (GUI) in two suites: GUIDE 
and Appdesigner. These will be covered in 3.3 Materials and Methods. Finally, 
although MATLAB is not free to use, applications packaged using MATLAB are 
independent and do not require that MATLAB be installed on the system. A 
requirement however is that the MATLAB Runtime library must be installed. The 
library is free to download and install from MathWorksb.  
Applications designed using the MATLAB Appdesigner are visually uncluttered, clear 
and appealing, making it suitable for designing Deuteros. The following sections of 
this thesis chapter will outline the development of Deuteros in the context of 
meeting these aims and objectives. 
  
                                                        
b https://uk.mathworks.com/products/compiler/matlab-runtime.html 
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3.3 Materials and Methods 
3.3.1 Datasets 
All experimental details of the CSN-CRL2 system can be found in Chapter 4 of this 
thesis. HDX-MS data for CSN and CRL2 complexes were collected by Dr Chloé 
Martens.  
3.3.2 Code development in MATLAB 
Deuteros is a standalone MATLAB graphical user interface (GUI) that is available to 
both Mac and Windows operating systems, providing it is capable of installing and 
running the MATLAB runtime library c  (free to download from MathWorks Inc., 
Massachusetts, USA). The first Deuteros program was conceptualised as a 
standalone script that processed data specifically from differential HDX-MS which 
was pre-processed by DynamX software (Waters). Early prototypes of Deuteros 
featured no GUI but principally required two inputs - the so called ‘state’ and 
‘difference’ files which could be exported from DynamX. Along with these files, the 
user would also have to supply the start and end residue numbers to the software. 
In addition to 'state' and 'difference' files, DynamX can further export peptide data in 
its ‘cluster’ format. Given the importance of these file structures, it is worth briefly 
introducing each of the export types and their differences. 
3.3.3 The ‘Cluster’ format 
The ‘cluster’ file is the lowest level of data exported from DynamX. It contains a per-
protein, per-state, per-timepoint, per-replicate and per-charge list of peptides. It 
does not contain deuterium uptake values. The major advantage of the ‘cluster’ 
format is that it retains all datapoints for each replicate observation, allowing more 
                                                        
c https://www.mathworks.com/products/compiler/matlab-runtime.html 
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complex statistical analysis to be performed. There are 15 columns in a ‘cluster’ file 
(Table 3.2). 
 
Table 3.2. Format of the DynamX ‘cluster’ file 
 
Protein refers to the protein identifier used initially in PLGS for peptide search. Start 
and End are the start and end residue numbers of peptide Sequence. Modifications 
and Fragments are shown if found in the PLGS search. MaxUptake is the theoretical 
maximum deuterium uptake of the peptide, calculated by equation (3.4) where  
and  are the total number of residues and prolines in the peptide respectively. 
  (3.4) 
MHP is the mass of the singly charged ion measured in Daltons. State and Exposure 
refer to the state name and exposure time designated by the user in DynamX during 
file import. Filename details the file that the replicate data has been sourced from. 
Typically, this is performed as a technical replicate. z is the charge of each peptide 
— more than one set of charges may be present in the cluster file. RT is the retention 
time of the peptide. Intensity refers to the signal intensity of the peptide. Center 
represents the centroid m/z for the isotopic envelope of the peptide.  
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3.3.4 The ‘State’ format 
The ‘state’ format is the next level upwards from the ‘cluster’ format and contains 
largely the same headings. However replicate data is no longer accessible and have 
been aggregated into a single value along with standard deviations for each set of 
observations. An advantage of the ‘state’ format over ‘cluster’ is that deuterium 
uptake values are readily available to users. The method of calculating the average 
uptakes and standard deviations over the replicate data is also poorly described in 
the DynamX documentation and thus may be prone to errors from manual 
calculation. There are 16 columns in a ‘state’ file (Table 3.3). 
Table 3.3. Format of the DynamX ‘state’ file 
 
Protein, Start, End, Sequence, Modifications, Fragments, MaxUptake, MHP, State and 
Exposure are identical to the ‘cluster’ file. In the ’state’ file, Center, Uptake and RT 
each represent the intensity-weighted mean over all replicate datapoints. The 
deuterium uptake ( ) of peptide  at time  (where ) is calculated by (3.5) and 
(3.6): 
 (3.5) 
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To calculate the intensity-weighted mean Uptake,  for each peptide at each 
timepoint, two matrices are generated: , the  matrix, and , the intensity matrix. 
The DU matrix is calculated by subtracting the  vector, , from each  vector, 
, generating an 𝑛 × 𝑚 matrix (3.7). The intensity matrix is generated as the cross 
product of  and  for the same  as .  
 
(3.7) 
 is then calculated as the sum product of  and , over the sum of  according to 
(3.8). Center and RT are calculated in the same manner. 
 
(3.8) 
The intensity-weighted standard deviation for each replicate set is given in Center 
SD, Uptake SD and RT SD is calculated according to (3.9). 
 
(3.9) 
Where  is the length of  and  is the length of . The method of calculating the 
intensity-weighted standard deviation displayed here is not explicitly given in the 
documentation of DynamX but have been cross-checked with values exported from 
the 'state' file. 
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3.3.5 The ‘Difference’ format 
Finally, the ‘difference’ format is one of the highest-level tabulated formats from 
DynamX. It can only be generated from a DynamX session which has been loaded 
with differential data and is accessed through interactively by copying the data to 
the clipboard via a right-click context menu spawned in the ‘Butterfly Plot’ window 
of DynamX. The plot must also first be switched to show the ‘difference plot’ 
representation in the plot settings menu, before the ‘difference’ data can be copy-
and-pasted into a spreadsheet editor. The difference data contains at least 5 
columns, and one additional column for every non-zero/reference exposure time 
(Table 3.4). 
Table 3.4. Format of the DynamX ‘difference’ file 
 
The ‘difference’ format is a highly simplified version of the ‘state’ file and only 
contains the Sequence, Start, End, Modification and ΔDU for each exposure time, 
between two user-selected states (expressed in Da). While the user can control 
which two states are used to generate the ‘difference’ data, caution should be taken 
to select the two states in the correct order such that the polarity of the difference 
values lead to the intended interpretation. Typically, ΔHDX-MS performs 
comparisons as Δ(variable condition - control condition), and positive changes in 
deuterium uptake are interpreted as deprotective or destabilising changes, and 
negative deuterium uptake differences as protective or stabilising. Additionally, 
since neither the filenames, states, or the comparison direction is recorded in the 
difference file, the 'difference' format is prone to mix-up, which complicates its 
usage. 
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3.3.6 Changes to the design of the original Deuteros 
There are a few notable differences between the original Deuteros138 and Deuteros 
2.0. These will be briefly highlighted here.  
3.3.7 GUIDE vs appdesigner 
The most significant difference between the old Deuteros and Deuteros 2.0 is 
something that is not visible to the user. The original release of Deuteros was 
designed using the MATLAB GUIDE interface which while provided an easy to use and 
accessible method of coding the software for beginners, was limited in its 
programmatic features (Figure 3.5). In Deuteros 2.0, the software has been re-written 
using the MATLAB appdesigner interface which is superior in terms of code editing 
functionality and GUI design (Figure 3.6). The appdesigner is a separate application 
to the MATLAB main window and is a development environment that facilitates the 
production of professional applications by providing developers with easy to use 
tools for designing and planning their software. In practice, the appdesigner is much 
more efficient to write and troubleshoot code due to its all-in-one environment that 
allows both GUI design and coding, while GUIDE only performs the design element 
of the software. 
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Figure 3.5. GUIDE app development interface for Deuteros. (a) The component palette of GUIDE 
allows UI elements (e.g. radio buttons, dropdown menus, axes, etc.) to be 'drag-and-dropped' 
onto (b), the layout editor for designing the Deuteros interface. GUIDE is only for designing the 
GUI and not directly for writing the underlying code.  
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Figure 3.6. appdesigner development interface for Deuteros 2.0. (a) The component library of 
appdesigner operates in a similar manner to GUIDE but offers additional elements for developers. 
Components can also be 'drag-and-dropped' onto (b) the layout editor. The component browser 
(c) lists all UI components and their handles (unique name of the component used for accessing 
its functions, e.g. app.ImportButton refers to the import button on in the data import panel) and 
the panels that they belong to. Unlike GUIDE, appdesigner keeps track of the component list and 
any re-named handles, removing the need to constantly refer back to the code and manually 
update. (d) Appdesigner can be switched between design view and code views using the view 
toggle. 
 
3.3.8 Cluster input 
Firstly, a decision was made to migrate the import function of the new Deuteros 2.0, 
from using 'state' and 'difference' files to using instead the 'cluster' file format. The 
'cluster' file is superior in terms of the information content that it includes, providing 
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a breakdown of data on all proteins, states, timepoints and replicates. Meanwhile, 
the in the old Deuteros, differential uptake values were accessed directly from the 
'difference' file which is both laborious to produce when a dataset contains more 
than one protein and state, contains a highly simplified version of a Δ
 comparison, and lacks any measure of statistical variation across replicates 
used to compose the data. As a result, the 'state' data - a less summarised version of 
the 'difference' file, but more summarised than the 'cluster' format, must be 
provided by the user to compensate for the lack of replicate information. In reality, 
the 'state' file alone can be used to calculate both the differential uptake (essentially 
rendering the 'difference' file useless) and provide statistical information. By 
requiring the user to supply both 'state' and 'difference' files was also cumbersome 
and prone to errors due to the large number of files that a user needed to keep 
organised in a typical dataset. Changing from ‘state’ and ‘difference’ files to ‘cluster’ 
input completes Objective 1: Develop a function for reading the output of DynamX with 
minimal manual edited needed. 
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3.4.1 Deuteros 2.0 overview 
As previously described, a typical HDX-MS experiment, from protein to 
interpretation, consists of four steps. These are 1) sample preparation and data 
acquisition, 2) peptide database search, 3) peptide mass assignment and 4) analysis 
and visualisation. Although not strictly enforced, Deuteros has been designed for 
data exported from Waters DynamX software. Deuteros adds a step 5 to the above 
workflow in that it performs downstream statistical filtering of peptides and 
enhances the repertoire of visualisation methods that is accessible to the user. 
Deuteros was designed with usability in mind and performs many layers of data 
processing behind the scene, to avoid unnecessary complications for the user. As a 
result, the graphical user interface (GUI) is clean and minimalist, and care has been 
taken to minimise the number of mouse clicks that a user needs to transform their 
HDX-MS data into graphical representations. This completes Objective 4: Design an 
accessible and simple to use graphical user interface described in 3.2 Aims & 
Objectives. 
 
To improve accessibility, the application has been packaged into standalone 
software both for Mac and Windows operating systems using the MATLAB Compilerd. 
The MATLAB Compiler generates a Windows Installer executable (.exe) or Mac disk 
image (.dmg) which can be used to install the software as a standalone program. As 
mentioned previously, Deuteros and other MATLAB-coded applications requires the 
MATLAB Runtime Library as a prerequisite. The MATLAB Runtime Library can be 
downloaded free of charge from MathWorks Inc. and is used to run MATLAB 
applications without the need for MATLAB to be installed and a license active.  
                                                        
d https://www.mathworks.com/products/compiler.html 
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Installation of Deuteros is straight forward as there are no other software 
dependencies or options to select during setup.  
3.4.2 Importing data to Deuteros 2.0 
The GUI of Deuteros can be subdivided into several regions (Figure 3.7), in particular, 
the Data Import panel which handles the parsing of the HDX-MS data in the form of 
the 'cluster' file.  
 
Figure 3.7. Deuteros 2.0 GUI. The GUI can be subdivided into five main regions: (a) The Data Import 
UI panel, (b-c) Coverage Plot and Advanced Plot UI panels, (d) Plot Options panel and (e) Export to 
Molecular Graphics options.  
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When a file is provided to Deuteros 2.0 via the Browse button, the program will 
generate a list of proteins and per-protein states which are used to populate the 
Protein, State A, State B and Control dropdown menus (Figure 3.8). There are no limits 
to the number of proteins and states that can be assigned to the dropdown menus. 
By default, the values of State B and Control dropdown menus are set to None, i.e. 
single-state analysis is performed. If multiple states are available, a second state can 
be selected in the State B dropdown to be used for differential analysis. The Control 
dropdown menus can be optionally set to a state housing back-exchange and in-
exchange data which are used for data correction. 
The Browse button has also been programmed to store in memory the path of the 
last file it accessed and to open at this path. To the right of the dropdown menus are 
edit boxes for Deuterium % and the start and end residue numbers. Deuterium % is 
the percentage deuterium content of the labelling buffer used during data 
acquisition. Deuterium % has been set to 100% by default. The value of is Deuterium 
% used to linearly scale the relative fractional uptake of the imported data. The start 
and end residue numbers are needed from the user to determine the length of the 
protein for both experimental coverage calculations and setting axis limits of plots. 
Although the 'cluster' file (which contains the highest level of detail) is used, the user 
must manually provide the length of the protein as this information is not available 
in any of the outputs of DynamX. In reality, there are benefits in designing the residue 
numbers to be input manually. Firstly, this allows a simple level of customisation if 
the user is dealing with a protein construct which does not canonically begin from 
residue 1. Secondly, the user will be made more aware of the length of their protein. 
In our experience, this can lead to the discovery that the user's system has been 
truncated or the incorrect isoform of the sequence has been provided initially to 
PLGS. Finally, this method of inputting the residue numbers is less troublesome than 
requiring the user to supply a FASTA file of their protein of interest, especially as this 
would need to be changed every time the user selects a different protein. Requiring 
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a FASTA file would also not eliminate the need for the user to manually edit their file 
in the case of truncated proteins. 
 
Figure 3.8. Data Import UI panel of Deuteros 2.0. On the left half of the import panel, interactive 
controls of cluster filename, protein, state A, state B dropdown menus, deuterium percentage 
and residue start, and end are found. Control states can also be selected using dropdown menus 
if back-exchange data is available for the selected state. On the right, a summary of the imported 
HDX-MS data for states A and B can be found. Metrics of this summary are those recommended 
by the HDX-MS community.  
After the Data Import form has been completed, the Import button is used to begin 
importing the 'cluster' data into the software. The Import button performs a 
significant number of important processing steps. In the first step, the protein and 
states selected from the dropdown menus by the user are used to filter the 'cluster' 
file so that only the relevant peptides are processed. Next, four different MATLAB 
data tables are generated: 
1. StateA.table - all State A peptides 
2. StateB.table - all State B peptides 
3. Common.table - Common peptides between States A and B 
4. Difference.table - Difference between common peptides of State B - common peptides of 
State A 
The four data tables are necessary due to the different representation styles that 
Deuteros 2.0 generates downstream of data import. StateA.table and StateB.table 
each houses a filtered list of peptides from each state. Unique peptides found in 
each state are preserved. Common.table is a concatenation of StateA.table and 
StateB.table, however only peptides that are common between States A and B are 
preserved. The intersect function (returns data common between two states) is 
additionally employed at the exposure time level to ensure that all exposures for 
each peptide match between the two states. Finally, Difference.table is generated 
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from iterating through a list of peptides and exposures in Common.table, and 
calculating the difference in Uptake between States A and B. The comparison is 
always performed as .  
Each of the four data tables are passed through an aggregate function which is used 
to convert the 'cluster' style data to a 'state' style table. The aggregate function 
calculates the intensity-weighted mean Uptake, RT, Center and corresponding 
standard deviation across all replicates for each peptide at each exposure time. In 




As the 'cluster' file retains all charge states that have been assigned to each peptide 
in DynamX, the aggregate function has been designed to perform an important 
sanitisation step which filters out all but one set of charge states for each peptide. 
This is necessary because mass assignment in DynamX requires users to manually 
inspect and assign the spectral peaks for every protein, state, peptide and timepoint 
within their dataset. It is part of the mass assignment procedure that only one set of 
charge states are assigned for each peptide, meaning that users must also manually 
unassign all other charge states. In practice, many charge states are often 
accidentally left assigned and thus will affect the calculation of deuterium uptake for 
those peptides. This highlights another advantage of accessing the HDX-MS data via 
the 'cluster' format as it preserves all charge states that are even partially assigned, 
allowing these to be filtered out to provide more accurate  and  
measurements. If multiple sets of charge states are found, the aggregate function 
will automatically remove all redundant sets based on their Uptake SD (Figure 3.9). 
Table 3.5 shows the format of cluster data following the aggregation function. In the 
modified cluster table,  the number of replicates that the  is calculated 
from, and  the replicate data are preserved. These values are needed in 
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later stages for statistical analysis of the ensemble and also to allow the user to 
access the underlying data more easily if needed since this is not available by default 
from the Cluster file. 
 
 
Figure 3.9. Flowchart for peptide charge state removal. Decisions, processes and outputs are 
represented by diamonds, rectangles and parallelograms respectively.  
A summary of the charge states found and removed are also printed to the MATLAB 
command window: 
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Peptides that are removed during the data import process are displayed in the 
Removed Data tab table. Peptides are added to this table through two routes, firstly, 
unique peptides and timepoints in State A that are not found in State B and vice 
versa, and those that are removed via the aggregate function. The aggregate 
function transforms the cluster-style data into a state-like format whereby the 
Uptake and UptakeSD values can be easily accessed. Another feature is that the 
centroid mass of the peptide under Center, now represents the mass of the singly 
charged ion. For transparency and also so that errors can be spotted more easily, 
the replicate values for Uptake and RFU can also be found under Uptake_Reps and 
RFU_Reps in the table. Finally, the last column Correction identifies whether the 
Uptake data for the peptide has been back-exchange corrected.  
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Table 3.5. Modified 'cluster' structure from following Import. 
 
To the far right of the Data Import UI panel, a text box has been added which displays 
a summary of the HDX-MS data. In the latest release of Deuteros, Summary and 
Removed Data tabs have been added. The Summary tab displays a list of general 
information for the protein and states selected. This information includes metrics 
which were recommended by a recent community guideline paper146: 
1. HDX time course 
2. HDX controls 
3. Back-exchange (mean / IQR) 
4. Number of peptides 
5. Sequence coverage 
6. Average peptide length/redundancy 
7. Number of replicates (and biological or technical) 
8. Repeatability (average standard deviation over replicates) 
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The motivation for including these metrics is to increase the transparency of data 
used for HDX visualisation and also to shape Deuteros into a software that abides by 
community guidelines. Addition of this feature complexes Objective 3: Include the 
latest recommendations from the HDX-MS community. The data summary box 
displays metrics for State A or both State A and B when available: 
 
The protein and state name are displayed for both States A and B. A breakdown of 
the HDX time course found in the data and any control samples is also detailed. If 
back-exchange data is available and has been enabled for States A and/or B, the 
metric displays the mean back-exchange percentage and interquartile range (IQR). 
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Where  and  are the centroid masses of the fully labelled and un-labelled 
peptide ,  is the theoretical maximum uptake and  is the deuterium fraction 
of the labelling buffer. Both  and  are calculated from a set of control data 
that is optionally supplied to Deuteros. It should be provided as another state in the 
same cluster file which can be selected using the dropdown boxes beside States A 
and B in the data import panel. The format of control data is identical to that of State 
A or B but contains only references and a single timepoint that fully deuterates the 
peptide. The control state is processed identically to State A and B to generate state-
style data.  and  can be found as the Center values for the fully labelled 
timepoint and reference respectively. The HDX-MS community also recognises that 
a degree of HDX can still occur during the quench phase146. However, for most state-
of-the-art HDX-MS setups,  is well approximated using the centroid mass of the 
unlabelled reference146. The back-exchange IQR is simply calculated using the inbuilt 
iqr function of MATLAB. The absolute deuterium uptake  of peptide  can be 
corrected for back-exchange, essentially scaling up the uptake level to approximate 
the full extent of deuterium incorporation. This is performed using equation (3.12). 
  (3.12) 
A few safety features have been programmed with respect to back-exchange 
correction with the aim of increasing awareness of how the user's data has been 
processed by the software. Firstly, should the user select only one state to be back-
exchange corrected, an error dialog box will appear, as this disqualifies the data for 
differential comparisons. Next, should back-exchange not be applied to certain 
peptides, an error dialog box will spawn, indicating the number of non-corrected 
peptides. A list of these peptides can be found in the Table tab of the main interface 
under 'Non-Corrected Data'. The value of the Correction column of the data table will 
additionally remain as 'Not corrected' so that the peptide can be easily identified, 
and the user encouraged to check the input files. Finally, during plotting of any 
graphs, should the data table contain peptides with Correction equal to 'Not 
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corrected', those data points will be highlighted with a yellow border to both allow 
instant identification and also as a cautionary note to the user to not mis-interpret 
the data. This feature is activated by default but can be switched off using a check 
box located under the Advanced Plot Options menu.  
The number of peptides, sequence coverage, average peptide length and redundancy 
can be calculated through straightforward means using the data table for States A 
and B. For the number of replicates, Masson et al. suggest indicating whether a 
biological or technical repeat has been performed. While data from a biological 
repeat can be input into Deuteros by manually concatenating the cluster file while 
keeping all protein identifiers (such as protein name, state names and sequences) 
identical, this is not an intended feature of Deuteros which has been programmed 
to accept technically replicated data. Thus, the replicate metric displays the number 
of technical replicates that are calculated from the input data. Finally, the 
repeatability metric indicates the average standard deviation across technical 
replicates. 
3.4.3 Data visualisation methods 
Since Deuteros is a data visualisation software, these are numerous different styles 
of representations for both single and differential state HDX-MS. Deuteros generates 
eight different styles of plots: 1) coverage map, 2) redundancy map, 3) differential 
Woods plot, 4) single-state Woods plot, 5) multi-state Wood plot, 6) single-state 
butterfly plot, 7) multi-state butterfly plot and 8) the volcano plot. Each flavour of 
plot has been designed to suit the needs to different users and to maximise the 
legibility of data. Each plot also employs statistical analysis which separate peptide 
data into those which show significant uptake differences and those that do not. 
Each of the eight plot types fall into one of the three categories: 1) linear data maps 
(coverage and redundancy), 2) time-resolved plots (Woods and butterfly plots) and 
3) ensemble plots (volcano plot). The inclusion of eight different plot and 
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visualisation types completes the 2D portion of Objective 2: Develop methods of data 
visualisation, including 2D and 3D representations . 
 
3.4.4 Linear data maps: data coverage & redundancy 
The coverage plot is the simplest type of plot that Deuteros generates (Figure 3.10). 
Although simple, the coverage map of Deuteros is easy to read from and is 
immediately publication quality. In addition, the side-by-side comparison of two 
states allow users to immediately identify regions of difference within their data. 
Coverage plots have only an horizontal axis of residue number and uses solid colours 
to represent different data types. The protein length is indicated by the strip of grey, 
and regions of coverage are highlighted in either of the Deuteros theme colours: 
'Shocking Pink' (rgb 0.87, 0.57, 0.74) or 'Jordy Blue' (rgb 0.45, 0.67, 0.84). The protein 
name is shown above the plot, and above each state are the state names, 
percentage coverage and number of peptides for each state.  
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Figure 3.10. Coverage and redundancy linear maps from Deuteros. (a) Coverage map of example 
data indicating coverage of two states and their percentage coverage. (b) Coverage map of the 
common peptides between states A and B. (c) Redundancy map showing per-residue 
redundancy. Colour bar represents the number of redundant peptides covering a particular 
region. The grey bar behind each state represents the length of the protein. 
 
In addition to the coverages of states A and B, the common coverage between the 
two states can also be generated. For differential comparisons, the data is pre-
filtered to include peptides and timepoints which are found in both states. The 
common coverage map is particularly useful as a simple graphic to demonstrate the 
coverage between a set of experiments and identify the regions of redundancy. Next, 
the redundancy plot of Deuteros follows the format of the coverage plot and displays 
not only the coverage, but also the residue-level redundancy of each state using the 
'parula' colourmap of MATLAB. The parula colour theme of MATLAB is a blue-
blue/green/yellow gradient which was selected to maximise the legibility of 
differences between data while also increasing the clarity of the gradient for colour-
blind individuals. When presenting HDX-MS, users should opt for the redundancy 
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plot over the coverage plot due to the extra layer of redundancy information that is 
available. 
Linear data maps are excellent for communicating a large set of data when only 
peptide coverage is concerned, such as assessing the reproducibility between 
experiments, or when used to display a coverage summary of a multi-subunit 
complex. When the redundancy map style is used, these plots are particularly 
information rich for displaying both coverage and redundancy of proteins in a 
simplistic manner (Figure 3.10). We anticipate that users will want full editing control 
over the figures that Deuteros generates, and as such, all exported plots are saved in 
a vector format (e.g. scalable vector graphics, svg, or portable document file, pdf) in 
order to retain access to all plot elements, should editing be necessary. Vector 
images can be edited using a range of software, both free and paid software such as 
Inkscapee or Adobe Illustratorf.  
 
3.4.5 Time-resolved plots: Single and multi-state Woods plot 
The Woods plot is a commonly used style of representing HDX-MS data. Where the 
linear coverage maps collapse the peptide data onto a single one-dimensional axis, 
the Woods plot adds an additional vertical axis which is typically a measure of 
deuterium uptake (Figure 3.11). Both absolute uptake and relative uptake are 
commonly plot. The Woods format also offers qualitative redundancy information 
since overlapping peptide regions can be easily identified. For both single and multi-
state Woods formats, Deuteros applies a standard one-tailed t-test for evaluating the 
statistical significance of peptide uptake for each timepoint. The confidence level 
can be selected using the dropdown menu found under the Advanced Plot Options 
                                                        
e https://inkscape.org/ 
f https://www.adobe.com/uk/products/illustrator.html 
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subpanel. Peptides which show deuterium uptake exceeding that of the confidence 
interval (CI) is coloured in blue, while those which are below are deemed as showing 
no uptake and are in grey. At the top of the plot, is a legend bar which displays the 
confidence level used for statistical filtering, the numerical confidence interval in 
Daltons, the number of peptides in each uptake and no-uptake categories and the 
name of the state.  
For multi-state Woods plots, two states are displayed on the horizontal axis and their 
corresponding deuterium uptake or relative uptake displayed on the vertical axis. 
Two colours are used to distinguish between peptides of the states, however there 
is no distinction between peptides of the no uptake category which are all plotted 
as grey. Equally, a legend bar is found both at the top and bottom of the plot to 
indicate which state has been plotted in which direction.  
 
Figure 3.11. Single and multi-state Woods plots in Deuteros. (a-b) Single-state and (c-d) multi-
state Woods plots of (a, c) absolute deuterium uptake in Daltons, and (b, d) the relative uptake 
expressed as a percentage. Each bar represents a single peptide, with the length on the horizontal 
axis corresponding to the peptide length. A confidence interval has been applied for statistical 
filtering of the peptide ensemble (dashed line). Peptides that have uptake above that of the 
confidence interval are shown in blue for single-state plots and blue/pink for multi-state plots. 
Peptides without significant uptake are shown in grey. The number of peptides in each category, 
confidence interval and state name are shown in the top legend bar.  
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3.4.6 Time-resolved plots: Differential Woods plot 
Where the single and multi-state Woods plots improve on the linear data maps by 
adding an additional vertical axis, the differential Woods plot simplifies the multi-
state Woods data by subtracting the peptide uptake of State B from State A, 
commonly denoted as  (Figure 3.12). The differential Woods 
plot follows the same format as the single and multi-state Woods plots and displays 
a per-peptide, per-timepoint view of the comparison. Similar to other Woods plots, 
the differential Woods employs a confidence interval calculated using a two-tailed 
t-test for statistically filtering peptides. The confidence limits are centred around 0 
uptake (no difference) and for timepoint measurements, are calculated according 
using (3.13)140.  
  (3.13) 
Where  is the standard deviation of the mean uptake for timepoint ,  is the 
number of replicates, and  is the critical value that can be found on a student t-
distribution table for degrees of freedom equal to 2, e.g.  of 6.965 for 99% 
confidence. For sum data, where the uptake over each experimental timepoint has 
been aggregated to one value, the confidence limits are calculated as a simple sum 
of variables (3.14)140. 
 
 (3.14) 
The confidence interval of the sum , is calculated as the square root of the sum 
of variance of all timepoints  divided by the square root of the number of 
timepoint observations  for  timepoints and multiplied by the critical value  for 
a particular confidence level. 
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Figure 3.12. Differential Woods plot. Example of differential data plotted using (a) absolute 
uptake and (b) relative uptake. Each bar represents a single peptide, with the length on the 
horizontal axis corresponding to the peptide length. Confidence limits around 0 Da or 0 % are 
shown as dotted lines. Peptides with uptake > CI or uptake < -CI show significant differences 
between States A and B and are shown in red or blue respectively. Non-significant peptides are 
shown in grey. The confidence level applied, CI and number of peptides in each category are 
shown in the legend bar.  
 
3.4.7 Time-resolved plots: Single and multi-state Butterfly plot 
The butterfly plot is a plot style that is inherited from DynamX (Waters Corp.) due to 
its simplistic representation of peptide uptake data. While limited in interpretation 
due to the anonymised peptide identity, the butterfly plot is visually appealing and 
allow trends in the uptake data to be easily spotted. The butterfly plot has a similar 
format to the single and multi-state Woods plot in which it displays one or two states 
on the positive and negative vertical axis (Figure 3.13).The butterfly plot retains 
uptake information on the vertical axis in the form of absolute or relative uptake, 
however, switches the horizontal axis to an anonymised peptide index. An 
interpolation curve is additionally plotted to maximise the legibility trends between 
peptides. The utility of the interpolation curve is immediately apparent in a side-by-
side comparison of the butterfly plot with and without the curve (Figure 3.14). 
In addition, peptides are spread evenly along the horizontal axis, avoiding 
overcrowding of datapoints (as may happen in Woods plots for regions of high 
redundancy), however in doing so, sacrifices redundancy information. Another 
shortcoming of the butterfly plot format is that by standardizing the horizontal axis 
DEUTEROS 2.0: IMPROVED SOFTWARE FOR RAPID ANALYSIS AND VISUALISATION OF DATA FROM 
HYDROGEN DEUTERIUM EXCHANGE-MASS SPECTROMETRY 
 
 122 
to an anonymous index value, information about the peptide length is lost. Since 
relative uptake is normalised to the maximum theoretical uptake of the peptide and 
thus the peptide length, plotting relative uptake in the butterfly format is preferred 
over absolute uptake. This additionally leads to large differences in the shape 
profiles between the absolute and relative uptake plots, such as seen for the 4-5th 
peptides of Figure 3.13a-b. 
 
Figure 3.13. Single and multi-state butterfly plots. (a-b) Single-state and (c-d) multi-state butterfly 
plots of (a, c) absolute deuterium uptake in Daltons, and (b, d) the relative uptake expressed as a 
percentage. Each scatter point represents a single peptide. A confidence interval has been 
applied for statistical filtering of the peptide ensemble (dashed line). Peptides that have uptake 
above that of the confidence interval are shown in blue for single-state plots and blue/pink for 
multi-state plots. Peptides without significant uptake are shown in grey. The number of peptides 
in each category, confidence interval and state name are shown in the top legend bar.  
Since a feature of the butterfly plot is that peptides similar in sequence position are 
found next to one another, it is imperative that the underlying peptide data for the 
plot must first be sorted via the start residue number, such that the peptide index 
appears in the correct order. Correctly ordering peptides allows the 'smoothness' of 
the data to be assessed as an additional feature of the plot. The 'smoothness' refers 
to how dramatically the deuterium uptake of a region of sequence changes, since a 
group of peptides from the same stretch of sequence should in theory exhibit similar 
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uptake levels. Assuming that there are no lapses in the coverage of the protein and 
that each sequential peptide is of similar length and shifts by a uniform number of 
residues, the interpolated curve should closely match that of a residue-level 
deuterium uptake plot.  
Statistical filtering for butterfly plots are performed as one-tailed t-tests in the same 
manner as for the differential Woods format. When applied to a butterfly plot, the 
confidence interval is used as a threshold to distinguish between peptides that show 
deuterium uptake and no uptake. For example, on a relative uptake plot, the 
percentage uptake of a peptide must exceed that of the confidence interval for the 
peptide to be classified as one which has uptaken deuterium. Practically, this 
filtering can be used to quickly distinguish between regions of the protein which may 
be solvent exposed or buried. We envision that this feature will be useful for 
membrane proteins or large soluble complexes which harbour extensive buried 
regions.  
 
Figure 3.14. Utility of the interpolation curve in butterfly plots. The same example data is plotted 
(a) with and (b) without interpolation curves in the butterfly plot format.  
3.4.8 Ensemble plot: The Volcano plot 
The volcano plot is an ensemble plot type whereby all datapoints of all timepoints 
are simultaneously shown in a single plot for a differential comparison, typically 
performed as . It takes its name from the appearance of the 
graph which when plotted, resembles that of an erupting volcano. The volcano plot 
plots a measure of uptake change between two states against the p-value of its 
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replicate measurements (Figure 3.15). Thus, a volcano plot assesses both the 
physical measured change in deuterium uptake between States A and B, and the 
variation of the measurement. Typically, the fold-change is plot against the p-value 
of the data however in Deuteros, both fold-change and ΔMass can be used as a 
measure of change between peptides of State A and B (Figure 3.15a-b). To 
exacerbate the appearance of the volcano,  and 
 is typically plot. The p-value is taken to the  in order to visually enhance 
differences between datapoints and reverses the vertical axis such that lower p-
values lead to the datapoint appearing at the top of the graph.  
 
Figure 3.15. Volcano plots of Deuteros. (a) Fold-change and (b) absolute change in mass of 
peptides between State A and B. Dashed vertical lines represent the fold-change (e.g. 2, 3 or 4-
fold) for (a) and confidence limits for (b) for the selected confidence level. Dashed horizontal line 
represents the p-value across technical replicates. Peptides with fold-change or Δmass greater 
than positive vertical bar and above the horizontal p-value threshold are in the deprotected 
category (red). Those with fold-change or Δmass less than the negative vertical bar and above 
the p-value threshold are in the protected category (blue). Those not in deprotected or protected 
categories show non-significant changes in the  comparison. The 
numerical values for each horizontal and vertical filter and number of peptides in each category 
are shown in the legend bar.  
 
Figure 3.16. Adding interactivity to volcano plots. Peptide data in volcano plots can be 
interactively accessed via clicking on individual datapoints. Peptide sequence information, 
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timepoint, the Δ Mass (including absolute deuterium uptake for states A and B), the P-value and 
number of replicates can be shown for each peptide. Data tips remain on exported plots.  
The volcano plot is the most statistically rigorous plot in Deuteros 2.0 since it 
employs two tests to identify peptides which show significant differences. The two 
statistical tests set up bidirectional filters and are used to determine whether a 
peptide is in one of the deprotected, protected or non-significant categories similar 
to the differential Woods plot. For the fold-change-type volcano (Figure 3.15a), the 
x-direction filter can be a positive or negative 2, 3 or 4-fold change in deuterium 
uptake. The p-value filter is calculated as the  of the p-value 
selected by the user. For Δmass-type volcano plots (Figure 3.15b), the vertical filter 
is a confidence interval calculated at a particular confidence level140. Selecting a 
confidence level for the ΔMass-type plot changes both the x and y-direction filters 
while it only affects the y-direction filter for the fold-change-type volcano plot. The 
data underlying each peptide, including as the peptide start and end residues, 
sequence and exposure, can be accessed interactively via clicking on individual 
datapoints within the volcano plot (Figure 3.16).  
3.4.9 Structural visualisation  
Another major feature and utility of Deuteros is its ability to transform HDX-MS data 
into formatting scripts that can be applied onto structures of proteins in order to 
visualise data more easily. The features described in this section competes the 3D 
portion of Objective 2: Develop methods of data visualisation, including 2D and 3D 
representations .This function is carried out by the 'Export to Molecular Graphics' 
subpanel of the Deuteros GUI. Currently exporting to the PyMOL g  and Chimera h 
molecular graphics viewers are supported. This feature supports the exporting of 
eight different data types: 1) coverage, 2) redundancy, 3) differential Woods, 4) 
                                                        
g https://pymol.org/2/ 
h https://www.rbvi.ucsf.edu/chimera/ 
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single-state Woods, 5) multi-state Woods, 6) single-state butterfly, 7) multi-state 
butterfly and 8) volcano (Figure 3.17).  
 
 
Figure 3.17. Summary of structural formatting from Deuteros 2.0. Export styles of (a) PyMOL and 
(b) Chimera for eight plot types. The colours used in each plot type correspond to colours used 
in each of the two-dimensional plots in Deuteros.  
To project HDX-MS data onto molecular structures, the data is first plot using the 
plot type of interest in Deuteros. The user then selects the relevant export options in 
the 'Export to Molecular Graphics' subpanel. Within this subpanel, several export 
options are available for customisation. The 'Export to' dropdown menu allows the 
selection between PyMOL and Chimera graphical viewers (Figure 3.18). The PDB 
chain ID of the protein structure to apply HDX-MS data to, is required to be input into 
the 'Chain' text box. Deuteros allows chain IDs to be input in two formats: either as a 
single chain (i.e. 'A') or multiple chains separated by commas (i.e. 'A,B,C'). An error 
dialog window spawns in the case that the user supplies a non-string or empty chain 
ID. Next, the 'Export Coverage data' and 'Export Advanced data' check boxes allow 
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the user to select which currently plotted data is to be exported. Under the 'Export 
Coverage data' section, colour options for areas of coverage, no coverage and the 
redundancy colour map can be selected. Finally, the 'Export' button can be pressed 
to bring up a save dialog window which allows the user to select the filename and 
location that the exported formatting scripts are saved under.  
 
Figure 3.18. HDX-MS data can be projected onto molecular structures in (a) PyMOL and (b) 
Chimera in two steps. The first step requires the model to be either opened locally or fetched 
from the PDB database using the inbuilt functions of PyMOL or Chimera. The second step applies 
the HDX-MS colour formatting using a customised python script. For PyMOL, a .pml script can be 
drag-and-dropped into the PyMOL window to apply colouring. In Chimera, a .py script is opened 
via the File > Open drop-down menu.  
When interpreting data on 3D structures, two aspects of the model must be 
considered. Firstly, it is important for the user to be aware of any residues and 
regions that might be missing from the model. For obvious reasons, data cannot be 
plotted onto missing regions of the model, and as such, users may unintentionally 
ignore biologically interesting areas of the data. Residues may be absent from the 
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structure due to gaps in the experimental data used to generate the model. The 
reasoning behind why there may be missing regions from a structure, is technique 
dependent. For example, for structures determined using X-ray crystallography, the 
highly flexible or disordered regions of a protein structure may manifest as missing 
residues in a PDB, due to a lack of occupancy in the crystal lattice for that region. 
Therefore, it is suggested that users should first familiarise themselves with the 
models that they wish to use for data visualisation. To aid in the transparency of 
missing residues, Deuteros 2.0 has been programmed to print a notice for the user 
should residues be absent when a formatting script is applied to a structure. Missing 
residues are calculated and printed on screen for only the user defined chain ID. The 
pseudocode for the calculation is shown below:  
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The second aspect to consider during 3D data visualisation is whether or not the 
residue numbers in the PDB matches that of the HDX-MS data. The sequence and 
peptide start and end values from HDX-MS are sourced from a FASTA file that is 
initially supplied to PLGS. Typically, protein sequences within the FASTA sequence 
file are accessed from the UniProti database. We suggest that protein sequences in 
the PDB file should be checked and matched with the HDX-MS data such that the 
residue numbers are aligned appropriately. Failure to do this will result in an offset 
to the colouration of the data applied to the structure and may be detrimental to the 
interpretation of the data. While this issue could be avoided by taking advantage of 
and using the sequence of the peptide (e.g. KKDVGLHPS) to identify the correct 
region of the protein in PyMOL or Chimera, this method has several shortcomings. 
Firstly, it is not uncommon for structures solved via X-ray crystallography, to possess 
mutations, deletions or other gene modifications, which would result in differences 
between the PDB and HDX-MS sequences. Secondly, HDX-MS attracts many systems 
which are difficult to characterise due to their structural elusiveness or high degree 
of dynamics, such as highly flexible, membranal or disordered proteins. These 
systems may in turn lack crystallographic representation, leading to homologous 
structures being used in their stead, and again, a difference between PDB and HDX-
MS sequences. Finally, the colouration of a peptide may be missed entirely if even a 
single residue is missing from the PDB. For example, if the KKDVGLHPS peptide was 
found in Deuteros 2.0 to be deprotected, but only GLHPS is present in the PDB 
model, no colouration will be applied since the full sequence cannot be located. In 
summary, a degree of caution must be exercised by users to ensure that the HDX-MS 
data is appropriately visualised on 3D models. We suggest two aspects of the 
structure should be checked as a minimum: 1) whether residues are absent from the 
structure and 2) whether the protein sequence of the PDB is in the correct number 
frame as the HDX-MS data.  
                                                        
i https://www.uniprot.org/ 
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3.4.10 Formatting in PyMOL and Chimera 
Formatting scripts generated for PyMOL and Chimera take advantage of the 
software's ability to parse and run python-based scripts. Although the interfaces and 
formatting scripts of PyMOL and Chimera are vastly different, HDX-MS data can be 
applied onto molecular structures in just two simple steps, beginning from the 
opened software window (Figure 3.18). The first step requires a model of the protein 
of interest to be opened. This can be done either by accessing the file in a local 
directory, or alternatively can be 'fetched' via the PDB database if an active internet 
connection is available. In PyMOL, fetching a PDB file can be easily performed by 
inputting directly into the command-line 'fetch 4D10' to import the 4D10 PDB model. 
In Chimera, fetching is done through the File > Fetch by ID dropdown menu and 
inputting the PDB ID.  
Once a PDB has been loaded into the software, the formatting script can be applied 
in the next step. In the most recent major update of PyMOL version 2.0 onwards, 
drag-and-drop is supported for opening files, and as such the formatting script can 
be dragged onto the window directly to apply HDX-MS colouration. In Chimera, this 
feature is not available and instead requires the under to open the formatting script 
through the traditional File > Open menu. For PyMOL, the formatting script utilises 
the file extension '.pml' while it is a '.py' file for Chimera. Both scripts are python 
based, however the formatting syntax is different and as such require different 
functions included in Deuteros to parse HDX-MS data into software-specific 
commands. Due to differences between software and plot types, the formatting 
scripts generated from Deuteros differ greatly however largely follow the format 
shown in (Figure 3.19). 
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Figure 3.19. Layout of Deuteros formatting script. Left shows a flowchart representation of the 
formatting script layout for most of Deuteros' plot types. Green sections are those that are 
identical across all plot types. Orange are software-specific sections. Grey, light grey, red and blue 
are plot type and timepoint specific sections. An example script from the CSN1 script designed 
for PyMOL is shown on the right.  
 
The formatting script contains a list of PyMOL or Chimera commands which 
transposes the visualised data from 2D plots onto 3D structures. To do this, the 
peptide categories of each 2D plot, are converted into colour commands which 
apply a colour to the region of the peptide on the 3D structure. For example, 
visualising a differential Woods plot, applies a red/white/blue and grey colour 
scheme to the 3D model to mark regions of deprotection, no significant difference, 
protection and no coverage. The software-specific syntax is shown below: 
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While both PyMOL and Chimera are supported by Deuteros 2.0, it is important to 
point out that PyMOL is inherently better suited for displaying HDX-MS data due to 
the software's 'scene' feature which allows interactive buttons to be programmed 
into the bottom left of the PyMOL GUI. Scene buttons allow users to toggle between 
different data representations, such as between coverage and redundancy, or 
between different timepoints of the data, without having to load a new file or spawn 
a new PyMOL session. As such, a direct benefit of coding the formatting script for 
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PyMOL, is that potentially, a single .pml file can store all data formatting types. 
Another software feature that makes PyMOL advantageous to Chimera, is 'grid' view, 
which allows two or more structures or states to be viewed simultaneously. This 
feature is especially useful for side-by-side comparisons of two HDX-MS states, such 
as for multi-state Woods or butterfly visualisation. Structures presented in the grid, 
also benefit from scene buttons, providing another layer of customisable data 
representation for the user.  
In contrast, Chimera does not possess any features equivalent to scene buttons or 
grid view, reducing the efficiency of data visualisation. The lack of scene buttons for 
toggling between data types or timepoints, means that these formatting outputs 
need to be separated into different formatting scripts. Coverage and redundancy 
data in Deuteros 2.0 is generated for State A, State B and Common peptides between 
the two states, giving a combination of  representation types. Where PyMOL can 
display these 6 data types in a single formatting script using scene buttons, 6 
separate files are output for Chimera.  
3.4.11 Structural projection of data onto molecular structures 
Mapping the coverage and redundancy data onto molecular structures allows the 
generation of informative but simplistic figures which depict which regions of the 
protein are covered by the HDX-MS experiment and to what extent. For specialised 
systems such as integral membrane proteins, or those with extensive buried surface 
area, mapping the regions of coverage onto structures is especially useful for 
demonstrating areas of high and low coverage. The ability to visualise the coverage 
of the experiment in the context of the biological structure, can also be helpful in 
experimental design, whereby different proteolytic enzymes can be tested for their 
efficacy in accessing certain regions of interest in the system. 
Both coverage and redundancy information for both single and multi-state HDX-MS 
datasets can be quickly visualised on 3D structures using the coverage and 
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redundancy formatting scripts. To generate residue-level values that can then be 
used for colouring molecular structures, the state data table of peptides used to 
generate the coverage and redundancy plots, are formatted into a residue-level list 
along with the number of times the residue appears over the whole peptide 
ensemble. In PyMOL, scene buttons are added to allow users to toggle between the 
coverage and redundancy of each experimental state, and the set of common 
peptides between the two states. A myriad of colouring options are available to 
select from within the 'Export to Molecular Graphics' subpanel of Deuteros 2.0. It is 
also important to note that no colour bar (as can be seen in Figure 3.20) is generated 
by default or shown in the PyMOL or Chimera session. The colour bar of appropriate 
scale can be generated and exported from the redundancy map plot of Deuteros 2.0.  
 
Figure 3.20. Visualising redundancy on 3D models using PyMOL. Example redundancy data 
shown for the CSN1 complex. Colour bar represents the residue-level redundancy. The insert 
displays the set of scene buttons that can be used to toggle between data types.  
Next, the per-residue deuterium uptake can be visualised by exporting formatting 
scripts from either the butterfly or non-differential Woods plots (Figure 3.21). To 
generate the residue-level data, the uptake level at each residue number is 
approximated by averaging the uptake over all peptides. This also means that the 
resolution and accuracy of the residue-level uptake is dependent on the redundancy 
of the residue, and also the lengths of the peptides that were used to calculate the 
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value. Data generated using this method is typically not seen or presented as true 
"residue level" uptake but is only necessary for converting a table of peptides into a 
linear data list that can then be applied to each residue of a PDB. Given that both the 
resolution and accuracy of the uptake values depend heavily on redundancy, it is 
suggested that users should review their uptake plots alongside the redundancy plot 
to assess the relative confidence of certain residues.  
 
Figure 3.21. Visualising (a) single and (b) multi-state uptake data on 3D models in PyMOL. Regions 
of the protein without experimental coverage are coloured in grey, Areas showing non-significant 
uptake are in white and those with significant uptake are in red. Scene buttons allow data for 
each timepoint to be toggled between. 
There are four export types in Deuteros 2.0 which project deuterium uptake onto 
structures: single-state and multi-state butterfly or Woods visualisation styles. In 
reality, there is repetition in the data that is presented by these four styles. Single-
state butterfly and single-state Woods plots show the same data and employ the 
same confidence filtering, resulting in identical visualisations when formatting 
scripts are applied to structures. The same State A data is additionally used for the 
multi-state butterfly and multi-state Woods plots. Both single-state and multi-state 
Woods and butterfly plots utilise scene buttons for toggling between timepoint data 
(Figure 3.21). As mentioned previously, the 'grid view' feature of PyMOL is used for 
multi-state formats in order to provide side-by-side comparisons of two states. In 
practice, if there are few regions of significant uptake difference between States A 
and B, it may be difficult spot these differences by eye in the graphical viewer. 
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Instead, regions of significant uptake differences are better pinpointed by using one 
of the differential Woods or volcano plotting styles. 
 
Figure 3.22. Visualising differential HDX-MS data using (a) differential Woods filtering and (b) 
volcano filtering methods. Regions without experimental coverage are coloured in grey. 
Significantly protected regions are in blue, and deprotected regions are in red. Areas without 
significant differences are in white. Scene buttons allow toggling between experimental 
timepoints.  
The differential Woods or Volcano plot simplifies a comparison between two 
experimental states by reducing the information content to only the difference 
between the two states (Figure 3.22). To generate the residue-level series for 
differential Woods and volcano formats, the same peptide-level data table used to 
plot the 2D graphs are re-used. It does not calculate the residue-level uptake map of 
each state and then compare between them. Converting to residue-level first, would 
bias the comparison if there are significant differences between the redundancy of 
the data between the differential states. By using peptide-level data, only peptides 
that are found in both states are compared and used to determine whether a 
significant difference is measured. In both differential Woods and volcano plots, 
peptide categories are shown for each individual timepoint and accessed via scene 
buttons in PyMOL. For differential Woods, the additional 'sum timepoint' is also 
available to provide consistency with the 2D differential Woods plot. The reader may 
have noticed however, that for the volcano style visualisation, the sum series has 
been replaced by 'all timepoints'. This scene instead shows all regions which have 
been identified as significant in any of the constituent timepoints. The inclusion of 
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this 'all timepoint' series as an alternative, was due to the fact that sum data could 
not be simply filtered in a volcano plot, using the same confidence interval and p-
value filters calculated from the constituent timepoints that compose the series in 
the first place.  
A comparison of data filtered using differential Woods and volcano plots reveals 
subtle differences between the two methods. As expected, applying an additional p-
value filter in the volcano plot, results in fewer peptides identified as statistically 
significant. A p-value filter essentially removes datapoints such that only those with 
the greatest evidence against the null hypothesis j  remain. This is visible when 
visually comparing structural models of the 30 min timepoint in Figure 3.23. As 
mentioned earlier, a potential issue arises when regions of the model are missing 
from the PDB file. These peptides have been highlighted in Figure 3.23a and the 
colouration is entirely missing from the structures presented in Figure 3.23b-c.  
In summary, this chapter has demonstrated the myriad of structural visualisation 
styles that Deuteros 2.0 produces. Both single-state, multi-state and differential 
comparisons are available, and for both PyMOL and Chimera visualisation software. 
The ability for users to transpose 2D HDX-MS data directly onto 3D structures in two 
simple steps, provides greater access for meaningful interpretation of results. 
Visualisation of coverage and redundancy information as mentioned, provides 
several benefits, one being that the visualisation can help with experimental design, 
such as optimising sample preparation steps and acquisition parameters to 
maximise the number of useful peptides recovered from an experiment. Visualising 
deuterium uptake levels using single-state and multi-state representations allow 
uses to review which regions of their protein are responsive to HDX and can inform 
on exposed and buried areas. Finally, the ability to project differential HDX-MS onto 
structures, is the hallmark of Deuteros 2.0. Using volcano plots for stringent filtering 
                                                        
j Null hypothesis/H0 : No difference in uptake between States A and B 
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of potentially interesting peptides, allows regions of biological interest to be 
pinpointed with greater confidence.  
 
Figure 3.23. Comparison of data filtered using differential Woods and volcano plot formats. (a) 
2D differential Woods plot for example data over 0.25, 5, 30 min and sum timepoints. Each bar 
represents a single peptide. The 99% confidence intervals are shown by the dotted lines and is 
used to statistically filter peptides to classify them into one of three categories:  
are deprotected (red),  are protected (blue) and those with 
 are non-significant (grey). Peptides which are missing from the PDB model in (b-c) are 
highlighted by blue circles. (b) Structural representation of differential Woods data shown in (a). 
Cartoon colours correspond to peptides categories determined in (a). Grey and white indicates 
peptides without coverage, and those that show non-significant  respectively. (c) 
Structural representation of volcano plot data (Figure 3.20). Peptide colours follow that of (b).  
DEUTEROS 2.0: IMPROVED SOFTWARE FOR RAPID ANALYSIS AND VISUALISATION OF DATA FROM 





In section 3.2 Aims & Objectives, we described five aims of Deuteros 2.0:  
1. To provide an easy to use platform for statistical analysis and visualisation of 
HDX-MS data 
2. To provide a method of extracting meaningful information from HDX-MS data in 
the context of structural interpretations 
3. To develop a foundation software that can be dynamically adjusted to the 
needs of the evolving HDX-MS field 
4. To keep user interaction to a minimum where unnecessary 
5. Free to use, offline and accessible on most computers 
In software engineering, the quality of software can be evaluated in terms of 
functional and structural quality. Functional quality refers to the ability of the 
software to fulfil functional requirements, both in terms of design and software 
features. On the other hand, structural quality refers to the robustness and structure 
of the underlying programming. With this in mind, we can simplify the five above 
aims of Deuteros 2.0 into those that can be assessed as functional or structural 
qualities. Aims 1, 2, 4 and 5 relate to software and data analysis features and as such, 
are functional qualities. The accessibility of the software is another important 
functional quality to discuss. This encompasses considerations such as whether the 
software is easy to physically access (e.g. webserver, standalone installation or 
command-line), the skill level required (is technical experience needed?) or how 
easy input data can be generated, especially if dependent on upstream software. 
Aim 3 on the other hand, refers to the development of the back-end code into an 
adjustable format that can be easily expanded. Each of the aims in the context of 
functional and structural quality will be discussed and compared with other 
software in the statistical analysis and data visualisation category. 
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3.5.1 A comparison of Deuteros 2.0 with other statistical and visualisation software 
As pointed out earlier, several software were developed for statistical analysis and 
visualisation of HDX-MS data. These are MSTools, MEMHDX, HDX-Analyzer and HDX-
Viewer. To systematically review the functional quality of Deuteros 2.0 against each 
of its competitor software, we assembled a list of features provided across the 
MSTools, MEMHDX, HDX-Analyzer, HDX-Viewer and Deuteros 2.0 software and 
generated a comparison table to better summarise similarities and differences 
(Table 3.6). The following sections will compare the accessibility of the software to 
users, difficulty of generating the input data and each of the software features to 
those of Deuteros 2.0.  
Table 3.6. Comparison of statistical and visualisation software 
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3.5.2 Software accessibility 
We first reviewed each software in the statistics and data visualisation category in 
terms of software accessibility and implementation. The more popular 
implementation method of HDX-MS software is in the form of webservers (MSTools, 
MEMHDX and HDX-Viewer), while only HDX-Analyzer and Deuteros are standalone 
software. While webservers are simpler to access than standalone installations from 
the user standpoint, webservers have several shortcomings. Firstly, they are more 
prone to downtime, both scheduled (maintenance and upgrades) and unscheduled 
(server crashes). Secondly, webservers are more difficult to maintain for long periods 
of time since they require someone capable of maintaining them, compared to a 
single installation of a software that can be used indefinitely. Finally, webservers are 
susceptible to web attacks which in combination with requiring users to upload data 
to a remote server, may compromise data. While webservers are easier to access, 
providing that standalone software such as Deuteros 2.0, does not require difficult 
installation, software licenses or other software dependences, distributing software 
as standalone installations does not restrict access to data analysis facilities. Out of 
the five software compared, we were able to access all with the exception of HDX-
Analyzer which appeared to be no longer available from the original download link. 
This highlights an issue in the HDX-MS software field in which some useful tools may 
become unmaintained and eventually disbanded. Deuteros 2.0 is only software 
written in a programming language (MATLAB) that is dependent on an external 
software license for editing its source code. For the average user however, there is 
the option of installing the MATLAB Runtime library which is freely available from 
MathWorks, however this means compared to the other webservers (MSTools, 
MEMHDX, HDX-Viewer), Deuteros 2.0 requires additional installation steps and is the 
least accessible in this category. 
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3.5.3 Accessibility of input data 
The five software utilise a myriad of different methods for interpreting data from an 
input file that is typically produced from data processing software such as DynamX 
for Deuteros 2.0 and MEMHDX. Since there are numerous software performing the 
data processing step and these can be in turn restricted by instrumentation, each 
software has evolved from different necessities and typically do not utilise the same 
input files. By far the most comparable software to Deuteros 2.0 in terms of data 
input, is MEMHDX which takes the cluster output from DynamX. Although both 
software are designed to be used in conjunction with DynamX, there are differences 
in the handling of the cluster file. In Deuteros 2.0, reading the peptide data from the 
DynamX cluster file is performed in a single step that requires no additional manual 
work. On the other hand, the same cluster file to be analysed by MEMHDX, requires 
first a significantly laborious editing step that involves manually adding the replicate 
number for each peptide datapoint. The time taken for an average user to add this 
information to the MEMHDX input file will vary depending on the experimental 
complexity, data quality and number of peptides, but may be between 5-20 minutes 
for each cluster file. For studies consisting of many experimental states, proteins or 
replicates, the requirement of manually adding to the cluster file, makes MEMHDX 
significantly less accessible to use for data analysis than Deuteros 2.0. From a 
programmatic standpoint, repetitive tasks such as simple data labelling, should be 
performed by the software and not the user. As such, Deuteros 2.0 provides better 
accessibility since the time taken to connect between DynamX and Deuteros 2.0 is 
effectively non-existent.  
We observed an interesting correlation which was that recent software such as 
MEMHDX, Deuteros 2.0 and HDX-Viewer (2016, 2019 and 2019 respectively) were 
more reliant on upstream data processing software to output data in a standardized 
format (such as the cluster format from DynamX), rather than earlier software 
(MSTools, 2010 and HDX-Analyzer, 2011) which utilised simple text files which were 
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vendor and software-independent. A good example of this is with the 'Draw Map' 
module of MSTools which generates coverage and heat maps for HDX-MS states. 
Three files can be supplied to 'Draw Map': 1) a sequence file that contains a simple 
list of peptides, 2) a digest file that contains % deuterium values for each sequence 
at various timepoints and experimental conditions, and 3) a structure file that 
includes annotations of secondary structure and domain classification for the 
peptide list. Generating these lists in the correct format for MSTools is significantly 
time consuming compared to more modern data formats such as the cluster file. An 
increase in the complexity and size of systems being studied by HDX-MS has also 
meant that modern peptide data files are comparatively larger than those of the last 
decade. The relationship between software age and dependence on upstream 
processing data formats is also visible in the most recent addition to the HDX-MS 
software family - the HDX-Viewer webserver. HDX-Viewer provides two options of 
source data - DynamX or HDExaminer. Interestingly however, unlike MEMHDX or 
Deuteros 2.0, HDX-Viewer does not make use of the DynamX cluster file, or any of the 
tabulated formats (state or difference). Instead, HDX-Viewer requires the PyMOL 
formatting script that DynamX generates along with a PDB model that uptake data 
is projected onto. The PyMOL .pml formatting file is similar to that generated by 
Deuteros 2.0 and has been designed to conduit peptide data in DynamX to protein 
models in PyMOL. In terms of input data accessibility, the PyMOL .pml file from 
DynamX is easy to generate and does not require any additional modifications 
before inputting to HDX-Viewer. The alternative input is a csv file generated from the 
commercial software HDExaminer which includes the columns for example: Start, 
End, 5s, 10s, 5s - spread, 10 - spread, where the spread values are a measure of 
replicate variance. Since HDX-Viewer provides two methods of importing data into 
its web-based graphical viewer, this increases the accessibility of the software to 
many additional users.  
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3.5.4 Comparison of statistical methods 
A review of the capabilities of each software (Table 3.6), reveal that the majority are 
developed for statistical analysis for differential HDX-MS and not single-state 
applications. Although MSTools has features for differential HDX-MS, it does not 
employ statistical tests of any kind for significance testing. HDX-Viewer does not 
perform differential nor statistical analysis. Software with features for performing 
statistical analysis of HDX-MS data and downstream visualisation include HDX-
Analyzer, MEMHDX and Deuteros 2.0, with each of these employing different 
statistical methods. Among these three software, HDX-Analyzer is unique in that 
statistics can be applied to either the deuterium uptake or centroid m/z of each 
peptide. In HDX-Analyzer, multiple linear regression is used to derive a model of 
deuterium uptake over time for a peptide of an experimental state. A paired 
Student's t-test or analysis of covariance (ANCOVA) is used to determine whether a 
statistically significant difference exists between the two states. In the ANCOVA 
model, experimental states are treated as groups, with the deuterium uptake or 
centroid m/z as the dependent variable, and time as a covariate that correlates with 
the dependent variable but is not a focus of the study. In ANCOVA, the potential 
effects of the covariate are used to adjust the mean value of the dependent variable, 
such that the effects of the covariate are minimised. In both paired Student's t-test 
and ANCOVA, the point estimate of the mean difference in uptake between two 
peptides is calculated, along with its confidence intervals and p-value for a given 
confidence level. These values are presented for each peptide and allow the user to 
assess statistical significance from multiple angles. Pairwise t-tests however suffer 
from the multiple comparisons problem in which the intended confidence level is 
compounded with each subsequent comparison. For example, three pairwise 
comparisons each with 0.95 confidence, results in an actual confidence level of 0.857 
( ) and a final confidence level of 85.7%. The unintended shift in the 
confidence level leads to potential type I errors or false positives in which a true null 
hypothesis (no change) is rejected. To avoid the multiple comparisons problem with 
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pairwise t-tests, multiple comparisons can instead be performed using other 
statistical methods such as the Tukey's range test as seen in HDX Workbench122 or 
employ the Bonferronik correction method147.  
Instead of using multiple linear regression for modelling of deuterium uptake over 
time, MEMHDX first fits the deuterium uptake data using a linear mixed effects 
model. The mixed effects model is interesting as it treats measurement variance over 
replicates, as a random effect on the deuterium uptake. In the mixed effects model, 
replicates can be seen as random effects on the true mean of the measurement, as 
in theory, there can be an infinite number of replicate measurements, each taken at 
different conditions leading to "random" variations across the measurement that 
need to be accounted for in the statistical model. The utilisation of a mixed effects 
model to estimate the deuterium uptake over time is a significant upgrade to the 
DynamX methodology in which uptake is taken as the simple intensity weighted 
average of the replicates composing the peptide. Deuteros 2.0 also follows DynamX 
and no statistical models are employed to attempt at accounting for differences 
across the measurement replicates. To determine whether a statistically significant 
difference exists between two peptides, MEMHDX calculates two P-values using a 
chi-squared test. Similar to HDX-Analyzer, the P-values of MEMHDX attempt to take 
into account the effect of time in the deuterium uptake measurement. This differs 
the P-value calculated in the Deuteros 2.0 volcano plot, which does not take into 
account the acquisition time. In MEMHDX, the P-valueMagnitude_of_Delta_D measures the 
statistical significance of deuterium uptake difference between the experimental 
conditions. The P-valueChange_in_Dynamics tests whether there is an observed change in 
deuterium uptake over time (hence uptake dynamics) between the two states and 
thus accounts for the time axis.  
                                                        
k The Bonferroni method corrects for type 1 errors (false positives) in multiple comparisons by adjusting  
of individual statistical tests, such that their combined significance is no more than the intended 
significance ( ). 
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3.5.5 Statistical filtering 
Statistics are applied to differential HDX-MS data ultimately with the aim of 
determining whether the observed deuterium uptake between two experimental 
states, is sufficiently large to yield statistical significance. The elaborate methods of 
applying statistics essentially allow a binary decision on whether or not a peptide 
has behaved differently in a different condition. In HDX-Analyzer, the user is left with 
a statistical breakdown of the comparison between states, and no conclusions are 
made for the user. A simpler method of making this decision compared to those of 
MEMHDX and HDX-Analyzer, is the confidence interval first conceived by Houde et al. 
which has been used in Deuteros 2.0. Specifically, this confidence interval is used to 
represent the expected range of random variation for replicate measurements and 
is calculated using the replicate variance. In practice, it is applied as a range around 
 representing the sample noise of the measurement. Thus, deuterium uptake 
differences outside of this range are designated as statistically significant. Also 
different, is that this confidence interval is measured across all peptides and is 
globally applied to each timepoint individually, rather than a per-peptide basis such 
as in ANCOVA or t-test methods. This time-centric application has led to Deuteros 
2.0 to focus on a per-timepoint representation of the differential HDX-MS data, rather 
than per-peptide or per-state. The confidence interval of Deuteros 2.0 will be referred 
to as the "global confidence interval". Using the global confidence interval 
approach, peptides are grouped into one of three categories: deprotected, 
protected and those with non-significant changes. The only other software to 
perform peptide grouping is MEMHDX.  
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Figure 3.24. The MEMHDX Logit plot feature. Left shows the options panel for controlling the Logit 
plot. Right shows the logit plot. Only customisations of the plot size and datapoint sizes are 
available in MEMHDX. Peptides can be highlighted in the Logit plot according to their 
classification in one of four categories. Red and blue peptides are those that are deprotected and 
protected in the holo state compared to the apo state. Grey and grey peptides show high or no 
dynamics in both states. Hovering over the single red data point at approximately (-50,-60) 
spawns the uptake plot at the lower right of the window.  
 
In MEMHDX, plotting the logit function of each P-value, logit(P-valueMagnitude_of_Delta_D) 
and logit(P-valueChange_in_Dynamics) allows clustering of peptides into one of four 
categories (Figure 3.24): 1) peptides showing increased uptake in the holo state 
compared to apo (equivalent to deprotected), 2) peptides showing decreased 
uptake in the holo state compared to apo (equivalent to protected), 3) peptides with 
no differences between apo and holo (non-significant) and 4) peptides dynamic in 
both apo and holo. The existence of peptides of the fourth category are not 
identified in Deuteros 2.0 and inclusion of this feature should be considered in future 
updates. Categorisation of peptide behaviour is through plotting the logit function 
of P-values, logit(P-valueMagnitude_of_Delta_D) against logit(P-valueChange_in_Dynamics) in 
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MEMHDX. A combination of the mixed effects model, dual P-values and category 
separation makes MEMHDX the most statistically stringent HDX-MS software 
currently available.  
Statistical analysis of peptide ensembles is an important feature of the HDX-MS 
technique and over the recent years, many systems have been elucidated using 
these methods. The global confidence interval approach introduced by Houde et al. 
(2011) is a popular method of statistical filtering of peptide data and have been used 
for the characterisation of systems including antibody flexibility148, antibody-drug 
conjugates149, lipid dependent effects on nanodisk scaffolds150 and secondary 
transporters141, bacterial translocases151 and lanthipeptide synthetases152. In these 
studies, authors either calculate the corresponding value of the global confidence 
interval for their system of acquisition using the equation (3.13), or directly apply the 
 limit detailed in the original Houde et al. publication140. Interestingly, the study 
by Habibi et al. utilised Deuteros only for calculation of the 99% confidence interval 
but did not use any of the plots generated by the software152. Instead, the confidence 
interval value was taken from the software and transplanted onto the difference plot 
produced by DynamX, potentially illustrating that some users may prefer a 
representation of peptide data that is not separated by timepoints. This should be 
kept in mind for future implementations of Deuteros 2.0.  
Recent studies that have utilised the statistical analysis features of MEMHDX include 
those that characterise protein-protein interactions involving monoclonal 
antibodies153, the CRISPR Cascade complex154, PPARγ/RXRα nuclear receptor 
transcription factors155 and the bacterial membrane secretin PulD156. In each of these 
publications, Logit plots and the corresponding peptide categories were not used 
for biological interpretations. Similar to that observed by Habibi et al., Terral et al. 
displays the differential HDX-MS data in the difference plot format and interestingly 
include the global confidence interval for significance testing - however this is 
function is not performed by MEMHDX and the authors do not elaborate the method 
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of their analysis. As such, while we may discuss the relative usefulness of either 
Deuteros 2.0 or MEMHDX, it is clear from this small sample of publications that the 
focus of the software features should be around users and their analysis needs, and 
not which software provides more and advanced functions.  
 






Chapter 4: Dynamic characterisation of large protein 
complexes: the COP9 Signalosome 
 
Preface 
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Beuron, F., Cronin, N. B., Morris, E. P., Politis, A. (2019). Structural basis of Cullin 2 RING 
E3 ligase regulation by the COP9 signalosome. Nature Communications, 10, 3814, 
doi:10.1038/s41467-019-11772-y. 
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4.1 Extended introduction into the biology of the COP9 Signalosome and its 
role as the regulator of NEDD8-activated CRL E3 Ligases 
4.1.1 Ubiquitin-Proteasome System 
The ubiquitin-proteasome system (UPS) comprises an impressive multicomponent 
network that regulates an extensive number of critical biochemical pathways 
ranging from cell-level protein turnover, cell signalling, DNA repair to organism-level 
processes such as angiogenesis and embryonic development158 (Figure 4.1). The 
discovery and mapping of the UPS network and its role in mediating cellular protein 
degradation, warranted the 2004 Nobel Prize in Chemistry award to Aaron 
Ciechanover, Irwin Rose and Avram Hershko.  
 
Figure 4.1. A simplified view of the Ubiquitin-Proteasome System. This chapter will discuss the 
different branches of the UPS including ubiquitination leading to proteasomal degradation and 
regulation of key effectors of the system known as Cullin RING ligases (CRLs). 
The turnover of proteins within cells is modulated through a highly regulated 
partnership involving two key players: the proteasome - a large 2 MDa complex that 
contains a myriad of enzymatic centres for endoproteolysis, and ubiquitin (Ub) - a 
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conversely small 8 kDa globular protein that functions as protein tag. Cellular 
proteins can undergo one of many post translational modifications, one of which is 
ubiquitination which involves the covalent ligation of ubiquitin via its C-terminal 
G76, onto a lysine residue of the substrate protein159. Ubiquitination of substrate 
proteins chaperone them into a number of downstream cellular fates, including 
protein degradation by the proteasome, sub-cellular trafficking and other signalling 
pathways. The process of substrate ubiquitination is catalysed by a well-defined 
cascade of three classes of proteins, termed the E1 ubiquitin activating enzymes, E2 
ubiquitin conjugation enzymes and E3 ubiquitin ligases. The E1, E2 and E3 cascade 
is established in a pyramidal scheme whereby in humans, only one to two E1 
enzymes are responsible for mobilisation of up to 40-100 E2 enzymes, which are in 
turn utilised by approximately 103 E3 ligases160-162. Similar diversity of E1-E3 enzymes 
have also been identified across different plant and yeast species163. 
In the first step of the ubiquitination cascade, a molecule of ubiquitin is fused to an 
E1 enzyme in an ATP-dependent reaction (Figure 4.2a). The E1 with its covalently 
conjugated ubiquitin, E1~Ub (where the "~" stylization denotes a covalent bond), 
next transfers ubiquitin to an E2 enzyme, forming an E2~Ub complex (Figure 4.2b). 
Most of the cellular E2 pool exists in the E2~Ub format, ready for utilisation by E3 
enzymes164. In the final step, an E3 ubiquitin ligase docks with the substrate protein 
and the primed E2~Ub forming the ubiquitination machinery (Figure 4.2c).  
 
 
Figure 4.2. Ubiquitination cascade. (a) An E1 ubiquitin activating enzyme in an ATP-dependent 
step, covalently bonds with a molecule of ubiquitin. (b) Ubiquitin from the E1~Ub complex is 
transferred to an E2 ubiquitin conjugation enzyme, forming E2~Ub. (c) E2~Ub and substrates 
dock with an E3 ubiquitin ligase which catalyses the transfer of ubiquitin from the E2 enzyme to 
the substrate. (d) Ubiquitination results in biochemical changes in the substrate that leads to a 
myriad of cellular fates. Figure adapted from Rape, 2018 159. 
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4.1.2 The Ubiquitin Code 
Besides ubiquitination of substrate molecules, ubiquitin itself can also be 
ubiquitinated at one of eight different residues - at seven lysines (K6, K11, K27, K29, 
K33, K48 and K63) and its N-terminal M1 methionine. Subsequent polyubiquitination 
can also occur, leading to elongation of the chain to more than 10 units of ubiquitin 
long165. Polyubiquitination at specific lysine linkages (e.g. K48 or K63) chaperone the 
substrate protein to specific cellular fates159. The combination of various ubiquitin 
chain lengths, topologies and modifications, impressively diversifies the possible 
array of ubiquitination motifs, leading to a highly complex and specific signalling 
system. In fact, entire sets of enzymes have been discovered that are capable of 
reading and editing this "ubiquitin code"165.  
 
Figure 4.3. Ubiquitin signalling motifs. Several different flavours of ubiquitination motifs are 
possible, including monoubiquitination and polyubiquitination. Successive polyubiquitination 
can involve the same lysine linkage (homotypic) or different lysine linkage (heterotypic) which 
can also be branched. Ubiquitin chains can be modified through different chemical 
modifications such as phosphorylation or acetylation, or ligation of other ubiquitin-like (Ubl) 
modifiers such as SUMO or NEDD8.  
 
Multiple rounds of successive ubiquitination can lead to chains of various lengths 
and topologies (Figure 4.3). Figure 4.4 demonstrates the ubiquity of the ubiquitin 
signalling network.  




Figure 4.4. Cellular roles of ubiquitin signalling. Various signalling processes and pathways are 
regulated via ubiquitin signalling, including ubiquitin-dependent proteolysis of expired or 
misfolded proteins, trafficking of post-Golgi or cell surface receptors, DNA repair and inhibition 
of cell signalling pathways such as Wnt.  
4.1.3 The Proteasome 
Proteolytic signals such as polyubiquitin linkages via K48 are recognised by the cell’s 
recycling powerhouse, known as the proteasome (Figure 4.4). Two flavours of 
proteasomes are found within the cell, the 26S and 30S, named so due to their 
sedimentation coefficients measured in Svedbergs166. The 30S is the functional 
variant of the proteasome, capable of proteolysis, while the 26S is in fact a partial 
subcomplex of the 30S. Readers may however find in literature that the naming of 
the 26 and 30S proteasome is controversial. The reason for this is historic167. 
Attempts at measuring the sedimentation coefficient of the fully assembled 30S 
using density-gradient centrifugation were in made on the 26S partial complex168, 
leading to the misnomer that the 26S is functionally active. Later biophysical 
analysis confirmed that the active proteasome has a sedimentation coefficient of 
30S and the 26S is likely a partial complex166,167.  
The 30S proteasome is formed by a 20S catalytic core particle and capped at both 
ends by 19S regulatory subunits (Figure 4.5). The core particle is a large barrel-like 
structure consisting of four stacks of α and β heptameric rings in an αββα 
configuration. Within the internal cavity, the 20S core contains several enzymatic 
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sites designed to hydrolyse peptide bonds of acidic, basic and hydrophobic 
residues. 
 
Figure 4.5. Protein degradation by the 30S proteasome. The 30S proteasome is composed of a 
20S core and two 19S regulatory particles. (a) Tetraubiquitinated substrates can be recruited to 
the 19S ubiquitin receptor, along with deubiquitinases. (b) Ubiquitin is cleaved from the substrate 
via proteolytic activity of the deubiquitinase, and the substrate is digested by the 20S core 
particle.  
 
In its isolated αββα configuration, the 20S is auto-inhibited due to the enzymatic 
sites being located at the β core of its cavity of which access is sterically restricted by 
the α7 rings. To activate the 20S, two 19S regulatory complexes are recruited to 
either end of the 20S (Figure 4.5). The 19S particles consist of a base and lid 
subcomplexes which contribute a variety of biochemical functions to the 
proteasome including receptors specific to substrates with particular ubiquitination 
motifs. In a series of steps, ubiquitin are stripped off the substrate by recruited 
deubiquitinases, the substrate is unfolded and lysed into oligopeptides by the 
catalytic centres of the 20S core. Free ubiquitin can then be recycled back into a 
number of biochemical pathways (Figure 4.4).  
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4.1.4 E3 Ubiquitin Ligases 
E3 ligases provide the ubiquitination cascade with substrate specificity and are 
involved in a number of highly important biochemical pathways including 
progression of the cell cycle, immune response and protein degradation via 
ubiquitination169. There are three currently identified classes of E3 ligases known as 
RING, HECT and RBRs.  
By far the most prominent family of E3 ligases with more than 600 members in 
mammals, are those that contain the RING or Really Interesting New Gene domain. 
The RING domain is a highly conserved and characteristic zinc-binding fold that is 
capable of associating with or allosterically activating E2~Ub complexes. RING E3 
ligases may function as monomeric, homo- and heterodimeric or multi-subunit 
complexes. Monomeric RING E3s include CBL that ubiquitinates activated receptor 
tyrosine kinases, triggering their endocytosis, or the TRAF family of E3 ligases that 
autoubiquitinate following activation of immune receptors (Figure 4.4) and lead to 
activation of the NF-κB pathway. Multi-subunit RING E3s include the Cullin RING E3 
ligases (CRLs) and also two related but otherwise distinct complexes - the APC2 
subunit of the anaphase promoting complex/cyclosome (APC/C) and the p53 
anchoring protein complex (PARC, also known as CUL9). 




Figure 4.6. Organisation of the modular Cullin-RING E3 ligases. Schematics depict the subunit 
layout for (a) CRL1 and its F-box binding substrate receptors, (b) SOCS-box CRL2 and CRL5, (c) 
BTB binding CRL3 and (d) CRL4A/4B in complex with its DDB1 substrate receptors. Cullins are 
shown in blue, RBX E3 in red, adaptors in green and substrate receptors in orange. CRLs must first 
be neddylated involving covalent ligation of NEDD8 (N8) before the E3 ligase activity of RBX 
subunits are active.  
CRLs are the largest family of E3 ligases consisting of modular scaffolds with E3 ligase 
activity170. It is thought that CRLs may mediate up to 1/5th of the cellular protein 
turnover via the proteasome171. Though there are exceptions, each CRL typically 
consists of several components: an elongated and curved Cullin (CUL) scaffold 
protein, a RING-box protein (RBX) that functions as the E3 ligase of the complex, and 
adaptor proteins and substrate receptors which provide substrate specificity (Figure 
4.6). So far, seven different Cullin scaffolds that have been identified - CUL1, 2, 3, 4A, 
4B, 5 and 7. All Cullins with the exception of CUL5 associate with RBX1, while a 
homologous RBX2 binds CUL5 exclusively (Figure 4.6). At the minimum, a Cullin must 
be in complex with its RBX E3 ligase for it to be termed a CRL, for example, CUL1-
RBX1 is termed CRL1, CUL2-RBX1 is CRL2 and so on. Each CRL is capable of 
associating with an individualised array of adaptor proteins and substrate receptors, 
totalling more than 400 interchangeable components172. This modularity provides 
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the UPS network with tremendous specificity for over 1000 substrates in a highly 
regulated system169,173.  
Table 4.1. Crystallographic structures of CRL complexes.  
System PDB Resolution (Å) Subunits Year Reference 
CRL1 1LDJ 3.00 CUL1, RBX1 2002 Zheng et al.174 
 1LDK 3.20 CUL1, RBX1, Skp1, Skp2 2002 Zheng et al.174 
 1U6G 3.20 CUL1, RBX1, TIP120 2004 Goldenberg et 
al.175 
 3RTR 3.21 CUL1, RBX1 2011 Calabrese et al.176 
 3TDU 1.50 CUL1, UBC12 (E2), DCNL1 2011 Scott et al.177 
 3TDZ 2.00 CUL1, DCNL1, Peptide 2011 Scott et al.177 
 4F52 3.00 CUL1, RBX1, Glomulin 2012 Duda et al.178 
 4P5O 3.11 CUL1, RBX1, DCNL1, UBC12 
(E2), NEDD8 
2014 Scott et al.179 
 5V89 1.55 CUL1, DCNL4 2017 Scott et al.180 
      
CRL2 4WQO 3.20 CUL2, ELOB, ELOC, VHL 2015 Nguyen et al.181 
 5N4W 3.90 CUL2, RBX1, ELOB, ELOC, 
VHL 
2017 Cardote et al.182 
      
CRL3 4EOZ 2.40 CUL3, SPOP 2012 Errington et al.183 
 4AP2 2.80 CUL3, KLHL11 2013 Canning et al.184 
 4APF 3.10 CUL3, KLHL11 2013 Canning et al.184 
 6I2M 2.30 CUL3, A55 2018 Gao et al.185 
 4HXI 3.51 CUL3, KLHL3 - To be published 
 5NLB 3.45 CUL3, KEAP1 - To be published 
      
CRL4A 2HYE 3.10 CUL4A, RBX1, Viral protein 2006 Angers et al.186 
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 4A0K 5.93 CUL4A, RBX1, DDB1, DDB2 2011 Fischer et al.187 
      
CRL4B 4A0C 3.80 CUL4B, RBX1, CAND1 2011 Fischer et al.187 
 4A0L 7.40 CUL4B, RBX1, CAND1 2011 Fischer et al.187 
 4A64 2.57 CUL4B - To be published 
      
CRL5 3DPL 2.60 CUL5, RBX1 2008 Duda et al.188 
 3DQV 3.00 CUL5, RBX1, NEDD8 2008 Duda et al.188 
 4JGH 3.00 CUL5, ELOB, ELOC, SOCS2 2013 Kim et al.189 
 4N9F 3.30 CUL5, ELOB, ELOC, CBFB, Vif 2014 Guo et al.190 
      
CRL7 - - - - - 
 
Most of the current information known about CRLs stem from the early discovery of 
the archetypal CRL1191,192. Complete and partial crystal structures of each of the CRLs 
soon followed over the next two decades, including complete structures of the CRL1, 
CRL2, CRL3, CRL4A, CRL4B and CRL5. A list of CRL crystal structures can be found in 
Table 4.1. Among the 26 crystal structures of CRLs solved thus far, only CRL7 has no 
structural representation. The intact structures of CRL3 and CRL5 have also not yet 
been determined, but only N or C-terminal fragments. Comparisons of the CRL1-5 
structures reveal a highly conserved Cullin topology consisting of seven domains 
(Figure 4.7). The N-terminal stalk is formed from three five-helix bundles known as 
Cullin-Repeat domains (CR1-3). A four-helix bundle connects the CR1-3 domains to 
the Cullin C-terminal which is formed from the Cullin homology C-terminal domain 
(CTD) and the Winged-Helix A and B domains (WHA/WHB) (Figure 4.6). CRLs can be 
divided into two portions - the N-terminal and C-terminal regions. The N-terminal 
CR1 domain functions as a substrate receptor complex binding site, providing 
specificity to substrates and allowing them to dock onto the N-termini of the CRL. At 
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the opposing C-terminal domain, the RBX subunit which functions as an E3 ligase, 
awaits for specific regulatory signals before recruiting a E2~Ub complex. In a lesser 
understood final step, ubiquitin is transferred from the E2 enzyme to the substrate 
and this marks the completion of one round of ubiquitination. 
Table 4.2. Adaptors and receptors for CRL complexes.  
System RING Adaptors Receptor motif 
CUL1 RBX1 Skp1 F-box 
CUL2 RBX1 ELOB/ELOC BC-box 
CUL3 RBX1 - BTB 
CUL4A RBX1 - DCAF 
CUL4B RBX1 - DCAF 
CUL5 RBX2 ELOB/ELOC SOCS-box 
CUL7 RBX1 Skp1 F-box 
Which adaptors and substrate receptors are capable of binding to the N-terminal of 
CRLs, depends on the flavour of Cullin. Several common binding motifs have been 
identified between the Cullin family members. These are summarised in Figure 4.6 
and Table 4.2. In the archetypal CRL1, the substrate adaptor is the S-phase kinase-
associated protein 1 (Skp1) which contains an F-box binding site170. The binding site 
provides CRL1 with modular access to F-box domain-containing substrate receptors 
such as Skp2 and Fbw7193, in turn connecting CRL1 with its important cognate 
substrates such as p53 (via Skp2)194 and cyclin E (via Fbw7)195. Both CRL2 and CRL5 
utilise the identical substrate adaptor proteins Transcription Elongation Factor B 
Polypeptides 1 and 2, also known as Elongin C (ELOC) and Elongin B (ELOB) 
respectively. Surprisingly, while ELOB and ELOC bind to both CRL2 and CRL5, their 
presence does not provide the Cullins with ubiquitous substrate specificity196. In fact, 
crystal structures of the CRL5 in complex the viral infectivity factor (Vif) receptor (PDB 
4N9F), revealed that a three-way interaction network occurs between the interfaces 
of CUL5, ELOB/C and Vif. Taken together these suggest that substrate specificity may 
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be determined at both the level of the substrate adaptor and the Cullin family 
member169. Receptors that bind to CRL2 are ELOB/ELOC (BC)-box binding proteins 
while those associated with CRL5 contain the suppressors of cytokine signalling 
(SOCS)-box169. Unlike the earlier CRLs, CRL3, CRL4A and CRL4B do not require 
substrate adaptor molecules. Instead, their receptors directly associate with their N-
termini. In CRL3, the binding motif is known as the Broad complex, Tramtrack, Bric-
a-brac (BTB) domain. CRL4A and 4B both associate with the DNA damage binding 
protein 1 (DDB1) coupling them to the DNA repair response and for some time their 
receptor motif was unknown169,170. Further studies identified over 50 candidate 
DDB1-binding proteins with a shared binding motif that is now known as the DDB1-
CUL4-associated factors (DCAF)197. 
 
 
Figure 4.7. Domain and subunit structure of the CRL2 E3 ligase. The structural of CRL2 can be 
used to generalise the topology of all CRLs. CUL2 contains seven domains: CR1-3, 4HB, CTD 
(Cullin homology domain) and WHA/B. The substrate adaptors ELOB and ELOC (green) allow the 
substrate receptor (SR) VHL (orange) to associate with the N-terminal CR1 domain of CRL2 (light 
purple). The RBX1 E3 ligase is cradled by the WHB domain. Model generated from a combination 
of both PDBs 5N4W (CUL2, RBX1) and 4WQO (VHL, ELOB and ELOC). 
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4.1.5 Biology of the Cullin 2-RING E3 Ligase 
As one of the most biochemically but least structurally characterised CRLs, the CRL2 
regulates a number of important cellular growth factors, including angiogenesis, 
viral resistance and cell migration196. The CRL2, through its substrate adaptors ELOB 
and ELOC, interacts with at least five BC-box binding receptors198 including VHLa, 
LRR-1b, FEM1c, PRAMEd and ZYG11e. All receptors interacting with the BC-box of ELOB 
and ELOC, further contain a Cullin-2 box that confers specificity to the CUL2 scaffold. 
Collectively, the BC and Cullin-2 boxes are known as the VHL box and is found in all 
CUL2-binding receptors198. Unsurprisingly, the VHL box was first identified in the VHL 
substrate receptor. In complex with VHL, the CRL2VBC (where VBC represents VHL-
ELOB-ELOC) regulates modulates the angiogenesis pathway via regulation of 
hypoxia inducible factor (HIF)196,198. The angiogenesis pathway oversees the 
regulation of biochemical processes that leads to the formation of new blood 
vessels199. HIF is a heterodimeric transcription factor composed of unstable HIF1-α 
and constitutively expressed HIF1-β. In hypoxic conditions (low oxygen), HIF1-α 
binds to HIF1-β, forming active HIF which then translocates to the nucleus where it 
binds to and activates DNA promoters known as hypoxia response elements (HRE). 
HREs are upstream of angiogenic genes including vascular endothelial growth factor 
(VEGF), glucose transporter 1 (GLUT1) and platelet-derived growth factor (PDGF)196. 
In normoxic conditions (normal oxygen), HIF1-α is hydroxylated at specific prolines 
by a class of prolyl hydroxylases, leading to recognition by VHL, ubiquitination and 
proteasomal degradation196,198. Mutations in VHL, cause the rare hereditary von 
Hippel-Lindau cancer syndrome which leads to uncontrolled vascular tumours due 
to non-regulation of angiogenesis and other cell growth pathways196.  
                                                        
a VHL: von Hippel Lindau 
b LRR-1: Lysine-rich repeat 1 
c FEM1: Feminization 1 
d PRAME: Preferentially expressed antigen of melanoma 
e ZYG11: Acronym not defined in literature 
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Studies have also explored the possibility of taking advantage of the high specificity 
of CRLs, coupling them target and degrade certain proteins contributing to 
pathology or cellular malfunction. These are so called proteolysis targeting chimeras 
(PROTAC), which are synthetic chimeric molecules that show specificity for an E3 
ligase substrate receptor, and a target protein (Figure 4.8)193. The first PROTAC was 
developed by Sakamoto et al. who showed that the estrogen receptor could be 
preferentially degraded in vitro by designing a PROTAC that could connect between 
the receptor and the CRL1 E3 ligase200,201. Later in 2004, the first successful in vivo use 
was demonstrated when the CRL2VBC was coupled to the estrogen receptor202. Since 
then, an overwhelming number of PROTAC successes have been developed using 
the CRL2VBC system201. Despite intense research interest and numerous structural 
models of CRLs provided through x-ray crystallography, the underlying 
conformational dynamics which allow CRL assemblies, including the CRL2, to 
perform their biological function, remain ambiguous. Given that there are 
differences between members of the CRL family, inferences may not be directly 
made between CRL2 and other CRLs. The emerging field of PROTACs which interact 
through VHL, also justifies the need for proper characterisation of the CRL2 system. 
 
Figure 4.8. PROTAC layout. PROTACs couple E3 ligases with non-cognate substrates using a 
synthetic molecule consisting of moieties that bind to both the E3 substrate receptor and the 
intended substrate. Coupling results in E3-dependent ubiquitination and proteasomal 
degradation.  
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4.1.6 Regulation of Cullin RING E3 Ligases 
The regulation of CRLs involves three different but related mechanisms: 1) 
neddylation, 2) deneddylation and 3) sequestration (Figure 4.9)203,204. Neddylation is 
a post-translational modification that like ubiquitin, consists of a three-tiered 
enzymatic cascade of E1, E2 and E3 proteins. In neddylation, a molecule of the 8 kDa 
UBL NEDD8, is covalently conjugated via its C-terminal G76 to a conserved acceptor 
lysine on Cullin proteins located within the WHB domain. Neddylation results in an 
isopeptide bond formed between the sidechain of the conserved lysine Cullin and 
NEDD8. Key stages of the neddylation reaction have been captured in CRL1 and CRL5 
systems via crystallography, allowing imagination of how neddylation occurs in 
order to activate CRLs. The current and widely recognised neddylation mechanism 
is displayed in Figure 4.9a.  
 
Figure 4.9. Key regulators of CRL activity. Various stages of the neddylation reaction have been 
accessed via X-ray crystallographic structures. (a) Pre-neddylated CRL1 (PDB 1LDJ) features the 
ubiquitin E3 ligase (UbE3) RBX1 inhibited against the WHB of CUL1. (b) The neddylation 
machinery consists of the N8E2 enzyme UBC12 and conjugated NEDD8 and the DCNL1 E3 ligase 
(not shown) which ligates NEDD8 via G76 onto the conserved lysine of CUL1 and forming an 
isopeptide bond (PDB 4P5O). (c) Dissociation of NEDD8 E2 and E3 enzymes results in the post 
neddylation conformation of CRL5 (3DQV) in which WHB~N8 is found dramatically rotated away 
from its inactive position in (a). RBX1 is conformationally less restricted following neddylation. (d) 
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Various modes of CRL regulation. Cellular CRLs are thought to be sequestered by CAND1. Binding 
of substrates or dissociation of CAND1 may lead to neddylation of the CRL2. Neddylation is 
reversed by the deneddylase activity of the COP9 Signalosome.  
In a non-neddylated state, the E3 ubiquitin ligase RBX1 is cradled against the WHB 
domain of Cullin and is inactive (Figure 4.9a). The role of the WHB in inhibiting E3 
activity of RBX is supported through mutagenesis studies which observed that a 
single residue substitution (Y761A) in the WHB domain of CUL1 was sufficient to 
promote neddylation-independent E3 activity205. The cellular pool of inactive non-
neddylated CRLs are also competed for by the 120 kDa Cullin-Associated NEDD8-
Dissociated 1 (CAND1) protein. Crystal structures of CAND1 in complex with CRL1 
(1U6G) and CRL4B (4A0C), revealed an elongated brace structure that clamps onto 
Cullin along its full length and sterically obstructs both N-terminal substrate and C-
terminal E2 binding sites175. CAND1 acts as a positive regulator of CRLs since 
sequestration prevents both auto-ubiquitination of substrate receptor complexes 
and also enhances their substrate receptor exchange of CRLs206. 
Only when not sequestered by CAND1, can CRLs undergo neddylation. Drawing 
many parallels with ubiquitination, neddylation first involves the E1 NEDD8-
activating enzyme, also referred to as NAE207. NAE auto-conjugates via one of its 
reactive cysteine side chains with NEDD8 in an ATP-dependent step, forming a high 
energy thioester bond. NEDD8 is then transferred from NAE~NEDD8 to the E2 UBC12, 
which together with the E3 Defective in Cullin Neddylation 1 (DCN1), transfers NEDD8 
to the acceptor lysine of Cullins (Figure 4.9b). Although neddylation is promoted in 
the presence of DCN1, its presence is not strictly necessary in vivo, leading to 
suggestions that RBX can function as a NEDD8 E3 ligase while DCN1 is a co-factor for 
neddylation208. Crystal structures of the neddylation intermediate complex for CRL1 
(PDB 4P5O), revealed that binding of UBC12~N8 to CRL1, pushes RBX1 from its WHB 
cradle (Figure 4.9b). It is useful to remind the reader that the primary functionality of 
the CRL as an E3 ligase comes from the RBX subunit. Conjugation of NEDD8 to CRLs 
appears to result in major conformational changes in the CRL C-terminal, leading to 
dramatic rotation of the WHB domain away from its original RBX-cradling position. 
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This appears to enhance flexibility of the RBX subunit which is free to mediate E2~Ub 
recruitment. Conformational changes in the CRL C-terminal also result in the 
inability of CAND1 to associate due to the disruption of the C-terminal binding site175. 
  





Structural basis of the Cullin 2 RING E3 ligase regulation 
by the COP9 signalosome 
 
4.2 Abstract 
Cullin-Ring E3 Ligases (CRLs) regulate a multitude of cellular pathways through 
specific substrate receptors. The COP9 signalosome (CSN) deactivates CRLs by 
removing NEDD8 from activated Cullins. Here we present structures of the 
neddylated and deneddylated CSN-CRL2 complexes by combining single-particle 
cryo-electron microscopy (cryo-EM) with chemical cross-linking mass spectrometry 
(XL-MS). These structures suggest a conserved mechanism of CSN activation, 
consisting of conformational clamping of the CRL2 substrate by CSN2/CSN4, release 
of the catalytic CSN5/CSN6 heterodimer and finally activation of the CSN5 
deneddylation machinery. Using hydrogen-deuterium exchange (HDX)-MS we show 
that CRL2 activates CSN5/CSN6 in a neddylation-independent manner. The 
presence of NEDD8 is required to activate the CSN5 active site. Overall, by 
synergising cryo-EM with MS, we identify sensory regions of the CSN that mediate its 
stepwise activation and provide a framework for understanding the regulatory 
mechanism of other Cullin family members. 
  





Cullin-RING Ligases (CRLs) are modular, multi-subunit complexes that constitute a 
major class of ubiquitin E3 ligases170,173. CRLs coordinate the ubiquitination of 
substrates as either a signal for degradation via the 26S proteasome, or to alter the 
function of the target protein170,209. The CRL2 E3 ligase consists of a Cullin 2 (CUL2) 
scaffold in association with a catalytic RING-box protein (RBX1), with the substrate 
adaptors Elongin B (ELOB) and C (ELOC) at its N-terminal198. When associated with 
the von Hippel–Lindau (VHL) tumour suppressor substrate receptor, the CRL2 
complex is the primary regulator of the Hypoxia Inducible Factor 1-α (HIF-1α) 
transcription factor210,211. Mutations in the interface between VHL, ELOB and ELOC 
can deactivate CRL2 leading to an accumulation of HIF-1α, which can in turn drive 
tumorigenesis through the over-activation of oncogenes212. Moreover, CRL2 has 
recently been identified as a potential target for small molecular inhibitors and 
PROTACs—a new class of cancer drugs that promote degradation of tumorigenic 
gene products182,213,214. These fascinating systems have been described in detail by a 
number of excellent reviews170,173,209. 
Activation of CRL2, in common with other members of the CRL family, involves a 
cascade of E1, E2 and E3 enzymes, which conjugate the ubiquitin-like protein NEDD8 
(N8) to residue K689 on the CUL2 scaffold215. In its activated state, CRL2~N8 (the ~ 
stylisation denotes a covalent interaction) recruits the ubiquitin-conjugated E2 
enzyme via the RING domain of RBX1179. Ubiquitination now takes place, covalently 
adding ubiquitin to the substrate molecule docked at the CRL2 N-terminal. The 
activity of CRL2 is negatively regulated by the 331 kDa Constitutive 
Photomorphogenesis 9 Signalosome (CSN) complex, frequently referred to as the 
COP9 signalosome complex216-218. The CSN was originally identified as consisting of 
eight subunits (designated as CSN1–8 by decreasing molecular weights of 57–22 
kDa), and is organised in a splayed hand architecture, which has high sequence and 
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structural homology to the proteasome lid216,217,219-221. CSN1, 2, 3, 4, 7 and 8 are 
structurally homologous to each other and together contribute to the fingers of the 
splayed hand which arise from extended N-terminal α-helical repeats219,221. Each 
CSN1-8 subunit includes an extended C-terminal helix which associates together 
forming a C-terminal helical bundle. CSN5 and 6 are also closely related structurally 
and form a globular heterodimer located on the palm of the hand. CSN5 is 
responsible for the deneddylase activity of the CSN. A ninth subunit, CSNAP, has 
recently been identified, and is thought to play a role in stabilising the CSN 
complex221. 
Electron microscopy (EM) based structural analysis has provided important insights 
into the mechanism of CRL1 regulation by CSN219,222. CRL4A and CRL3 have also been 
observed to form such complexes223. However, despite intense interest, structural 
information of the CSN bound to CRLs remains limited to CRL1179,219,222, CRL4A223, and 
a low-resolution map of a dimeric CSN–CRL3~N8223 complex. In particular, the 
analysis of the CSN–CRL4A~N8 complex223 identified at least three major steps by 
which CRL~N8 is deneddylated by the CSN. In the first step, the extended N-terminal 
helical modules of CSN2 and CSN4 conformationally clamp the C-terminal domain 
of the CRL4A~N8 and RBX1219,222,223. The second step involves the release and 
consequent relocation of CSN5/CSN6 closer to NEDD8, brought about by disruption 
of the CSN4/CSN6 interface223. Disrupting the binding interface between CSN4/CSN6 
through removal of the CSN6 insertion-2 loop (Ins-2), resulted in enhanced 
deneddylase activity217, presumably due to more complete release of CSN5/CSN6. In 
the final step, the mobile CSN5 binds to NEDD8, leading to deneddylation via its 
JAB1/MPN/MOV34 (JAMM) metalloprotease domain224. The JAMM motif consists of 
H138, H140 and D151 zinc-coordinating residues, and residue E104 of the CSN5 
insertion-1 loop (Ins-1)217. In apo-CSN, the Ins-1 loop occludes the CSN5 active site, 
auto-inhibiting the deneddylase225. Deneddylation is also severely diminished by a 
H138A point mutation in CSN5217. 
DYNAMIC CHARACTERISATION OF LARGE PROTEIN COMPLEXES: THE COP9 SIGNALOSOME 
 
 171 
Surprisingly, the CSN can also form complexes with each of the Cullin 1-5 family 
members even without NEDD8226. Free CRLs such as CRL1 have been reported to 
readily bind and inhibit the CSN, albeit at relatively lower affinity than the 
neddylated CRL1227. While the exact role of CSN-CRL complexes remains unclear, it 
has been hypothesised that these complexes may function to regulate the cellular 
level of ubiquitin ligase activity of CRLs once they have been deneddylated, 
effectively sequestering E3 ligases from the intracellular environment227. 
Building on the existing knowledge of the CSN–CRL systems, here we pose the 
question: are similar structural changes to be found in other CSN–CRL complexes, 
and how does binding of neddylated CRLs lead to activation of the CSN5 catalytic 
site? To address this, we present structures of the CSN–CRL2~N8 complex, together 
with the structure of the CSN–CRL2 deneddylation product. We complement our 
cryo-EM analysis with chemical cross-linking mass spectrometry (XL-MS) allowing us 
to clarify the positions of particularly dynamic regions in the complexes. We use 
hydrogen-deuterium exchange mass spectrometry (HDX-MS) to interrogate the role 
of the CSN4/CSN6 interface in communicating CRL binding to the CSN5 active site. 
Overall, our structures of the CSN–CRL2~N8 and its deneddylation product, the 
CSN–CRL2, reveal the intricate conformational changes of CSN that lead to 
deneddylation of the CRL2. 
  




4.4 Materials and Methods 
4.4.1 Preparation and expression of bacmids 
WT and catalytically reduced CSN5H138A bacmids were a kind gift from Radoslav 
Enchev (The Francis Crick Institute, London)222. pcDNA3-myc3-CUL2 was a gift from 
Yue Xiong (Addgene plasmid #19892228). HA-VHL wt-pBabe-puro was a gift from 
William Kaelin (Addgene plasmid #19234229). RBX1, ELOB and ELOC were cloned 
from cDNA from the Mammalian Gene Collection (MGC) purchased from 
Dharmacon. To improve protein yield, an N-terminally truncated (1-53) natural 
isoform of VHL was also produced for use with mass spectrometry. Both isoforms of 
VHL were sub-cloned into a pET-52b(+) vector (Novagen) to add an N-terminal Step-
Tag II. Genes were assembled into pACEBac1 using I-CeuI/BstXI restriction sites via 
the MultiBac system230. RBX1 and CUL2 were assembled into one vector and ELOB, 
Strep II-VHL(ΔN) and ELOC into a second vector. Correct assembly was confirmed by 
sequencing of entire genes. DH10EmBacY cells were transformed with each 
assembly and blue/white selection was performed on L-agar plates containing 50 μg 
ml-1 kanamycin, 7 μg ml-1 gentamycin, 10 μg ml-1 tetracyclin, 100 μg ml-1 Bluo-Gal 
(Thermo Scientific) and 40 mg ml-1 IPTG. DH10MultiBac bacmid DNA was isolated 
from single white colonies. Recombinant baculoviruses were generated in Sf9 insect 
cells (a clonal isolate from Sf21, Life Technologies #11496015) using standard 
amplification procedures. 
4.4.2 Expression and Purification of Recombinant CRL2 
High Five Cells (BTI-TN-5B1-4, from embryonic tissue of the cabbage 
looper, Trichoplusia ni, Life Technologies #B85502) were co-infected with bacmids 
containing RBX1/CUL2 and ELOB/Strep-II VHL(ΔN)/ELOC and incubated at 27 °C and 
130 rpm for 72 hours. Cells were harvested by centrifugation at 250xg for 10 mins at 
4 oC before storage at -80 oC. Freeze-thawed pellets were resuspended in 50 mM Tris 
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pH 7.5, 150 mM NaCl, 2 mM DTT containing complete EDTA-free protease inhibitor 
tablets (Roche) and Benzonase (Sigma-Aldrich). Cells were lysed by sonication and 
clarified by centrifugation at 25,000 xg for 1 hour (Beckman JA-20 rotor). Supernatant 
was bound to a 3x 5 ml StrepTrap HP columns (GE Healthcare) in tandem, 
equilibrated with 50 mM Tris pH 7.5, 150 mM NaCl, 2 mM DTT. Protein was eluted by 
the addition of 2.5 mM d-desthiobiotin. The eluted peak fractions were concentrated 
to 2 ml and loaded onto a Superdex 200 16/600 (GE Healthcare) size exclusion 
column equilibrated with 50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM TCEP. All CRL2 
and CRL2~N8 samples used throughout were in 50 mM HEPES pH 7.5, 150 mM NaCl, 
1 mM TCEP. 
4.4.3 In vitro Neddylation of CRL2 
APPBP1-Uba3, UbcH12 and Nedd8-His were purchased from (Enzo Life Sciences). 
The neddylation reaction was carried out for 10 min at 37 °C with 8 μM CRL2, 350 nM 
APPBP1-Uba3, 1.8 μM UbcH12 and 50 μM Nedd8 in a reaction buffer (50 mM HEPES 
pH 7.5 and 150 mM NaCl) supplemented with 1.25 mM ATP and 10 mM MgCl2. The 
reaction was quenched with 15 mM DTT and ice prior to loading onto a 1 ml 
StrepTrap HP column (GE Healthcare). CRL2~N8 was eluted with reaction buffer 
supplemented with 2.5 mM desthiobiotin and neddylation was confirmed by SDS-
PAGE. 
4.4.4 Expression and Purification of Recombinant CSN 
High Five Cells were co-infected with the bacmids gifted by Radoslav Enchev (The 
Francis Crick Institute, London) and protein were expressed as described for CRL2, 
with an additional Ni-affinity step prior to gel filtration to exploit the His6-tag on the 
CSN5 subunit. For Strep-affinity chromatography 50 mM HEPES pH 7.5, 200 mM 
NaCl, 2 mM TCEP and 4% glycerol buffer was used, with the addition of 2.5 mM d-
desthiobiotin for elution. For Ni-affinity using 2× HisTrap HP columns (GE 
Healthcare) in tandem, the same buffer was used, but protein was eluted by a 0–300 
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mM imidazole gradient across 45 ml. For size exclusion chromatography using a 
Superdex 200 16/600 (GE Healthcare), the column was equilibrated with 50 mM 
HEPES pH 7.5, 150 mM NaCl, 1 mM TCEP and 2% glycerol. All CSN and CSNWT samples 
used throughout were in 50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT and 1% 
glycerol. 
4.4.5 Cryo-EM of CSN-CRL2~N8 
The CSN–CRL2~N8 complex was formed by incubation between CRL2~N8 (1.1× 
molar excess) and CSN at room temperature for 90 min. The preparation (~0.5 MDa) 
was subjected to size exclusion chromatography using a Superose 6 Increase 
3.2/300 column (GE Healthcare), equilibrated in 15 mM HEPES pH 7.5, 100 mM NaCl, 
0.5 mM DTT and 1% glycerol to reduce the contribution of apo components. 
Fractions from the leading edge of the peak were buffer exchanged into 15 mM 
HEPES pH 7.5 and 100 mM NaCl using PD SpinTrap G-25 columns (GE Healthcare) 
before initial assessment by negative stain EM. Cryo-grids were prepared using a 
Vitrobot (FEI). A cryo-EM dataset was collected beamline M02 from Quantifoil grids 
with an extra carbon layer at the Electron Bio-Imaging Centre (eBIC - Diamond Light 
Source, UK) on a Titan Krios 300 kV with Gatan K2 detector (M02), Å pix-1 = 1.06. 
Movies of 25 frames (dose = 1.85 e Å-2) were motion corrected in RELION231 (2.0) using 
MOTIONCOR2232 (01-30-2017) and subsequent CTF estimation of micrographs was 
performed using CTFFIND4233 (4.1.5) (Supplementary Figure 6.18). Auto-picking 
selected ~317,000 particles from ~3100 micrographs. Particles were subjected to 
reference free 2D classification to assess data quality and to remove contaminants 
selected by auto-picking. This process reduced the particle number to ~250,000. 
Following particle selection through 2D classification, particles were divided into 15 
3D classes. Three of these classes (~69,000 particles) were selected for further 
classification and processing, as described in Supplementary Figure 6.19. 
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4.4.6 Cryo-EM of CSN-CRL2 
The CSN–CRL2 complex was formed by incubation between CRL2 (1.1× molar 
excess) and CSN at room temperature for 90 min. Samples were loaded onto a 5–
50% glycerol GraFix234 gradient containing 0–0.2% glutaraldehyde and 
ultracentrifuged at 86,000 ×g for 24 h at 4 °C. Gradients were manually fractionated 
and the resultant aliquots assessed by SDS-PAGE to determine the extent of cross-
linking. Fractions were also assessed using negative stain EM in-house. In order to 
reduce the glycerol content of samples for cryo-EM, fractions containing the desired 
complex (as determined by negative stain EM) were pooled together and gel filtered 
into 15 mM HEPES pH 7.5, 100 mM NaCl and 0.5 mM DTT using a Superose 6 Increase 
10/300 GL column (GE Healthcare). Fractions were again assessed by negative stain 
before preparing cryo-grids using a Vitrobot (FEI). A cryo-EM dataset was collected 
at the Electron Bio-Imaging Centre (eBIC - Diamond Light Source, UK) on a Titan 
Krios 300 kV with Gatan K2 detector (M02), with a sampling of 1.047 Å pix-1. Movies of 
85 frames (dose = 1.0 e Å-2) were motion corrected in RELION235 (3.0) using 
MOTIONCOR2232 (01-30-2017) and subsequent CTF estimation of micrographs was 
performed using CTFFIND4233 (4.1.5). Auto-picking selected ~309,000 particles from 
~6800 micrographs. Particles were subjected to reference free 2D classification to 
assess data quality and to remove contaminants selected by auto-picking. This 
process reduced the particle number to ~208,000. Following particle selection 
through 2D classification, particles were divided into six 3D classes first with 
alignment, then subsequently without alignment with a mask around CSN5/CSN6 in 
order to perform focused classification on this area. The map that showed the 
greatest recovery of detail for CSN5/CSN6 (Supplementary Figure 6.28)215 was then 
subjected to 3D auto refinement and post-processing. Local resolution was 
estimated using ResMap236 as part of the RELION wrapper.  
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4.4.7 Band-shift assays 
In order to test the activity of the CSN and CSNWT, 3 μg of each complex was 
separately incubated with 3 μg of CRL2~N8 at 37 °C for 0, 15, 30, 45 and 60 s. 
Deneddylation was quenched through rapid denaturation by the addition of 
NuPAGE lithium dodecyl sulphate sample buffer (Thermo Fisher) and placing on a 
heat block, pre-heated to 90 °C. Samples were analysed by SDS-PAGE. 
Deneddylation in samples with the CSNWT were confirmed by a band shift the gel 
band corresponding to CUL2, by comparison with CRL2~N8 and CRL2 controls. 
4.4.8 Homology modelling of the CRL2 
Homology modelling of the CRL2 was necessary due to a combination of missing 
domain structure for the CUL2 Winged-Helix A (WHA) and VHL subunit in the only 
crystal structure of CRL2 (PDB 5N4W). Homology modelling was performed through 
two stages: first, generating a CRL2 structure with a correct WHA domain, and 
second, generating the complete CRL2 intact with the VHL-ELOB-ELOC adaptor 
complex. In the first stage, we performed structural alignment of the CRL2 (5N4W) 
and CRL1 (1LDJ) structures in PyMOL (2.0.6). Using MODELLER237, a single model of 
the CRL2 was generated using the slow molecular refinement option of MODELLER. 
The model was manually evaluated for correct fold, including the correct positioning 
of residues (such as the CUL2 K689 NEDD8-acceptor site) already present in the 
5N4W crystal structure. In the second stage, we aligned the CRL2 model with the 
VHL-ELOB-ELOC-CUL2 fragment (4WQO) to generate a template for homology 
modelling. The isoform 3 of VHL (missing residues 1–53) was used for modelling to 
maintain consistency with the experimental construct. Again, a single model of the 
CRL2 (with VHL/ELOB/ELOC) was generated using the slow molecular refinement 
option of MODELLER. The final model of the CRL2 shows a RMSD of 3.6 Å when 
compared with the initial crystal structure (5N4W) but includes a complete WHA 
domain and VHL subunit.  
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4.4.9 Model fitting of EM maps 
All models were fitted using CSN subunits sourced from the 4D10 crystal structure 
(chains A–H) and the CRL2 (VHL-ELOB-ELOC) structure generated and described in 
section 4.4.8. We performed map fitting first by performing rigid body fitting of the 
CSN and CRL2 subunits to each map in Chimera238 (1.13.1rc) then using the 
Molecular Dynamics Flexible Fitting (MDFF)239 (0.5) feature of NAMD240 for positional 
refinement. In the rigid body fitting step, elongated subunits such as CSN2, CSN4 
and CUL2 were first dissected into smaller rigid bodies to permit better fitting into 
their densities. Following map fitting of all CSN and CRL2 subunits, we then 
converted the structures into MDFF-compatible topology files using the protein 
structure file builder function of VMD62 (1.9.3). MDFF was performed in two steps: an 
initial energy minimisation step (scaling factor = 0.3 for 50,000 steps) which coerced 
each subunit into their map densities, and a second equilibration run (scaling factor 
= 10 for 200,000 steps) which applied molecular dynamics to produce structurally 
and energetically realistic structures. Secondary structure, cis-peptide and chirality 
characteristics of the initial models were calculated and enforced throughout each 
step to avoid a loss of internal structure for each subunit. For each of the CSN–
CRL2~N8 and CSN–CRL2 structures, subunits/domains which lacked clear density 
were not included to avoid interference with the fitting of other subunits. These were 
the WHB domain (CUL2 residues 656–745) for all maps, NEDD8 in all NEDD8-
including maps, and VHL in the CSN–CRL2 map. The cross-correlation coefficient 
which calculates the degree of overlap between the cryo-EM map and a simulated 
map of the same resolution from the atomic model, are reported for each model in 
Table 4.3 of the manuscript. 
4.4.10 Native mass spectrometry 
All spectral data were collected using a SYNAPT G2-Si (Waters Corp., Manchester, UK) 
high-definition mass spectrometer and samples were ionised using a 
NanoLockSpray™ dual electrospray inlet source (Waters Corporation) run with 
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positive polarity in sensitivity mode. Capillaries were pulled using a Flaming/Brown 
P-97 micropipette puller (Sutter Instrument) and coated with Au:Pd (80:20) using a 
sputter coater (Quorum Q150RS). The following mass spectrometer settings were 
used: capillary voltage 1.60–1.75 kV, sampling cone of 75–150 V, source temperature 
of 20 °C, desolvation temperature 150 °C and collision energy of 25–75 eV. Gas 
pressures were: source 9.3 × 10-3 mbar, trap 3.3 × 10-2 mbar, helium cell 3.4 mbar, drift 
tube 2.6 mbar, transfer 3.1 × 10-2 mbar and time-of-flight 5.7 × 10-7 mbar. 
A 1:1 ratio of CSN:CRL2~N8 and CSNWT:CRL2 at a 5–15 μM concentration were pre-
incubated for 1 h prior to buffer exchange. Pre-incubated protein samples were 
buffer exchanged and desalted using Vivaspin 500 (30 kDa MWCO) centrifugal 
concentrators (Sartorius) into pH 7.5 150 mM ammonium acetate (four wash steps). 
All spectra were analysed using MassLynx (4.1, Waters Corp.). 
4.4.11 Hydrogen deuterium exchange mass spectrometry 
HDX-MS experiments were performed on a Synapt G2-Si HDMS coupled to an 
Acquity UPLC M-Class system with HDX and automation (Waters Corporation, 
Manchester, UK). Data were collected in positive polarity in sensitivity mode and 
calibrated using sodium iodide. The following mass spectrometer settings were 
used: capillary voltage of 3 kV, sampling cone of 100 V, source temperature of 80 °C 
and desolvation temperature of 150 °C. Acquisition mass range was set to 50–2000 
Da. Gas pressures were: source 6.6 × 10-3 mbar, trap 2.9 × 10-2 mbar, helium cell 4.5 
mbar, drift tube 3.1 mbar, transfer 2.8 × 10-2 mbar and time-of-flight 8.2 × 10-7 mbar. 
Protein samples were prepared at a concentration of 7.5 μM. Isotope labelling was 
initiated by diluting 5 μl of each protein sample into 95 μl of buffer L (10 mM 
potassium phosphate in D2O pD 6.6). The protein was incubated at various time 
points (0.25, 5 and 30 min) and then quenched in ice cold buffer Q (100 mM 
potassium phosphate, brought to pH 2.3 with formic acid (FA)) before being digested 
online with a Waters Enzymate BEH pepsin column at 20 °C. The same procedure 
was used for undeuterated control, with the labelling buffer being replaced by buffer 
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E (10 mM potassium phosphate in H2O pH 7.0). The peptides were trapped on a 
Waters BEH C18 VanGuard pre-column for 3 min at a flow rate of 200 μl min-1 in buffer 
A (0.1% FA ~pH 2.5) before being applied to a Waters BEH C18 analytical column. 
Peptides were eluted over 7 min with a linear gradient of buffer B (8–40% gradient of 
0.1% FA in acetonitrile) at a flow rate of 40 μl min-1 with a runtime of 11 min. All 
trapping and chromatography were performed at 0.5 °C to minimise back exchange. 
MSE data were acquired with a 25–45 eV transfer collision energy ramp for high-
energy acquisition of product ions. Leucine Enkephalin (LeuEnk-Sigma) was used as 
a lock mass for mass accuracy correction and the MS was calibrated with sodium 
iodide. The online Enzymate pepsin column was washed with pepsin wash (1.5 M 
Gu-HCl, 4% MeOH and 0.8% FA) recommended by the manufacturer and a blank run 
using the pepsin wash was performed between each sample to prevent significant 
peptide carry-over from the pepsin column. Optimised peptide identification and 
peptide coverage for all samples was performed from undeuterated controls (three–
four replicates). All deuterium time points were performed in triplicate on different 
samples on distinct samples. 
Sequence identification was made from MSE data from the undeuterated samples 
using the Waters ProteinLynx Global Server 2.5.1 (PLGS). Processing parameters of 
PLGS were set to: lock mass for charge 1 of 556.2771 Da e-1, lock mass window of 0.4 
Da, low energy threshold of 135.0 counts, elevated energy threshold of 30.0 counts 
and intensity threshold of 750 counts. Workflow parameters were: peptide and 
fragment mass tolerance set to automatic, minimum fragment ion matches per 
peptide set to 1, minimum fragment ion matches per protein set to 7, minimum 
peptide matches per protein set to 3, primary digest reagent set to non-specific, 
number of missed cleavages 0, false discovery rate of 100%. 
The output peptides were filtered using DynamX (3.0) using the following filtering 
parameters: minimum intensity of 2500, minimum and maximum peptide sequence 
length of 5 and 30, respectively, minimum MS/MS products of 3, minimum products 
per amino acid of 0.1, and a minimum peptide score of 5. In addition, all the spectra 
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were visually examined and only those with high signal to noise ratios were used for 
HDX-MS analysis. The amount of relative deuterium uptake for each peptide was 
determined using DynamX (3.0) and are not corrected for back exchange. State 
(listing the deuterium uptake per-peptide, per-timepoint and per-experimental 
state) and difference (listing the difference in deuterium uptake between identical 
peptides of two states compared for each timepoint), were exported from DynamX. 
These files were input to Deuteros138 (1.0.8) which format the differential data into 
the Woods Plot format. Statistical filtering of peptides is then performed to identify 
those which exhibit significant uptake differences between the two states. Deuteros 
applies a blanket confidence interval (specifically, the 98% confidence interval given 
as 0 ± DU where DU is the Deuterium uptake threshold in Daltons) across all peptides 
of each timepoint. Significant peptides for each timepoint are then exported into a 
formatting script which is used to project the filtered data onto a 3D model of the 
protein (Supplementary Figure 6.36-Supplementary Figure 6.37). 
4.4.12 PLIMSTEX for CSN-CRL2 complexes 
In addition to performing traditional time-resolved HDX-MS experiments, we also 
performed PLIMSTEX (protein–ligand interactions by MS, titrations and HDX) 
measured on combinations of CSN/CSNWT and CRL2/CRL2~N8 to derive dissociation 
constants (Kd). We performed PLIMSTEX for three complexes: (1) CSN–CRL2~N8, (2) 
CSN–CRL2 and (3) CSNWT–CRL2 complexes. The final concentration of CSN or CSNWT 
was fixed at 250 nM. CRL2 or CRL2~N8 were titrated at either 1:0, 1:0.1, 1:0.5, 1:1, 1:2 
or 1:0, 1:0.1, 1:0.5, 1:1, 1:5 molar ratios of CSN:CRL2 (0–1250 nM). The sample setup 
for each of the three complexes consisted of five undeuterated references of CSN or 
CSNWT, three samples of deuterated CSN or CSNWT, followed by three of each of the 
above molar ratios of CSN:CRL2. Datasets for CSN–CRL2~N8, CSN–CRL2 or CSNWT–
CRL2 underwent labelling for either 15 sec or 2 min depending on which exposure 
time yielded better deuterium uptake differences as a function of [CRL2] or 
[CRL2~N8]. HDX-MS data acquisition and data analysis using PLGS and DynamX were 
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performed as above. Kd values for each complex were derived using a MathCAD 
worksheet (v14, Parametric Technology Corp., Needham, USA) kindly provided by 
Michael Gross (Washington University in St. Louis, USA). Briefly, the deuterium 
uptake of each peptide as a function of increasing [CRL2] or [CRL2~N8] were fitted 
using a 1:1 binding model, optimising for three parameters: D0 (initial deuterium 
uptake in the absence of [CRL2] or [CRL2~N8]), ΔD (maximum decrease in deuterium 
uptake observed) and  (where  is equal to the association constant, Ka, for 1:1 
binding). The quality of the fit is calculated as the root mean square of the residuals 
between experimental datapoints and the model values. The PLIMSTEX data fitting 
process has been documented in much greater detail elsewhere67,241,242. 
4.4.13 Chemical cross-linking mass spectrometry 
Twenty microlitres of ~20 μM CSN–CRL2~N8, CSNWT–CRL2 and apo-CSNWT were each 
incubated with 1–5 mM BS3 cross-linker for 1 h at 25 °C and 350 r.p.m. in a 
thermomixer. After cross-linking, complexes were (i) separated by gel 
electrophoresis (NuPAGE) followed by in-gel digestion (CSNWT–CRL2, CSNWT and 
CSN–CRL2~N8) or (ii) digested in solution (CSNWT–CRL2) and generated peptides 
were pre-fractionated by gel filtration (CSN–CRL2~N8). Gel electrophoresis was 
performed using the NuPAGE system according to manufacturer’s protocols. In-gel 
digestion was performed as described before243. Digestion in solution was 
performed in the presence of RapiGest (Waters) according to manufacturer’s 
protocols. For gel filtration, peptides were dissolved in 30% acetonitrile (MeCN), 
0.1% trifluoroacetic acid and separated on a Superdex Peptide PC 3.2/30 column (GE 
Healthcare) at a flow rate of 50 µl min-1. 
4.4.14 Mass spectrometry for XL-MS 
Peptides were dissolved in 2% MeCN, 0.1% FA and separated by nano-flow liquid 
chromatography (Dionex UltiMate 3000 RSLC, Thermo Scientific; mobile phase A: 
0.1% (v/v) FA; mobile phase B: 80% (v/v) MeCN, 0.08% (v/v) FA). Peptides were loaded 
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onto a trap column (μ-Pre-column, C18, 100 μm I.D., particle size 5 μm; Thermo 
Scientific) and separated with a flow rate of 300 nl min-1 on an analytical C18 capillary 
column (Acclaim PepMap 100, C18, 75 μm I.D., particle size 3 μm, 50 cm; Thermo 
Scientific), with a gradient of 4–90% (v/v) mobile phase B over 66 min. Separated 
peptides were directly eluted into a Q Exactive Plus hybrid quadrupole-Orbitrap 
(CRL2 and CRL2~N8) or an Orbitrap Fusion Tribrid Mass Spectrometer (CSN–
CRL2~N8) (Thermo Scientific). 
Typical mass spectrometric conditions for the Q Exactive Plus were: spray voltage of 
1.6–2.1 kV; capillary temperature of 250 °C; normalised collision energy of 30%, 
activation Q of 0.25. The mass spectrometer was operated in data-dependent mode. 
Survey full scan MS spectra were acquired in the Orbitrap from 350–1600 or 2000 m/z 
with a resolution of 70,000 at an automatic gain control (AGC) target of 3 × 106. The 
top 20 most intense ions were selected for Higher Energy Collisional Dissociation 
(HCD) MS/MS fragmentation in the Orbitrap (isolation window, 1.5 or 1.6 m/z). 
MS/MS spectra were acquired at a resolution of 17,500 at an AGC target of 1 × 105 or 
5 × 104. Previously selected ions within previous 30 s were dynamically excluded for 
30 s. Only ions with charge states 2–7+ were selected. Singly charged ions as well as 
ions with unrecognised charge state were excluded. Internal calibration of the 
Orbitrap was performed using the lock mass option (lock mass: m/z 445.120025)244. 
Typical mass spectrometric conditions for the Orbitrap Fusion were: spray voltage 
of 2.5 kV; capillary temperature of 275 °C; collision energy of 30% and activation Q of 
0.25. The mass spectrometer was operated in data-dependent mode. Survey full 
scan MS spectra were acquired in the Orbitrap from 500–1700 or 2000 m/z with a 
resolution of 120,000 at an AGC target of 5 × 104. The most intense ions were selected 
for HCD MS/MS fragmentation in the Orbitrap (3 s cycle time with a maximum 
injection time of 128 ms; isolation window, 1.6 m/z). MS/MS spectra were acquired 
at a resolution of 30,000 at an AGC target of 5 × 104. Previously selected ions within 
previous 30 s were dynamically excluded for 20 s. Only ions with charge states 3–8+ 
were selected. Singly and doubly charged ions as well as ions with unrecognised 
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charge state were excluded. Internal calibration of the Orbitrap was performed using 
the lock mass option (lock mass: m/z 445.120025)244. 
4.4.15 Data analysis for XL-MS 
Raw files were converted into Mascot generic format (mgf) files using pXtractf. Mgf’s 
were searched against a reduced database containing CSN and CRL2 proteins using 
pLink 1.0 search engine. Search parameters were: instrument spectra, HCD; enzyme, 
trypsin; max missed cleavage sites, 3; variable modifications, oxidation (methionine) 
and carbamidomethylation (cysteine); cross-linker, BS3; min peptide length, 4; max 
peptide length, 100; min peptide mass, 400 Da; max peptide mass, 10,000 Da; false 
discovery rate, 1%. Potential cross-linked dipeptides were evaluated by their 
spectral quality. Circular network plots were generated using the XVisg,61 webserver. 
4.4.16 XL-MS guided placement of the WHB, NEDD8 and VHL subunits 
Cross-links determined from XL-MS for the CSN-CRL2~N8 and CSN-CRL2 complexes 
were used to clarify the position of the WHB, NEDD8 and VHL subunits which lacked 
clear density in our cryo-EM maps. We performed XL-guided placement using the 
Integrative Modelling Platform (IMP)108 (2.6), using as input, the map-fitted models of 
the CSN-CRL2~N8 and CSN-CRL2. The CSN-CRL2~N8 model post-map fitting, 
included all subunits except the WHB and NEDD8. Similarly, the CSN-CRL2 model 
included all subunits except the WHB and VHL. Separately, the subunits of each 
complex were initialized as coarse-grained bead models, representing each residue 
as a single bead. The WHB domain (Cullin-2 residues 656-745) and VHL was sourced 
from the homology model of the CRL2 (detailed in the section Homology Modelling 
of the CRL2). NEDD8 was sourced from the crystal structure of neddylated CRL5 
                                                        
f http://pfind.ict.ac.cn/software/pXtract/index.html 
g https://xvis.genzentrum.lmu.de/login.php 
DYNAMIC CHARACTERISATION OF LARGE PROTEIN COMPLEXES: THE COP9 SIGNALOSOME 
 
 184 
(3DQV). WHB, NEDD8 and VHL were set as mobile rigid bodies, while all other 
subunits were kept stationary.  
Our modelling procedure utilised two types of cross-links. The first type are pseudo-
cross-links that maintain the correct topology of the complex: a single pseudo-cross-
link between CUL2T655 to WHBT656 of 5 Å to mimic a covalent bond, and connections 
between VHL-ELOB, VHL-ELOC and VHL-CUL2 to maintain integrity of the VHL-ELOB-
ELOC adaptor complex and its interface with CUL2. A single pseudo-cross-link of 10 
Å was used to mimic the isopeptide bond of WHBK689~N8G76 (7.5 Å lysine side chain + 
~3 Å glycine C-terminus). The second type are cross-links determined experimentally 
between WHB, NEDD8 and VHL with its surrounding subunits which utilised a 
distance threshold of 35 Å (two lysine side chains at 15 Å, BS3 linker length at 10 Å, 
plus 10 Å for flexibility). IMP was parametrised to perform 1000 iterations, with each 
iteration randomly moving WHB, NEDD8 and VHL relative to the stationary CSN and 
CRL subunits. IMP parameters used were num_mc_steps = 10, rb_max_trans = 2, 
rb_max_rot = 0.1, bead_max_trans = 0.5 and excluded volume restraint resolution 
of 20. The single best model was evaluated by projecting all cross-links for the 
complex onto the structure and confirming that all distances were below the 35 Å 
distance threshold. A table of cross-links can be found in Supplementary Data 6.1 for 
CSN–CRL2~N8 and Supplementary Data 6.2 for CSNWT–CRL2. The script used can be 
found in Supplementary Note 6.2. 
  





4.5.1 Cryo-EM structures of the CSN–CRL2~N8 complex 
To study the molecular interactions between neddylated CRL2 (CRL2~N8) and the 
CSN, we performed single-particle cryo-EM to resolve a structure of the assembled 
CSN–CRL2~N8 (referred to as the holocomplex) (Supplementary Figure 6.18-
Supplementary Figure 6.19). The H138A mutation in the catalytic site of CSN5 
subunit makes it possible to assemble CSN–CRL2~N8 complexes in which NEDD8 
remains covalently attached over the time scale of the experiment219,222. To justify the 
use of the H138A point mutation, we performed a band-shift assay comparing the 
deneddylation activity of the CSNWT and CSN5H138A mutant enzymes (Supplementary 
Figure 6.20). As expected, CSNWT rapidly cleaves NEDD8 from CRL2~N8 within 
seconds of incubation, while little to no deneddylation activity is seen from the 
CSN5H138A complex (Supplementary Figure 6.20). This mutant form of CSN was used 
throughout the work described below, unless otherwise specified. 
Using 3D classification, we were able to generate maps of three different structures: 
(a) a holocomplex map at 8.2 Å, (b) a map of the complex with little or no density for 
VHL at 8.0 Å, and (c) a map of the complex with little or no density for 
CSN5/CSN6/VHL at 6.5 Å (Supplementary Figure 6.19, Supplementary Figure 6.21-
Supplementary Figure 6.22). The two partial complexes likely arise from 
compositional heterogeneity in the original samples from which the structural 
analysis has succeeded in isolating subpopulations. To verify the existence of 
subcomplexes, we subjected the CSN–CRL2~N8 to native MS (Supplementary Figure 
6.23). In line with subpopulation observations from our cryo-EM, we identified 
subcomplexes of the CSN-CRL2~N8 missing the CSN5, VHL, ELOB or ELOC subunits. 
These observations support the notion that similar levels of heterogeneity observed 
in the cryo-EM analysis of other CSN-CRL complexes, CSN-CRL1 and CSN-CRL4A222,223 
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is also likely to arise from variable subunit composition and may be ubiquitous to all 
CSN-CRL complexes. 
Next, we fitted into each map, the highest resolution crystallographic structure of 
the CSN (PDB 4D10)217 and a homology model of the CRL2 (including the VHL-ELOB-
ELOC) using molecular dynamics flexible fitting239 (MDFF; Table 4.1, 4.4.9 Model 
fitting of EM maps). In the model of the holocomplex (8.2 Å), the main interactions 
occur between the C-terminal end of CUL2 and the extended N-terminal helical 
repeats of CSN2 and CSN4 (Figure 4.10a-b). Compared to their conformation in the 
highest resolution apo-CSN crystal structure217 (PDB 4D10), CSN2 and CSN4 are 
moved by 30 and 51 Å, respectively, towards CUL2 (Figure 4.10e, Supplementary 
Movie 6.1). We additionally reviewed the conformations of CSN2 and CSN4 in all nine 
available intact structures of the apo-CSN (PDBs 4D10, 4D18 and 4WSN; 
Supplementary Figure 6.24). We compared each of the apo-CSN structures with our 
holocomplexes and with other fitted models of the CSN in complex with CRL1~N8 
and CRL4A~N8. Significant structural variation in CSN2 and CSN4 is observed within 
these apo-CSN structures, but in all cases, their conformations were substantially 
different to any found in the holocomplexes. In each of our CSN–CRL2 structures, the 
clamping motion of CSN2 and CSN4 is a swinging rotation about hinges located 
close to the CSN2 and CSN4 winged helix domains. For CSN2 this is coupled with an 
additional rotation about the axis of the superhelix formed from its N-terminal 
helical repeats. In the case of CSN4 the movement is coupled to the detachment of 
CSN4 from the Ins-2 loop of CSN6 by ~30 Å and leads to an ~12 Å shift in CSN5 (Figure 
4.10c, f). Only minor conformational changes were found in the CSN1, CSN3, CSN7B 
or CSN8 subunits. In the CRL2~N8 moiety, a number of relatively small 
rearrangements of CUL2, RBX1, ELOB, ELOC and VHL subunits were observed 
compared to its crystal structure182 (Supplementary Figure 6.25a-b). 




Figure 4.10. Structures and interactions of the CSN–CRL2~N8 complex. (a) The molecular model 
of CSN–CRL2~N8 fitted into cryo-EM density (8.2 Å resolution) from front and back views. (b) 
Conformational clamping of CRL2~N8 by CSN2 and CSN4. Cross-links shown are between CSN4-
RBX1 (CSN4K200-RBX1K105, purple-green spheres), and four between CSN2–CUL2 (CSN2K157-
CUL2K489, CSN2K263–CUL2K462, CSN2K225–CUL2K462, CSN2K64–CUL2K404, beige-blue spheres). (c) View 
showing ~30 Å separation of CSN6 Ins-2 loop from CSN4 following CRL2~N8 binding. (d) Modelled 
position of WHB~N8 using cross-links of the CSN–CRL2~N8. Large scale conformational changes 
(e) between CSN2 and CSN4 in all apo-CSN crystal structures (PDB 4WSN, 4D10 and 4D18) and 
CSN–CRL2~N8 (f) CSN5/CSN6 (PDB 4D10) upon binding of CRL2~N8 (holo). Subunits of the CSN–
CRL2~N8 were compared with the apo-CSN crystal structure (PDB 4D10) following structural 
alignment. The structure of the CRL2~N8 has been hidden for clarity. 




In our EM maps and the other published CSN-CRL structures219,222,223, the exact 
position of NEDD8 and the CUL2 Winged-Helix B (WHB) domain were difficult to 
determine. To address this limitation, we carried out XL-MS experiments on the CSN-
CRL2~N8 complex using the bis(sulfosuccinimidyl)suberate (BS3) cross-linker which 
targets lysine sidechains (4.4 Materials and Methods). We identified a total of 24 
inter- and 60 intra-protein cross-links (Supplementary Data 6.1, Supplementary 
Figure 6.26a-b). To generate a model of the CSN–CRL2~N8, we performed cross-link 
guided modelling which allows the placement of the WHB, NEDD8 and VHL subunits 
using identified cross-links from XL-MS (4.4 Materials and Methods). We imposed a 
cross-link distance threshold of 35 Å which takes into account the length of two 
lysine side chains (15 Å), the BS3 cross-linker length (10 Å) and an extra 10 Å to allow 
for domain-level flexibility (4.4 Materials and Methods). Our model of the CSN–
CRL2~N8 satisfies all cross-link distances (Supplementary Figure 6.26c). Three cross-
links between CUL2-WHB (CUL2K382-WHBK720, CUL2K382-WHBK677 and CUL2K433-
WHBK677) were used for the positioning of the WHB domain (Supplementary Figure 
6.26d, red text). A further two cross-links between CUL2 and NEDD8 (CUL2K382-N8K33 
and CUL2K433-N8K6) allowed the positioning of NEDD8 near CSN5 (Figure 4.10d, 
Supplementary Figure 6.26d, green text). In this conformation, the isopeptide bond 
of NEDD8 is juxtaposed to the CSN5 active site. For the isopeptide bond of NEDD8 to 
reach the CSN5 active site, the WHB domain must be extended from its 
crystallographic conformation towards the CSN5 by 19 Å (Supplementary Figure 
6.26e). 
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EMDB 4739 4744 4742 4736 4741 






VHL None None 
DATA COLLECTION AND PROCESSING 
MAGNIFICATION 47,170 47,170 47,170 47,170 47,755 
VOLTAGE (kV) 300 300 300 300 300 
ELECTRON 
EXPOSURE (eÅ-2) 
45 45 45 45 83 
DEFOCUS 
RANGE (mm) 
1.8-3.0 1.8-3.0 1.8-3.0 1.8-3.0 1.8-3.0 
PIXEL SIZE (Å) 1.060 1.060 1.060 1.060 1.047 
SYMMETRY 
IMPOSED 
C1 C1 C1 C1 C1 
INITIAL NUMBER 
OF PARTICLES 
316,921 316,921 316,921 316,921 308,936 
FINAL NUMBER 
OF PARTICLES 
20,055 22,471 24,552 24,049 17,191 
MAP 
RESOLUTION (Å) 
8.2 6.5 8.0 8.4 8.8 
FSC 
THRESHOLD 





















3727 2974 3578 3716 3251 
 
4.5.2 Structure of the deneddylated CSN–CRL2 complex 
Having determined the structure of the CSN-CRL2~N8 complex, we next sought to 
detail any conformational differences in the deneddylated CSN-CRL2. The affinity of 
CSN for the non-neddylated CRLs is significantly lower than for the neddylated 
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forms, limiting the yield of the desired product222. To stabilise the formation of a 
complex between CSN and CRL2, we employed GraFix234  (4.4 Materials and 
Methods) prior to cryo-EM. Moreover, native MS confirmed the formation of CSN–
CRL2 complex (Supplementary Figure 6.27). We next resolved a cryo-EM map of the 
CSN–CRL2 to 8.8 Å resolution (Supplementary Figure 6.28-Supplementary Figure 
6.29). Although the resolution of the CSN–CRL2 map is similar to that for CSN–
CRL2~N8 holocomplex, we only observed partial density for VHL and CSN4. Next 
using the same procedure as for the neddylated CSN–CRL2~N8 complex, we fitted 
CSN and CRL2 subunits into the density map of the CSN–CRL2 complex (4.4 Materials 
and Methods). We then utilised cross-link guided modelling to establish the position 
of the WHB which lacked clear density, similar to the neddylated holocomplex 
(Supplementary Figure 6.30, Supplementary Data 6.2, 4.4 Materials and Methods). 
To determine whether the lack of density for the CSN4 may be due to flexibility of the 
CSN4 N-terminal domain, we carried out XL-MS for the apo-CSN complex 
(Supplementary Figure 6.31, Supplementary Data 6.3). A total of 18 cross-links were 
identified involving CSN4: 12 of which were intra-CSN4 cross-links, 4 between CSN2-
CSN4 and 2 between CSN6–CSN4. We measured the distances of these cross-links 
on the structure of the apo-CSN (PDB 4D10) and on our cryo-EM fitted model of the 
CSN–CRL2 (which represented the CSN4 in a lowered conformation; Supplementary 
Figure 6.31). Applying a 35 Å distance threshold, we identified cross-links which were 
exclusively satisfied in each of the two conformations of CSN4 (Supplementary 
Figure 6.31, 4.4 Materials and Methods). The presence of exclusively satisfied cross-
links indicates that both conformations have been sampled experimentally and 
suggest that the apo CSN4 can wave between the two conformations represented 
by the crystal structure and CRL2-bound structures, even in the absence of the CRL2 
substrate. 
To evaluate any local changes across the CSN–CRL2~N8 in the absence of NEDD8, 
we aligned the cryo-EM models of neddylated and deneddylated holocomplexes 
using the C-terminal helical bundle as a reference point (Supplementary Figure 
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6.32a-b). We systematically compared the conformations of each subunit 
(Supplementary Figure 6.32c-j, Supplementary Movie 6.1). Compared with its 
structure in the CSN–CRL2~N8, the N-terminal helices of CSN2 are shifted by ~21 Å 
towards the CUL2 C-terminal domain (Figure 4.11). This change in CSN2 in the 
absence of NEDD8, leads to a structural difference in CUL2 which rotates upwards 
towards the rest of the CSN by 20 Å (Figure 4.11c). The position adopted by CUL2 in 
the deneddylated holocomplex, places ELOB closer to CSN1, forming a CSN1–ELOB 
interface (Figure 4.11d). An interface between CSN1–ELOB can also be seen in the 
partial structures of CSN–CRL2~N8 missing VHL and CSN5/CSN6 (Supplementary 
Figure 6.19, Supplementary Figure 6.33). The dissociation of VHL and CSN5/CSN6 
causes the N-terminus of CUL2 to shift downwards, away from the CSN 
(Supplementary Figure 6.33). The plasticity of the CSN results in changes in the C-
terminus of CUL2, which is clamped between CSN2 and CSN4, in order to 
accommodate this shift. The formation of the CSN1-ELOB interface appears to arise 
as result of this movement in both the deneddylated structure and the incomplete 
CSN-CRL2~N8 structures. Interactions between substrate adaptor complexes and 
CSN1 have similarly been reported for the CSN-CRL1~N8219 and CSN-CRL4A~N8223. 
RBX1 remains clamped between CSN2 and CSN4 (Figure 4.11e). 




Figure 4.11. Structure of the deneddylated CSN–CRL2 complex. (a) The fitted density map of 
deneddylated CSN–CRL2 structure determined by combining cryo-EM and XL-MS. Alignment of 
the CSN C-terminal helical bundle from the neddylated and deneddylated holocomplexes 
reveals differences in (b) CSN2 and (c) CUL2. (d) CSN1-ELOB interface established from the 
rotation of CUL2 in (c). (e) RBX1 is clamped between CSN2 and CSN4. (f) Conformational changes 
in CSN6 in the absence of NEDD8. 
 
The most striking conformational differences were observed in CSN6 (Figure 4.11f, 
Supplementary Movie 6.1). In the absence of NEDD8, CSN6 is dramatically shifted 
away from its position in the neddylated holocomplex by ~40 Å (Figure 4.11f). This 
previously unknown conformation of CSN6 differs from the conformation captured 
in our neddylated holocomplex, the CSN-CRL1~N8222 and CSN-CRL4A~N8223 
structures (Supplementary Figure 6.34-Supplementary Figure 6.35). We compared 
the conformation of CSN6 seen in the structures of apo-CSN (4D10), CSN–CRL1~N8 
(EMD-3401), CSN–CRL4A~N8 (EMD-3315), CSN–CRL4ADDB2~N8 (EMD-3316) and our 
neddylated and non-neddylated CSN–CRL2 complexes through systematic 
structural alignments and measuring their pairwise root mean squared deviation 
(RMSD) (Supplementary Figure 6.34-Supplementary Figure 6.35). The conformation 
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of CSN6 in the non-neddylated CSN–CRL2 complex shows consistently high RMSD 
(16–25 Å) when compared with CSN6 in any of the other complexes indicating a high 
degree of conformational difference. CSN6 in the CSN–CRL2 structure has its Ins-2 
loop dramatically shifted away from its apo-CSN conformation, pointing upwards to 
CSN7B (Supplementary Figure 6.34, Supplementary Movie 6.1). We anticipate that 
this conformation of CSN6 in our model of the non-neddylated CSN–CRL2 is 
attributed to the lack of NEDD8. Similar to the neddylated holocomplex, no 
significant changes were identified in CSN3, CSN7B and CSN8 subunits in the CSN–
CRL2. Overall, comparison between the CSN–CRL2~N8 and CSN–CRL2 structure 
reveal significant conformational rearrangements in CSN5/CSN6 and the N-terminal 
domain of CSN2. 
4.5.3 HDX-MS reveals a stepwise mechanism of CSN activation 
Having determined the structures of the neddylated and deneddylated CSN–CRL2 
complexes, we set off to characterise the local dynamics using HDX-MS. HDX-MS 
provides peptide-level information on the dynamics of proteins through monitoring 
the exchange events of amide hydrogens for bulk deuterium in the surrounding 
solution environment65,142,182,245-248.  Here, we performed a set of two differential HDX-
MS experiments to determine the effect of: (a) CRL2~N8 binding to CSN, denoted as 
Δ(CSN–CRL2~N8 - CSN), and (b) CRL2 binding to CSN, denoted as Δ(CSNWT–CRL2 - 
CSNWT) (Figure 4.12a, Supplementary Figure 6.36-Supplementary Figure 6.37). 
Regions that exhibit significant HDX differences brought about by the addition of the 
ligand (i.e. CRL2 and CRL2~N8) are labelled as stabilising (negative ΔHDX; coloured 
blue) or destabilising (positive ΔHDX; coloured red). 





Figure 4.12. Effect of NEDD8 on the CSN4/CSN6 interface. (a) Investigating the effect of CRL2~N8 
and CRL2 binding on CSN and CSNWT, respectively. The two experiments involve deuterating the 
complexes for 0.25, 5 and 30 min time points, a quench step to halt the deuteration, and digestion 
to the peptide level. Peptides are then identified using liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) and a database search. (b) Effect of CRL2~N8 binding on the CSN. (c) 
Relative deuterium uptake over 30 min for the CSN6 Ins-2 peptide (170SVIDIING177). Error bars 
indicate the deuterium uptake standard deviation for triplicate measurements (N = 3). (d) Effect 
of CSN on the C-terminal domain of CRL2~N8. Colour scheme follows that of (b). 
 
In both Δ(CSN–CRL2~N8 - CSN) and Δ(CSNWT–CRL2 - CSNWT) experiments, extensive 
regions in the N-terminal helices of CSN2, CSN4 and the globular domain of RBX1 
exhibited stabilisation upon the incubation of CSN with its CRL2~N8 and CRL2 
substrates (Figure 4.12b, Supplementary Figure 6.38a-b). These observations are in 
line with the conformational clamping by CSN2/CSN4 onto the C-terminal of CRL2 
as seen in the cryo-EM structures of neddylated and deneddylated complexes. 
Within CSN2 of both experiments, we observed significantly destabilised regions 
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around helical modules 6–9. These observations have likely identified the hinge 
points which permit the bending of CSN2 to clamp onto the CUL2 C-terminus (Figure 
4.12b, Supplementary Figure 6.38a-b). Stabilised peptides belonging to CSN1 (143–
156) and ELOB (17–25) were identified in the Δ(CSNWT–CRL2 - CSNWT) condition, 
indicating that an interface exists between CSN1–ELOB (Supplementary Figure 6.39). 
It is noted that since the CSNWT–CRL2 sample used for HDX were not treated with 
GraFix (as they were for cryo-EM), it is unlikely that the CSN1–ELOB interface is 
caused by glutaraldehyde cross-linking. In the neddylated Δ(CSN–CRL2~N8 - CSN) 
condition, ELOB (17–25) was not found due to the lack of proteomic coverage. 
However, CSN1 (143–156) is stabilised, suggesting that the CSN1–ELOB interface is 
present in the neddylated holocomplex. 
To assess the affinity between CSN4 and CRL2, we performed PLIMSTEX (protein–
ligand interactions by mass spectrometry, titration and HDX) experiments (4.4 
Materials and Methods). In these experiments, we performed HDX-MS of CSN or 
CSNWT in the presence of increasing concentrations of CRL2 or CRL2~N8, to derive 
dissociation constants (Kd) between CSN4 and CRL2/CRL2~N8. PLIMSTEX differs 
from differential HDX-MS in several ways. First, no differential comparison is 
performed from PLIMSTEX. Second, PLIMSTEX experiments utilise a single 
deuteration time for all samples. PLIMSTEX requires a sufficiently long deuteration 
time to observe differences between holo and apo states, but short enough to 
prevent over-deuteration of interfaces as the complex naturally dissociates and re-
associates. Finally, PLIMSTEX is a titration experiment which observes deuteration 
changes as a function of ligand concentration, while differential HDX-MS utilises a 
1:1 molar ratio of our CSN and CRL2 substrates. 
We tested the affinity of CSN4 for CRL2 or CRL2~N8 in CSN–CRL2~N8, CSN–CRL2 and 
CSNWT–CRL2 complexes. Our PLIMSTEX experiments identified three regions of CSN4 
which exhibit a dramatic decrease in deuterium uptake when exposed to the CRL2 
substrate. These regions correspond to CSN4 α-helices which are in contact with 
CRL2~N8 in our cryo-EM fitted model of the CSN–CRL2~N8 (Supplementary Figure 
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6.40). The Kd measurements for the different regions of CSN4 in CSNWT–CRL2 (11.3–
34.5 nM), CSN–CRL2 (138.1–218.8 nM) and CSN–CRL2~N8 (118.9–389.0 nM) are each 
in the low nanomolar region, suggesting limited differences in local affinity brought 
about by changes such as the neddylation status of CRL2. These Kd values for the 
CSN–CRL2 system all fall within a similar overall range to the published global Kd to 
the CSN-CRL1 system222 (1.6–310 nM; Supplementary Table 6.2), indicating a crucial 
role for CSN4 in stabilising CSN–CRL2. In addition, HDX-MS based Kd measurements 
also allowed us to localise individual regions of CSN4 responsible for interacting with 
CRL2 at the peptide level (Supplementary Figure 6.40). 
4.5.4 Remodelling of the CSN5 active site in the presence of NEDD8 
We next considered the release mechanism of the CSN5/CSN6 subunits of both the 
neddylated and deneddylated holocomplexes. In both Δ(CSN-CRL2~N8 – CSN) and 
Δ(CSNWT-CRL2 – CSNWT) experiments, the Ins-2 loop of CSN6 was destabilised, 
correlating with the release of CSN6 from its interface with CSN4 and in line with the 
allosteric activation mechanism of CSN by CRL4A223 (Figure 4.13a-b, i). An interesting 
difference between the neddylated and deneddylated complexes is that the CSN6 
α4 helix is destabilised only in the absence of NEDD8 (Figure 4.13b, i). Similarly, the 
CSN5 α7 helix is also destabilised in both neddylated and deneddylated conditions 
(Figure 4.13b, ii). The CSN6 α4 and CSN5 α7 helices are topologically knotted in the 
CSN5/CSN6 heterodimer and tether the globular domains of CSN5/CSN6 to the C-
terminal helical bundle217. These observations suggest that structural changes are 
required in the helical knot to bring about release of the CSN5/CSN6 globular 
domains from their apo conformation. 
 




Figure 4.13. Conformational response of CSN5/CSN6 to NEDD8. Differential HDX-MS of (a) Δ(CSN–
CRL2~N8 - CSN) and (b) Δ(CSNWT–CRL2 - CSNWT). Regions exhibiting significant deuterium uptake 
differences in (i) CSN6, (ii) CSN5 and (iii) CSN5 active site are highlighted in red for destabilised 
and blue for stabilised areas. Regions without coverage or exhibit non-significant changes are in 
grey and white, respectively. (c–d) Deuteration profiles of CSN5 active site (as shown in a–b iii). 
Profiles of the c non-neddylated and d neddylated holocomplex (red) are compared with 
deuteration profiles of the isolated CSN (blue). The ion distribution of active site peptide is shown 
for (c) and (d) across reference 0 s, 15 s, 5 m and 30 m timepoints. The mass of the non-deuterated 
reference peptide is shown by the dotted line. A second dotted line for the holocomplexes (red) 
DYNAMIC CHARACTERISATION OF LARGE PROTEIN COMPLEXES: THE COP9 SIGNALOSOME 
 
 198 
indicates the mass of the peptide at the 30 m timepoint. The relative deuterium changes of the 
active site peptide in (c) following binding of CRL2 is negligible, while in (d), presence of CRL2~N8 
leads to a significant increase in mass. 
  
Another finding is that we identified destabilisation in the Ins-2 loop of CSN5 (Figure 
4.13a-b, i). The Ins-2 loop of CSN5 has a lesser understood role in CSN activation. In 
isolated CSN5, the Ins-2 loop is highly disordered225 (Supplementary Figure 6.41a), 
while it folds into a helical-loop structure when incorporated into the CSN217 
(Supplementary Figure 6.41b). Accompanying the changes in the CSN5 Ins-2 loop, in 
both comparative HDX-MS experiments, we detected destabilisation of the α5 helix 
area which surrounds the CSN5 active site (Figure 4.13a-b, ii). The changes in both 
the CSN5 Ins-2 and α5 helix indicate a major conformational remodelling in the area 
adjacent to the CSN5 active site, which can be triggered through the binding of both 
CRL2 or CRL2~N8 to the CSN in a NEDD8-independent manner. It is only in the 
presence of NEDD8, that the CSN5 active site is further destabilised suggesting that 
in a final activation step, NEDD8 induces conformational changes in the active site 
itself (Figure 4.13). To eliminate the possibility that the observed changes in the 
CSN5 active site are due to the H138A point mutation, we compared the deuterium 
uptake profiles of CSN5 from apo-CSNWT and CSN5H138A constructs (Supplementary 
Figure 6.42). Calculating the deuterium uptake differences between peptides of the 
CSN5WT and CSN5H138A and visualising this through a Woods plot, identified no 
significant uptake differences (Supplementary Figure 6.42). With this considered, the 
deprotection observed in the CSN5 active site of the CSN–CRL2~N8 complex can be 
seen to result from the binding of CRL2~N8 and not the H138A mutation of the CSN5 
active site. 
4.6 Discussion 
Here we have combined EM and MS analyses to provide insights into the mediation 
of CRL2 by the CSN. We have described the molecular structures of CSN–CRL2~N8 
and its deneddylated CSN–CRL2 counterpart. Furthermore, we combined cryo-EM 
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maps with comparative HDX-MS to expand on the stepwise activation mechanism 
of the CSN, involving a conformational network of both NEDD8-independent and 
dependent stages. We suggest that the steps which lead to deneddylation are mostly 
NEDD8-independent, except for the remodelling of the CSN5 active site which 
requires NEDD8 to encounter the CSN5 active site. 
Our map of the deneddylated CSN–CRL2 holocomplex represents a complex in 
which the CSN is still associated with its CRL2 reaction product. Resolving this 
structure has provided several important details into how activation of the CSN is 
achieved. Our comparison of the neddylated and deneddylated holocomplex 
structures indicated that the CSN2 contacts the CRL2 C-terminal domain in a slightly 
different conformation to when the CRL2 is modified with NEDD8. Between both 
neddylated and deneddylated conformations, we suggest that the clamping by 
CSN2 involves destabilization of the CSN2 helical modules 6–9 which function 
possibly as a hinge that allows the CSN2 to bend upwards towards the CRL2. The 
plasticity of these N-terminal helices presumably permits the binding of 
deneddylated and alternative Cullin isoforms. HDX-MS further indicates that RBX1 
and CSN4 form an interface, which is more prominent in the absence of NEDD8, as 
shown through stabilisation of the two interfaces (Supplementary Figure 6.38b). 
Overall, the conformational variations seen in the CSN2 N-terminal helical modules 
(Figure 4.11b), the bend of CRL2 (Figure 4.11c) and the HDX differences in CSN4/RBX1 
(Supplementary Figure 6.38b) may therefore be attributable to the seemingly 
promiscuous affinity that allows CSN2 to bind to each of the different Cullins 
regardless of neddylation. 
We uncovered structural and dynamical aspects of both the neddylated and 
deneddylated CSN–CRL2 complexes. Beginning our interpretation from valuable 
studies of the CSN–CRL1~N8 and CSN–CRL4A~N8 systems, we propose several 
major conformational switches of the CSN which must be activated by the CRL2 
substrate to bring about deneddylation. While some of these steps are conserved 
ubiquitously among other CSN-CRL complexes (e.g. CSN2/CSN4 clamping in CSN–
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CRL1~N8 and CSN–CRL4A~N8), our study suggests additional steps for the CRL2-
bound CSN complex (Figure 4.14). In the first activation step, the CSN and CRL2~N8 
associate through major conformational changes in CSN2 and CSN4, which clamp 
onto the CRL2 (Figure 4.14a-b). Our data suggest that the conformational change in 
CSN4 breaks its interface with CSN6 through the CSN6 Ins-2 loop and with the 
eventual release of the CSN5/CSN6 heterodimer (Figure 4.14c). Removal of the CSN6 
Ins-2 loop has been shown in CSN-CRL1 to disrupt the CSN4-CSN6 interface, leading 
to sustained enzymatic activity of the CSN217. In future studies, targeted deletion of 
the CSN6 Ins-2 loop can be performed alongside differential HDX-MS for the CSN-
CRL2 system, to further probe the differences in active site remodelling of CSN5 as a 
result of disrupting the CSN4-CSN6 interface. 
 
Figure 4.14. Schematic of CRL2 regulation by the CSN. (a) Neddylated (active) CRL2~N8 is 
regulated by the CSN. (b) CRL2~N8 is bound by the CSN, principally through clamping by the 
extended N-terminal helical modules of subunits CSN2 and CSN4. (c) The topological changes 
that occur in CSN4 upon CRL2 binding result in detachment of the CSN6 Ins-2 loop and 
subsequent release of the CSN5/CSN6 heterodimer in a NEDD8-independent step. (d) The 
presence of NEDD8 triggers remodelling of the CSN5 active site, (e) permitting deneddylation of 
CRL2. (f) Cleavage of NEDD8 results in dissociation of the CSN and inactive CRL2. 




The release of CSN5/CSN6 appears consistent with the destabilised knotted helices 
of CSN6 that our HDX has identified. It is plausible that these two helices function as 
the mechanical hinges which allow the CSN5/CSN6 to be released from their auto-
inhibited conformations but remain tethered to the rest of the CSN. Although the 
resolution presented by CSN5 in our cryo-EM structures prevents us from making 
molecular level observations, our HDX data can provide local detail for the CSN5 
active site. The release of CSN5/CSN6 is accompanied by HDX changes in areas 
surrounding the CSN5 active site, including the CSN5 Ins-2 loop. Up to here, the 
changes experienced by the CSN can be brought about in a NEDD8-independent 
manner. In the next stage, the presence of NEDD8 acts as a selectivity filter which 
results in remodelling of the CSN5 active site itself (Figure 4.14d). These changes 
presumably expose the CSN5 JAMM ligands of the metalloprotease site and allow 
subsequent deneddylation to occur (Figure 4.14e). Finally, deneddylation ensues 
with the cleavage of NEDD8 from CRL2 and the dissociation of the complex (Figure 
4.14f). The fact that CSN can then re-associate with its CRL2 reaction product 
following dissociation, as shown by our study and structure of the CSN–CRL2, 
suggests that the non-neddylated complex may possess an alternative role to 
deneddylation. By associating with non-neddylated CRLs, the CSN sterically blocks 
access of both ubiquitination E2 enzymes and substrates to the CRLs219,223. Further 
studies will be required to fully understand the deneddylation-independent roles of 
the CSN. Interestingly, a comparison of our non-neddylated CSN–CRL2 with the apo-
CSN and neddylated CSN–CRL4~N8 and CSN–CRL2~N8 complexes, highlighted the 
dramatic differences in the conformation of CSN6. In the absence of NEDD8, the 
CSN5/CSN6 are released much further than any other observed conformation of 
CSN6. We hypothesise that this difference may arise from the lack of steric 
hinderance usually presented by NEDD8, allowing CSN5/CSN6 to rotate and meet 
the Cullin scaffold much closer than in the neddylated structure. 
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In our study we have made interpretations of the CSN2 and CSN4 conformational 
clamping through comparing our cryo-EM holocomplexes with crystal structures of 
the apo-CSN. From reviewing the conformations of all nine currently available 
independent copies of the apo-CSN molecule it is apparent that CSN2 and CSN4 
appear to exist in a range of open conformations that are quite distinct from the 
closed conformations that we observed in CSN–CRL2 complexes (Supplementary 
Figure 6.25), and the similarly closed conformations observed in CSN complexes 
with CRL1~N8 and CRL4A~N8. However, each of the apo-CSN crystal structures is 
characterised by crystal contacts involving CSN2 and CSN4 which in principle could 
have biased their conformations. 
Therefore, we used XL-MS to further monitor the conformation of CSN4 within the 
solution structure of apo-CSN and found that both open and closed conformations 
of apo-CSN are required to satisfy a number of unique cross-links (Supplementary 
Figure 6.35). Since our study used lysine cross-links, our distance measurements do 
not allow for a high level of scrutiny in our modelling due to the uncertainty of lysine 
side chain rotamers in our models. Nonetheless, given that the violated cross-link 
distances are well above 40–50 Å for one model and close to 35 Å for the other 
(Supplementary Figure 6.31), we can assume that both open and closed 
conformations are simultaneously represented within the cross-link ensemble. Thus 
it seems likely that crystal formation has stabilised CSN conformations already 
present in solution. Hence, while we cannot completely rule out the possibility that 
the crystallographically defined open conformations of apo-CSN are atypical, it 
seems likely that the solution structure of the apo-CSN corresponds to an ensemble 
containing a range of open structures including those seen crystallographically as 
well as some closed or nearly closed structures. In comparison, CSN2 and CSN4 in 
the cryo-EM structures of CSN–CRL2 complexes adopt consistently closed 
conformations sandwiching the C-terminal end of CUL2 with rather little apparent 
conformational variation. It is likely here that conformational variation is limited by 
interactions formed with CUL2. Thus it would appear that the interaction between 
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CSN and CRL2 involves the transition of CSN from an ensemble of conformers with 
substantial variation in the distance between CSN2 and CSN4 to a bound complex 
in which CSN2 and CSN4 clamp onto the C-terminal region of CUL2 which is 
characterised by greatly reduced conformational variation. 
To further explore the nature of such clamped complexes, we additionally 
performed PLIMSTEX experiments which provided localised affinity values between 
CSN4 and CUL2 for each combination of the CSN–CRL2. From a functional 
perspective, our PLIMSTEX experiments also determined that the H138A mutation of 
CSN5 leads to measurable changes in Kd between CSN4 and CRL2. It is also 
important to note that the Kd values presented are not representative of the global 
Kd between CSN and CRL2 complexes but are only local affinities between the CSN4 
and CRL2 subunits. PLIMSTEX experiments require that the labelling time of the 
experiment is carefully selected based on preliminary experiments249. While 
powerful, a concern is that if the labelling time is too long, protein interfaces may 
become over-deuterated, leading to an underestimated deuterium uptake decrease 
and a higher Kd value. Likewise, some interfaces may appear invisible if the labelling 
time is not sufficiently long to allow deuteration to occur. 
In both neddylated and non-neddylated CSN-CRL2 complexes, we identified an 
interface between CSN1 and ELOB. So far, CSN1 has been shown to interact with 
Skp2 and Fbw7 in CRL1219 and DDB1 in CRL4A holocomplexes223. Mutations of the 
CSN1-DDB1 interface did not affect binding to the CSN nor perturb deneddylation 
activity223. In the absence of Cullin-1 or RBX1, CRL1 substrate receptors do not 
associate with the CSN1219. Although no CSN activator role has been assigned to 
CSN1-substrate receptor interactions, their presence increases the interface 
between CSN and their CRL substrates219 and may stabilise these interactions.  
Furthermore, there may be additional roles for the CSN as suggested by the 
compositional plasticity seen in our CSN–CRL2~N8 classes. In our map of the CSN–
CRL2~N8, the Cullin arm was observed to shift downwards away from CSN3 in maps 
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deficient of the VHL substrate receptor (Supplementary Figure 6.43), consistent with 
the coupling of VHL binding to a conformational change in the rest of the CRL2 
portion of the protein. This type of behavior may allow the CRL2 to adapt to 
individual substrates and substrate receptors which vary in size and geometry as has 
been suggested with the CRL4A system223. In addition, it may reflect changes 
associated with remodeling of the CRL2 by the dissociation of the VHL and the 
binding of alternative substrate receptors. In future work we will seek to determine 
whether the CSN can mediate substrate receptor dissociation. 
Overall, our study has provided greater detail into the role of CRL2 and NEDD8 in 
regulating the activation mechanism of CSN. We propose that the series of 
mechanistic responses of the CSN that lead up to deneddylation, can be triggered 
even by the CRL2 reaction product in a NEDD8-independent manner. The presence 
of NEDD8 on the activated CRL2 substrate would then trigger the remodeling within 
the catalytic site of the CSN5 subunit during the final stage of CSN activation. We 
envision that this type of mechanism would have implications for the entire family 
of CRL proteins and their regulatory relationship with the CSN. Our study therefore 
provides a template not only for assisting investigations of other CRL-based systems 
but also for bringing together data from different structural biology techniques that 
otherwise will be reported independently. 
  





Chapter 5: Conclusions and Future Outlook 
From the perspective of a structural biologist, the discovery of a protein’s structure 
can be thought of as overcoming a major energy barrier in the understanding of its 
function. The challenge of protein structure determination in the past has been 
served by techniques such as X-ray crystallography and NMR. The advent of cryo-EM 
and its “resolution revolution” has brought with it a new era of structural 
determination, particularly allowing access to previously insuperable systems such 
as dynamic macromolecules and membrane protein systems. MS has served a 
complementary role to these techniques by providing a toolkit that can probe 
multiple structural and dynamic dimensions of biological molecules. Combined 
interpretation of atomistic structures with MS data provides a more complete 
understanding than reviewing either of the techniques alone and can be streamlined 
through the use of computational strategies as demonstrated in this thesis. As the 
structures of increasing numbers of proteins become available, the understanding 
of protein function will be limited by the next energy barrier, in the form of its 
conformational landscape and interactome. Mapping out the dynamic mechanisms 
and interactions of proteins will lead to better knowledge of cellular function and its 
relationship to health and disease. 
In this thesis, I have demonstrated three methods of dynamic characterization of 
proteins. In the first chapter, a computational workflow capable of replicating the 
gas phase structures of large flexible proteins was demonstrated. This methodology 
combined modelling strategies with MD simulations and produced representative 
models of each of the IgG1-4 isotypes based on agreement with IM-MS 
measurements. Previous attempts to replicate the gas phase topologies of IgG1 
directly from their crystal structures were less successful. The utility of the 
methodology is two-fold. First, it highlights the need to consider the solution 
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ensemble of flexible molecules prior to any gas phase simulations. In solution, 
flexible proteins occupy a wide continuum of conformations. We propose a model 
envisioning that flexible proteins are coaxed into occupying a subset of compact 
solution conformations during ESI droplet shrinkage, and that these compact 
conformations later populate the gas phase distribution. Second, we demonstrate 
that a combination of a topological sampling with short gas phase MD (~5 ns) is a 
computationally inexpensive alternative to trajectory stitching methods. This 
approach can be in theory applied to any proteins which derive their flexibility from 
hinge or linker regions.  
Since structural collapse in the gas phase is directly related to flexibility in solution, 
this methodology opens exciting avenues into the use of IM-MS for characterisation 
of protein flexibility. One such application may be in the development of 
biotherapeutics whereby our method can be used in a differential manner to 
characterise changes in the conformational space of antibodies as a function of 
mutation or drug binding (Figure 5.1). Such integration may streamline the drug 
screening process by providing existing IM-MS workflows with the means of 
generating representative structures for detailed comparisons.  
 
Figure 5.1. Modelling workflow can be used to assess differences in conformational space of 
antibodies upon drug binding. (a-b) Antibodies and drug compounds can be screened using IM-
MS. (c) Identify compounds leading to changes in conformation. (d) Identify candidate binding 
sites, e.g. through docking analysis. (e) Application of our computational workflow to assess gas 
phase conformations of antibody-drug pairs. (f) Validate possible candidate sites through 
matching CCS.  
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The use of HDX-MS for protein characterisation has gained traction over the recent 
years due to its ability to capture dynamic aspects of protein behaviour. 
Developments into instrumentation capable of performing high-throughput HDX-
MS, has been paralleled with studies of increasing biological complexity, and equal 
developments into data analysis software. The timeline of HDX-MS over the last few 
decades has seen multiple shifts in the technique’s bottleneck, from first, data 
acquisition speeds, to data processing and now finally to meaningful visualisation 
and interpretation. Chapter 3 describes the development of Deuteros – statistical 
analysis and visualisation software designed to facilitate interpretation of HDX-MS 
results. Analysis of protein behaviour in differential comparisons remains one of the 
most commonly applied methods of HDX-MS. The extraction of potentially 
interesting peptides using statistical methods, is one of the strengths of Deuteros 
through its Woods and volcano plotting facilities. While the software still has much 
room for improvement, its utility is evident in the growing number of publications 
that showcase Deuteros-analysed data. Improvements to the backend and analysis 
workflow such as those documented in this thesis, will hopefully continue to be of 
use to the HDX-MS community upon the release of Deuteros 2.0. We anticipate that 
the new features of Deuteros 2.0 will further enhance interpretation of HDX-MS data 
leading to fruitful discoveries in protein functionality. 
Dynamic behaviours occur not only in flexible molecules such as antibodies, but also 
manifest during transitions along a protein’s mechanistic landscape. An example of 
a complex reaction pathway involving several conformational transitions, can be 
found in the CSN complex of the UPS. In Chapter 4, we demonstrated the utility of a 
combinatory structural MS and cryo-EM approach to determine the precise steps of 
the deneddylation cascade of the CSN. The activation of the CSN involves a dynamic 
network of conformational events, relayed through binding to neddylated CRLs. 
Uniting several structural techniques offers a synergistic advantage since the 
shortcomings of individual techniques can be compensated for by information 
contained in others. Several techniques offering redundancy to observations also 
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gives confidence to conclusions and can avoid false positives from being reported. 
Cryo-EM provided unprecedented resolution into the topology and arrangement of 
the CSN, however was unable to resolve dynamic regions critical to the 
understanding of how deneddylation occurs. We utilised XL-MS to capture proximity 
information on the dynamic regions and used the resultant cross-links in 
computational modelling to guide their placement. Sub-complexes of the CSN were 
identified in both cryo-EM and native MS spectra, suggesting their natural 
occurrence within the distribution of CSN structures in solution. Further differential 
HDX-MS provided a method of capturing dynamic events upon binding of both the 
neddylated and non-neddylated CRL2 to CSN, and biologically interesting regions 
were extracted using Deuteros. Overall, our multi-technique approach has 
determined several novel and key events that occur during activation of the CSN. 
Our study supports the notion of conserved interactions between the CSN and its 
cognate CRLs, but also demonstrates the utility and often, necessity of complex 
characterisation from multiple structural angles.  
In summary, this thesis has contributed towards developing methodologies for the 
characterisation of protein dynamics, through the integration of structural MS and 
computational modelling. As structural biology progresses into the “dynamic era”, 
methods capable of dynamic characterisation will be indispensable to 
understanding the mechanisms of increasingly complex biological systems and 
even interactions at the cellular level. The potential applications of integrative 
modelling are endless, and will no doubt stimulate further discussions, spark 
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Chapter 6: Appendix 
 
6.1 Supplementary Information: Developing a workflow for modelling protein 
flexibility using ion-mobility MS and gas phase simulations 
The original supplementary information files can be found online at:  
https://onlinelibrary.wiley.com/doi/full/10.1002/anie.201812018 
6.1.1 Supplementary Tables 
Supplementary Table 6.1. Experimental values for IgG1 samples 
Subclass IgG from Sigma Herceptin Waters mAb standard 
Theoretical mass (kDa)h 150 150 150 
Experimental mass (Da)i 149,328 (±89) 148,620 (±64) 149,719 (±54) 
Experimental chargej 21+ 21+ 20+ 
Glycosylated CCS (Å2)k 6827 (±81) 6875 (±50) 6883 (±57) 
Deglycosylated CCS (Å2)l 6851 (±61) 6786 (±54) 6762 (±63) 
  
                                                        
h Approximate mass of glycosylated protein given glycoform variability, and sequence variability in Fc and 
Fab regions for Sigma IgG1. 
i Experimentally observed glycosylated mass via MS (± standard deviation). 
j Lowest observed experimental charge. 
k Average CCS for lowest charge over T-waves 550, 600 and 640 ms-1 (± standard deviation) for glycosylated 
proteins. 










Supplementary Figure 6.1. Schematic of IgG Fc binding sites. (a) FcγR, C1q and FcRn binding sites 
are shown for the IgG Fc. (b) Alignment of FcγR crystal structure (orange/green; PDB 1T83) and 
FcRn (red; PDB 1FRT) to Fc of IgG2 (teal; PDB 1IGT). The hinge is located at the top of the Fc for 







Supplementary Figure 6.2. Sequences of IgG1-4 homology models. The source of the variable 
and canonical sequences of each IgG heavy and light chain are shown. Variable regions (red) were 
inherited from crystal structures used for homology modelling for each IgG. Canonical sequences 
of the heavy (purple) and light (blue) chains were accessed from UniProt. The number of acidic 
and basic residues were calculated via the ProtParam m  webserver for each half of the IgG 
molecule. The net charge displayed is calculated for the whole IgG molecule. 
  






Supplementary Figure 6.3. Solution simulation of IgG3 homology model. (a) Timeline of IgG3 
structure. Heavy chains are shown in teal and violet, light chains are in blue. Simulation 
parameters (b) radius of gyration, (c) RMSD, (d) solvent accessible surface area (SASA) and (e) root 
mean squared fluctuation of sidechain atoms over the simulation time. (f) System potential and 
kinetic energy, temperature and pressure parameters over simulation time. Analysis performed 







Supplementary Figure 6.4. Hinge length of human IgG3. (a) Homology model of human IgG3 
showing the approximately 110 Å hinge region. (b) Average conformation of human IgG3 






Supplementary Figure 6.5. MS spectra of glycosylated IgG1-4. Native mass spectra of all four 






Supplementary Figure 6.6. CCS distributions of IgG1-4. Collisional cross section distributions for 








Supplementary Figure 6.7. MS spectra of deglycosylated IgG1-4. Native mass spectra of all four 
subtypes of deglycosylated IgG showing charge envelope resulting from electrospray ionisation. 







Supplementary Figure 6.8. Deconvoluted MS spectra of glycosylated and deglycosylated IgG1. 
Deconvolution performed using Waters MassLynx mass measurement tool and transform 






Supplementary Figure 6.9. CCSexp of IgG1-4. CCSexp for IgG1-4 shown for the lowest experimental 
charge states (21+ for IgG1, IgG2 and IgG4, 22+ for IgG3). Measurements were recorded and 
averaged for 550, 600 and 640 ms-1 T-wave velocities. Error bars show standard deviations of 






Supplementary Figure 6.10. High resolution native MS of Herceptin, Waters mAb and Sigma 
human plasma IgG1 samples, revealing glycoform heterogeneity. The individual glycoforms are 









Supplementary Figure 6.11. CCS of all Fab conformations of IgG1-4 post-sampling. Values 








Supplementary Figure 6.12. RMSD matrices of 50 lowest CCS models of IgG1-4. Low RMSD 
variation between lowest CCS models of IgG2 compared to IgG1, IgG3 and IgG4 suggest a more 
confined conformational space populated by homogenous models. IgG3 model ensemble 
exhibits high RMSD variation frequently greater than 70 Å, indicating compact conformations can 







Supplementary Figure 6.13. Analysis of IgG1 gas phase simulations. (a) Structure similarity 
measurements RMSD and RMSF, (b) size measurements radius of gyration and CCS, and (c) 






Supplementary Figure 6.14. Analysis of IgG2 gas phase simulations. (a) Structure similarity 
measurements RMSD and RMSF, (b) size measurements radius of gyration and CCS, and (c) 






Supplementary Figure 6.15. Analysis of IgG3 gas phase simulations. (a) Structure similarity 
measurements RMSD and RMSF, (b) size measurements radius of gyration and CCS, and (c) 







Supplementary Figure 6.16. Analysis of IgG4 gas phase simulations. (a) Structure similarity 
measurements RMSD and RMSF, (b) size measurements radius of gyration and CCS, and (c) 






Supplementary Figure 6.17. Gas phase simulations of IgG4 for charges 22-25+. Beginning from an 
identical IgG4 model, we performed four simulations, reflecting 22-25+ experimental charge 
states. Each model was pre-charged using a different random distribution of charge sites and 
simulated for 10 ns. The average CCS and CCS variation over the last 1 ns of each simulation is 
shown by the orange data point and error bars. The experimental CCS and standard deviation 
are shown in blue. The final model of each simulation is shown under each data point. The 








6.2 Original publication: Deuteros: software for rapid analysis and visualization 
of data from differential hydrogen deuterium exchange-mass spectrometry  
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1Department of Chemistry, King's College London, 7 Trinity Street, London, SE1 1DB, United 
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6.2.1 Abstract  
Summary: Hydrogen deuterium exchange-mass spectrometry (HDX-MS) has 
emerged as a powerful technique for interrogating the conformational dynamics of 
proteins and their complexes. Currently, analysis of HDX-MS data remains a 
laborious procedure, mainly due to the lack of streamlined software to process the 
large datasets. We present Deuteros which is a standalone software designed to be 
coupled with Waters DynamX HDX data analysis software, allowing the rapid analysis 
and visualization of data from differential HDX-MS.  
Availability and implementation: Deuteros is open-source and can be downloaded 
from https://github.com/andymlau/Deuteros, under the Apache 2.0 license. Written 
in MATLAB and supported on both Windows and MacOS. Requires the MATLAB 
runtime library. According to the Wellcome Trust and UK research councils’ 




and sharing, all data supporting this study will be openly available from the software 
repository.  
 
6.2.2 Introduction  
Hydrogen deuterium exchange mass spectrometry (HDX-MS) is a structural 
technique which has garnered attention for its ability to assess protein-protein and 
protein-ligand interactions, protein folding, and the associated dynamics of these 
processes64,65,247,250. The basis of HDX-MS relies on the exchange of labile amide 
hydrogens of the protein backbones, for bulk deuterium within solution. The protein 
of interest is allowed to undergo exchange in a deuterium-rich buffer for a set 
number of timepoints and then quenched. The protein is then enzymatically cleaved 
to the peptide level, and the mixture is subjected to liquid chromatography coupled 
to mass spectrometry (LC-MS). Using LC-MS, the mass of the peptide acquired 
through deuteration can be determined via a database search. Peptides which 
participate in hydrogen bonding of amide hydrogens result in lesser exchange248. 
Additionally, those which comprise the accessible surfaces of proteins, may 
experience relatively greater deuteration, than those found in the protein interior248. 
In differential HDX-MS (ΔHDX-MS), peptides from a reference state are compared 
with those from an altered state (which could be for instance a mutation or a ligand) 
to report on regions of the protein which are affected by structural or conformational 
perturbations.  
After data acquisition, the analysis of HDX-MS data using Waters Instrumentation 
consists of several steps: (i) peptide identification using the Protein Lynx Global 
Server (Waters Corp.), (ii) peptide mass assignment using DynamX (Waters Corp.) 
and (iii) visualization and interpretation of data. In particular, interpretation of the 
results can be challenging due to the size of the datasets involved. A typical HDX-MS 
experiment will result in the order of 102 peptides depending on the system size and 




on the ensemble of peptides generated from HDX-MS. Waters offers in DynamX, 
‘butterfly’ and ‘difference’ plots which while useful during data analysis, have several 
shortcomings. They do not show the identity of each peptide, their lengths or 
regional peptide redundancy. As an alternative, the ‘Woods’ plot126 (developed 
separately from Waters), provides a per-timepoint breakdown of the peptide 
ensemble, with each subplot displaying peptide length, start and end residues, 
global coverage and a vertical axis metric which may be absolute uptake (in Daltons) 
or relative fractional uptake (RFU). HDX data can additionally be visualized on 
uptake maps, and molecular representations where uptake and other data are 
projected onto 3-dimensional structures of the system131.  
To simplify the HDX-MS analysis workflow, we have developed Deuteros for the rapid 
visualization of differential HDX-MS data. Development of the software was primarily 
motivated by the lack of data representation methods for differential HDX-MS. 
Deuteros has been designed to be used post-DynamX, for the downstream statistical 
filtering and visualization of data from differential HDX-MS. It provides alternative 
visualization capabilities in the form of statistically filtered ‘Woods’ plots and 
through PyMOL-compatible scripts, which allow differential HDX-MS data to be 
projected onto three- dimensional structures of proteins. A combination of these 
visualization methods provides users with the ability to effortlessly identify 
biologically interestingly regions of proteins. Finally, inputs to Deuteros have been 
standardized to csv files, allowing the software to be potentially compatible with any 
instrumentation.  
We have applied our software to a comparison of the wild-type xylose transporter 
(XylE) and a E153Q mutant. XylE is a secondary membrane transporter protein 
tasked with the role of shuttling xylose sugar across bacterial cell membranes251. A 
member of the Major Facilitator Superfamily (MFS), XylE operates through an 
alternating-access mechanism, transitioning be- tween inward-facing and outward-




6.2.3 How does it work?  
Deuteros is a standalone MATLAB application available to both MacOS and Windows 
and requires the MATLAB runtime library. Deuteros is designed to assist 
interpretation of HDX-MS data that has been analyzed using DynamX (Waters Corp.) 
and provides complementary data visualization capabilities. Deuteros requires two 
inputs: the ‘state’ and ‘difference’ files exported from DynamX. Deuteros consists of 
four steps including data input and three visualization stages: flattened data maps, 
Woods plot (with statistical peptide filtering) and output to PyMOL.  
6.2.4 Input data 
The DynamX ‘state’ file contains a per-protein, per- peptide, per-time point 
aggregation of peptide deuterium uptake data from the ΔHDX-MS conditions. State 
files contain information including m/z, maximum possible deuterium uptake, 
observed deuterium uptake, standard deviation, retention time, and any residue 
modifications reported. Users should only enable proteins and states of interest and 
disable all others within the DynamX session file. The ‘difference’ file contains a per-
peptide, per-timepoint comparison of peptide deuterium uptake from two user 
defined states. The difference file can only be generated from DynamX when two or 
more states are loaded into the dataset. Users should ensure that the correct 
comparison is made by selecting the correct states within DynamX. A video tutorial 
and example datasets have been provided alongside the software.  
6.2.5 Visualization 
Deuteros produces flattened data maps including coverage, residue-level 
redundancy, deuterium uptake heat maps and Woods plots. Coverage, redundancy 
and various deuterium uptake styles can also be exported from Deuteros, to be 
projected onto atomic models of the protein of interest in the PyMOL molecular 




MacOS, or PyMOL version 2.0 and above for Windows), or alternatively copy and 
paste the con- tents of the file into the PyMOL command line.  
6.2.6 Statistics 
Confidence limits are calculated as140:  
  (6.1) 
where  is the standard deviation of the mean uptake for timepoint ,  is the 
number of sample replicates, and  is the critical value desired. By default, Deuteros 
provides critical values for 98 and 99% confidence limits (6.965 and 9.925) for a two-
tailed t-test with 2 degrees of freedom. For ‘sum’ data, where peptide deuterium 
uptake differences from each timepoint are aggregated together to better identify 
potential peptides that are conformationally active, the confidence limits are 
calculated using:  
 
 (6.2) 
where  is the variance of all peptides for timepoint ,  is the number of timepoint 
observations for the variance,  is the number of timepoints and  is the critical 
value as in (6.1). Errors are propagated as a simple sum of variables as according to 
Houde et al.140.  
6.2.7 Application 
To showcase the capabilities of Deuteros, we imported state and difference files 
from the wild-type and E153Q mutant XylE membrane transporter Martens et al.141. 
The coverage map of XylE indicate a 92.5% coverage, with the largest non-covered 
region around residues 230–240 (Figure 6.1a). The redundancy map expands on the 
coverage map, displaying the same coverage, but with a white-magenta color 




highest redundancy of the XylE dataset was at 12 peptide copies around residues 
465 (Figure 6.1b). The N-terminal, residues 90, 180, 260 and 360 have only a single 
peptide representing these regions.  
The Woods plot section displays a per-timepoint breakdown of the differential 
dataset in a grid layout. Deuteros can display a maximum of approximately 8 
timepoints simultaneously before individual Woods plots become too crowded, 
depending on the screen size and resolution. Woods plots first apply confidence 
filtering to all peptides in each timepoint (Figure 6.1c). Peptides with differential 
deuteration outside of the user selected confidence limits are non-significant and 
are shown in grey. The significant peptides are shown as red for deprotected and 
blue for those that are protected. While only one set of confidence limits are applied 
to the data, two boundaries are shown on each Woods plot as a visual aid for users 
to view which peptides might be significant, should they wish to tighten or relax the 
filter used. The legend section displays the confidence limits as 6 Da (to two decimal 
places) values around 0 (or no difference). To facilitate interpretation, significant 
peptides can also be exported as a csv file containing a per-peptide per-timepoint 
breakdown of the ΔHDX-MS data. Users may also take advantage of the in-built 
MATLAB data cursor which displays the residue number and differential uptake of a 





Figure 6.1. Overview of Deuteros demonstrated on the XylE transporter. Visualization of (a) 
experimental protein coverage, (b) data redundancy and (c) deuterium up- take differences in 
Woods plot format. Dashed and dotted lines indicate 98 and 99% confidence limits applied to 
the dataset to identify peptides with significant deuteration differences. Deprotected, protected 
and non-significantly different peptides are in red, blue and grey respectively. (d) Differential HDX-
MS data for the wild-type and E153Q mutant XylE has been projected onto its crystal structure 
(PDB ID: 4GBY)  
The PyMOL export section consists of options for formatting the data from the linear 
coverage map and Woods plot sections, for visualization in PyMOL through pml files. 
Coverage and redundancy can be projected onto structures and a range of color 
palettes are available. Differential deuteration data can also be exported for 
projection onto the molecular structure of XylE (PDB ID: 4GBY; Figure 6.1d). For this 
representation, the deuteration data type can show absolute differential uptake (in 
Daltons), or the differential relative fractional uptake (ΔRFU). The ΔRFU considers the 
peptide length and its maximum deuteration and scales the absolute uptake as a 
percentage of this value, which may be more informative for some datasets. Similar 




protected, deprotected, non-significant and non-covered regions. Through 
projection of deuteration data onto the structure of XylE, structural effects caused 
by the E153Q mutation are immediately visible (Figure 6.1d). The extracellular-facing 
portion of XylE experiences protection (blue), while the intracellular portion 
experiences deprotection (red).  
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6.3 Supplementary Information for Structural basis of the Cullin 2 RING E3 
ligase regulation by the COP9 signalosome 
The original supplementary information files can be found online at: 
https://www.nature.com/articles/s41467-019-11772-y#Sec26 
 
6.3.1 Supplementary Figures 
 
Supplementary Figure 6.18. Cryo-electron micrographs. Micrographs of (a) CSN-CRL2~N8 and (b) 
CSN-CRL2 complexes. (i) Representative power spectrum and (ii) various single molecular views 





Supplementary Figure 6.19. Flowchart depicting the workflow for processing cryo-EM data. A set 
of ~3100 micrographs were subjected to manual and auto-picking in order to acquire particles 
for 2D reference-free classification (a). 2D classification was used for the positive selection of 




heterogeneity and presence of a small component of apo-CSN (purple model) in the data set. 
Particles from the three models containing the CSN and CRL2~N8 in (b) were pooled and further 
processed as described in the workflow. Maps (e) (CSN-CRL2-VHL~N8) and (f) (CSN-CRL2~N8) were 
generated using focused refinement by applying a mask and using the area of interest as a 
starting model. (g) shows the Fourier shell correlation (FSC) for the four maps (c-f). 
 
Supplementary Figure 6.20. Deneddylation activity of CSNWT and CSN5H138A. (a) Bands 
corresponding to denatured CSN and CRL2 complexes. (b) Incubation of CSNWT with CRL2~N8 
and (c) CSN5H138A with CRL2~N8 over time. Proteins were incubated at 37˚C and reactions were 
inhibited through the addition of lithium dodecyl sulphate (LDS) and quickly heating to 90˚C 
using a pre-heated heat block to ensure rapid denaturation. Bands corresponding to CUL2~N8 





Supplementary Figure 6.21. Cryo-EM structures of the CSN-CRL2~N8 segmented to highlight 
subunit composition. Maps of the (a) CSN-CRL2~N8 holocomplex, (b) holocomplex (from VHL 
focused refinement), (c) holocomplex missing VHL (d) holocomplex missing CSN5/CSN6 and VHL, 
are shown in various orientations. (e) Resolution maps of (a-d) from front and back views. Map 





Supplementary Figure 6.22. Stereo images of CSN-CRL2~N8 complexes. Maps of the (a) CSN-
CRL2~N8 holocomplex (threshold 0.022), (b) holocomplex (from VHL focused refinement; 
threshold 0.014), (c) holocomplex missing VHL (threshold 0.014) and (d) holocomplex missing 





Supplementary Figure 6.23. Native MS of the CSN-CRL2~N8 complex. Spectra were collected 
from a 1:1 ratio of CSN and CRL2~N8, following a 1-hour incubation at room temperature and de-
salting into 150 mM ammonium acetate (pH 7.5). The mass of each species were assigned using 
Waters MassLynx (4.1). The identity, charge, observed mass and percentage mass difference 
(compared to the expected mass) is shown for each complex. CSN3 and CSN5 subunits included 
a 2x StrepII and 6HIS N-terminal tags, respectively. The mass of all CSN complexes identified in 
the spectra include the tag masses of CSN3 and CSN5. The presence of the VBC complex on CRL2 





Supplementary Figure 6.24. Conformations of CSN2 and CSN4 in apo and holo CSN. (a-i) 
Conformations and crystal contacts of CSN2 and CSN4 for the nine independent molecules of 
apo-CSN in PDBs 4WSN, 4D10 and 4D18. Crystal contacts of CSN2 and CSN4 and neighbouring 
asymmetric units within 5 Å are shown by the green mesh. (j) Overlay of apo-CSN molecules in (a-
i) showing range of CSN2 and CSN4 conformations. (k) Overlay of holo-CSN molecules in cryo-EM 
structures of CSN-CRL1 (dark blue), CSN-CRL2 (teal) and CSN-CRL4 (light blue). (l) Overlay of (j) 







Supplementary Figure 6.25. Structural alignment of the CRL2. (a) C-terminal domain and (b) N-
terminal domain in isolated (apo; 5N4W) and CSN-associated (holo) conformations. The 





Supplementary Figure 6.26. Cross-links of the CSN-CRL2~N8 complex. (a) Circular plot of cross-
links identified for the CSN-CRL2~N8 complex. (b) Inter- (red) and intra-subunit (blue) cross-links 
projected onto the cryo-EM structure of CSN-CRL2~N8. Nine cross-links were omitted due to 
missing residues in the C-terminal loops of CSN subunits (six) and self-residue cross-links (three) 
(Supplementary Data 6.2). (c) Euclidean distances for cross-links shown in (b). All measurements 
made between lysine Nz-Nz atoms using PyMOL. 35 Å cross-link distance threshold is shown by 
the dotted line. 35 Å takes into account two lysine sidechains (15 Å), 10 Å cross-linker length for 
BS3 and an additional 10 Å to account for domain-level flexibility. (d) Zoom of the WHB~N8 region 
of the CSN-CRL2~N8 model generated from cryo-EM and cross-link. The WHB domain is shown 
in teal, CUL2 in light blue (transparent), NEDD8 in yellow and CSN5 in grey. (e) Comparison of 
WHB~N8 from our hybrid cryo-EM/cross-linking CSN-CRL2~N8 model (teal) with non-neddylated 
WHB from CRL2 crystal structure (5N4W; purple). Vector arrows depict the 19 Å movement of WHB 











Supplementary Figure 6.28. Cryo-EM map of the CSN-CRL2 complex. A set of 6800 micrographs 
were subjected to manual and auto-picking in order to acquire particles for 2D reference-free 
classification (a). 2D classification was used for the positive selection of particles prior to 3D 
classification. (b) six classes generated, demonstrate subunit heterogeneity in the data set. (c) 
Resolution map of the CSN-CRL2 was generated using RELION231.  (d) Fourier shell correlations 
(FSC) for the single CSN-CRL2 map.  
 





Supplementary Figure 6.30. Cross-links of the deneddylated CSN-CRL2 complex. (a) Circular plot 
of cross-links identified for the CSN-CRL2 complex. (b) Inter- (red) and intra-subunit (blue) cross-
links projected onto the cryo-EM structure of CSN-CRL2. Six cross-links were omitted due to 
missing residues in the C-terminal loops of CSN subunits (five) and self-residue cross-links (one) 
(Supplementary Data 6.3). (c) Euclidean distances for cross-links shown in (b). All measurements 
made between lysine Nz-Nz atoms using PyMOL. 35 Å cross-link distance threshold is shown by 
the dotted line. 35 Å takes into account two lysine sidechains (15 Å), 10 Å cross-linker length for 
BS3 and an additional 10 Å to account for domain-level flexibility. (e) Comparison of 
deneddylated WHB from our hybrid cryo-EM/cross-linking CSN-CRL2 model (teal) with WHB from 






Supplementary Figure 6.31. Cross-links of CSN4 from apo-CSNWT. Location and distances of CSN4 
cross-links in apo-CSNWT, projected onto the structures of (a) apo-CSN crystal structure (PDB 
4D10) and (b) cryo-EM map fitted model of CSN-CRL2. Cross-links with distances satisfied under 
the cut-off of 35 Å are shown by dashed red lines, while those that are satisfied are in blue. (c) Bar 
plot showing distances of cross-links from (a-b). Dashed line represents a 35 Å distance threshold. 
Arrows mark cross-links which are satisfied in one conformation of the CSN but not the other. For 
K116-K200, K364-K214, K253-K200 and K415-K200 cross-links we included the shortest distance 
model in the satisfied category due to the distances being close to 35 Å, while the alternative 
conformation is much greater than 35 Å. All measurements were from lysine NZ atoms. The three 
CSN2-CSN4 cross links which differentiate between open and closed models (red arrows) are 
each located relatively close to the hinge domain of CSN4, nevertheless the distance between 
lysine residues changes quite substantially. Although potential cross links between residues 
closer to the N-termini of CSN2 and CSN4 would undergo a significantly greater change in 
separation, they were not observed and would not be expected to occur with the cross-linking 






Supplementary Figure 6.32. Per-subunit comparisons of the CSN in neddylated and non-
neddylated CSN-CRL2 complexes. (a) Superposition of the CSN-CRL2~N8 and CSN-CRL2. CSN1, 
CSN3, CSN7B, CSN8, RBX1, ELOB/C and VHL are shown in white to highlight the changes in 
CSN5/CSN6, CSN2/CSN4 and Cullin-2. Cullin-2 rotates upwards by ~20 Å in the absence of NEDD8. 
(b) Alignment of the C-terminal helical bundle of CSN-CRL2 and CSN-CRL2~N8 complexes. Per-




CSN8 between CSN-CRL2~N8 and CSN-CRL2 structures. The per-residue RMSD of each CSN1-8 
subunit between CSN-CRL2~N8 and CSN-CRL2 complexes are indicated by the blue-red gradient. 
Each colour bar and colour gradient has been normalised to the maximum RMSD calculated for 
that subunit. The structure shown is the non-neddylated CSN-CRL2. The maximum per-subunit 
RMSDs measured were: CSN1 17.6 Å, CSN2 23.6 Å, CSN3 9.6 Å, CSN4 17.6 Å, CSN5 30.6 Å, CSN6 
44.3 Å, CSN7B 13.5 Å, CSN8 5 Å.  
 
 
Supplementary Figure 6.33. CSN1-ELOB interface in CSN-CRL2~N8 complexes. The distance 
between CSN1 and ELOB of CSN-CRL2~N8, after loss of VHL and after loss of CSN5/CSN6 is shown 





Supplementary Figure 6.34. Comparison of CSN6 conformations in published CSN and CSN-CRL 
complexes. Alignment of CSN-CRL2 (orange) with (a) crystal structure of apo CSN (PDB 4D10), (b) 
CSN-CRL1~N8 (EMD-3401), (c-d) fitted coordinates of CSN-CRL4A~N8 (EMD-3315) and CSN-
CRL4ADDB2~N8 (EMD-3316), (e-g) fitted coordinates of neddylated CSN-CRL2~N8 intact complex, 
missing VHL and VHL-refined (all purple). The CSN6 Ins-2 loop for each CSN6 has been highlighted 
for clarity (CSN6 of CSN-CRL2 with dashed ellipses, CSN6 of all other complexes in solid ellipses). 
Numerical quantification of similarity between CSN6 conformations is presented in 





Supplementary Figure 6.35. Pairwise RMSD matrix of CSN6 in CSN and CSN-CRL complexes. 
Matrix indicates the RMSD between comparisons of CSN6 combinations in the apo CSN, CSN-
CRL1~N8 (EMD-3401), CSN-CRL4A~N8 (EMD-3315), CSN-CRL4ADDB2~N8 (EMD-3316), CSN-
CRL2~N8, CSN-CRL2~N8 (-VHL), CSN-CRL2~N8 (VHL refined) and non-neddylated CSN-CRL2 
complexes. The CSN1, CSN2, CSN3, CSN4, CSN7 and CSN8 subunits were aligned in each 
comparison and the RMSD was calculated between the non-fitted coordinates of CSN6 in each 













Supplementary Figure 6.36. HDX-MS of CSN-CRL2~N8 per protein per timepoint. Differential 
comparison of Δ(CSN-CRL2~N8 – CSN). Peptides experiencing stabilisation upon CRL2~N8 
binding to CSN, compared to the peptide in apo-CSN, are shown as blue, destabilised peptides 
are shown in red. CSN2, CSN4, CSN5 and CSN6 have been highlighted by grey boxes. The CSN2 
hinge and Cullin-2 WHB domain have been highlighted in grey for clarity. Peptides were filtered 
applying a 98% confidence limit (critical value of 6.965; dotted lines). Structures show data for 













Supplementary Figure 6.37. HDX-MS of CSNWT-CRL2 per protein per timepoint. Differential 
comparison of Δ(CSNWT-CRL2 – CSNWT). Peptides experiencing stabilisation upon non-neddylated 
CRL2 binding to CSNWT, compared to the peptide in apo-CSNWT, are shown as blue, destabilised 
peptides are shown in red. CSN2, CSN4, CSN5 and CSN6 have been highlighted by grey boxes. 
The CSN2 hinge and Cullin-2 WHB domain have been highlighted for clarity. Peptides were 
filtered applying a 98% confidence limit (critical value of 6.965; dotted lines). Structures show 





Supplementary Figure 6.38. ΔHDX changes in CSN2/CSN4/RBX1, CSN3/CSN8 and CUL2. Regions 
showing significant destabilisation (red) and stabilisation (blue) are shown on the structures of 
CSN-CRL2~N8 (left) and CSN-CRL2 (right) and highlighted for clarity. (a-b) Stabilisation of CSN2 




interface between the two subunits (b; top right blue circles). (c-d) HDX changes in CSN3, CSN8. 
VHL and CSN1 (shown in white) are displayed for reference. Both CSN3 and CSN8 experience 
destabilisation at their interfaces in both left and right complexes. The CSN3 surface closest to 
VHL (red) and the CSN3 winged helix domain (blue) also shows consistent differences. (e-f) 
Destabilisation of the WHB domain Cullin-2 (CUL2) in both conditions. 
 
 
Supplementary Figure 6.39. CSN1-ELOB interface of CSNWT-CRL2 in HDX-MS. (a) Structure of CSN-
CRL2 fitted to cryo-EM density. Significantly stabilised peptides from CSN1 and ELOB between its 
interface is highlighted in blue. (b) Deuterium uptake curves over 30 minutes for CSN1 and ELOB 
peptides are shown for the Δ(CSNWT-CRL2 – CSNWT) comparison. Error bars represent the 







Supplementary Figure 6.40. Dissociation constants between CSN4 and CRL2/CRL2~N8 in CSN-
CRL2 complexes. (a) Structure and density map of the intact CSN-CRL2~N8 shown for reference. 
Three peptides identified as interacting with CRL2/CRL2~N8 in PLIMSTEX experiments have been 
highlighted in red. An example of a peptide with no observed changes is shown in orange. (b) 
PLIMSTEX curve plots showing the deuterium uptake of CSN peptides from (i) CSN-CRL2~N8, (ii) 
CSN-CRL2 and (iii) CSNWT-CRL2, as a function of increasing concentrations of either CRL2 or 
CRL2~N8. Data points represent the average deuterium uptake and error bars indicate standard 
deviation of technical triplicates. The red curve for interacting peptides was fitted using a 3-
parameter 1:1 binding model for 250 nM CSN or CSNWT, titrated with CRL2 or CRL2~N8 from 1:0 to 







Supplementary Figure 6.41. CSN5 Ins-2 loop in isolated and CSN incorporated structures. (a) 
Disordered Ins-2 loop in isolated CSN (PDB 4F7O). (b) Structured Ins-2 loop in CSN incorporated 







Supplementary Figure 6.42. Woods plot comparing deuterium uptake difference of CSN5 
peptides from apo-CSNWT and CSN5H138A complexes. Each CSN5 peptide is represented by a 
horizontal bar and are coloured according to the significance of its uptake difference. Dotted line 
represents a 98% confidence interval used to filter peptides for statistical significance. All 102 
peptides identified from CSN5 showed non-statistically significant changes in deuterium uptake. 
The position of the CSN5 H138A mutation has been highlighted by the blue box. Plots generated 
using Deuteros (v1.08). 
 
 
Supplementary Figure 6.43. Conformational heterogeneity of the CSN-CRL2~N8 structures. The 
distance between CSN3-CUL2 N-terminal domain of CSN-CRL2~N8, after loss of VHL and after 
loss of CSN5/CSN6 is shown by the dashed red line. All other CSN-CRL2 subunits have been 




6.3.2 Supplementary Tables 
Supplementary Table 6.2. Kd values determined for CSN-CRL1 and CSN-CRL2 complexes  
 CRL1n CRL1~N8n CRL2o CRL2~N8o 
CSNWT 310.0 - 22.3 - 
CSN5H138A 10.0 1.6 228.8 225.6 
  
                                                        
n Values accessed from Mosadeghi et al. 2016 ref 222 




6.3.3 Supplementary Notes 


























6.3.4 Supplementary Data & Movie 
Supplementary Data 6.1-Supplementary Data 6.3 each contain cross-link lists of the 
CSN-CRL2~N8, CSN-CRL2 and CSN complexes including the exact peptide sequence, 
number of spectra, max pLink score, calculated precursor mass and observed 
charge states. Supplementary Data files 6.1-6.3 are too large to be included in this 
thesis, hence a summarised list for each complex has been included here.  
Supplementary Movie 6.1. The showcases conformational changes between the 
different CSN-CRL2 structures shown in this article and can be accessed Nature 
Communications websitep. 
  
                                                        




Supplementary Data 6.1. Chemical cross-links of the CSN-CRL2~N8 complex. 
Index Protein A Protein B Residue A Residue B 
Intra-subunit     
1 CSN1 CSN1 183 153 
2 CSN1 CSN1 444 451 
3 CSN1 CSN1 144 136 
4 CSN1 CSN1 343 332 
5 CSN2 CSN2 150 157 
6 CSN2 CSN2 110 150 
7 CSN2 CSN2 253 215 
8 CSN2 CSN2 415 364 
9 CSN2 CSN2 426 364 
10 q CSN1 CSN1 467 467 
11 CSN2 CSN2 243 157 
12 CSN2 CSN2 56 43 
13 CSN2 CSN2 64 93 
14 CSN2 CSN2 81 48 
15 CSN2 CSN2 48 64 
16 CSN2 CSN2 48 93 
17 CSN2 CSN2 93 73 
18 CSN2 CSN2 64 73 
19 q CSN2 CSN2 415 415 
20 CSN3 CSN3 254 243 
21 CSN3 CSN3 125 115 
22 CSN3 CSN3 254 281 
23 CSN4 CSN4 227 214 
24 CSN4 CSN4 214 188 
25 CSN5 CSN5 308 179 
26 CSN5 CSN5 193 218 
27 CSN5 CSN5 218 294 
28 CSN5 CSN5 218 298 
29 CSN6 CSN6 75 113 
30 CSN6 CSN6 229 236 
                                                        





31 r CSN7b CSN7b 221 217 
32 r CSN7b CSN7b 221 257 
33 r CSN7b CSN7b 217 199 
34 r CSN7b CSN7b 218 217 
35 CUL2 CUL2 393 382 
36 CUL2 CUL2 179 252 
37 CUL2 CUL2 393 404 
38 CUL2 CUL2 677 720 
39 CUL2 CUL2 720 382 
40 CUL2 CUL2 728 677 
41 CUL2 CUL2 252 244 
42 CUL2 CUL2 433 386 
43 CUL2 CUL2 608 615 
44 CUL2 CUL2 238 244 
45 CUL2 CUL2 404 400 
46 CUL2 CUL2 433 677 
47 CUL2 CUL2 62 149 
48 CUL2 CUL2 179 96 
49 CUL2 CUL2 433 472 
50 CUL2 CUL2 677 382 
51 ELOB ELOB 19 36 
52 ELOB ELOB 36 28 
53 ELOB ELOB 36 46 
54 ELOB ELOB 11 28 
55 ELOB ELOB 11 36 
56 ELOB ELOB 46 28 
57 q ELOB ELOB 104 104 
58 NEDD8 NEDD8 60 6 
59 NEDD8 NEDD8 11 33 
60 VHL VHL 196 171 
Inter-subunit     
1 CSN1 CSN2 438 426 
2 CSN1 CSN2 438 415 
3 r CSN1 CSN3 467 406 
4 CSN2 CSN3 426 243 
                                                        
r Indicates six cross-links omitted from projection onto the CSN-CRL2~N8 structure in Supplementary Figure 




5 CSN2 CSN4 361 337 
6 CSN2 CSN4 376 337 
7 CSN2 CSN7b 426 199 
8 CSN3 CSN8 296 58 
9 CSN3 CSN8 115 65 
10 CSN3 CSN8 115 58 
11 CSN5 CSN7b 308 199 
12 CSN5 CSN7b 179 199 
13 r CSN5 CSN7b 294 217 
14 CUL2 NEDD8 382 33 
15 CUL2 NEDD8 433 6 
16 CUL2 VHL 114 196 
17 CUL2 ELOC 96 43 
18 CUL2 ELOC 114 43 
Inter-complex     
19 CSN1 ELOB 158 19 
20 CSN2 CUL2 263 462 
21 CSN2 CUL2 157 489 
22 CSN2 CUL2 225 462 
23 CSN2 CUL2 64 404 






Supplementary Data 6.2. Chemical cross-links of the CSN-CRL2 complex. 
Index Protein A Protein B Residue A Residue B 
Intra-subunit     
1 CSN1 183 CSN1 153 
2 CSN1 444 CSN1 451 
3 CSN2 64 CSN2 93 
4 CSN2 110 CSN2 150 
5 CSN2 225 CSN2 189 
6 CSN2 225 CSN2 253 
7 CSN2 253 CSN2 215 
8 CSN2 253 CSN2 300 
9 CSN2 415 CSN2 364 
10 CSN2 426 CSN2 415 
11 CSN2 150 CSN2 157 
12 CSN2 157 CSN2 243 
13 CSN2 48 CSN2 81 
14 CSN2 48 CSN2 93 
15 CSN3 125 CSN3 115 
16 CSN3 254 CSN3 243 
17 CSN3 254 CSN3 281 
18 CSN4 214 CSN4 200 
19 CSN4 150 CSN4 200 
20 CSN4 188 CSN4 214 
21 CSN5 191 CSN5 219 
22 CSN5 194 CSN5 219 
23 CSN5 180 CSN5 309 
24 s CSN7b 221 CSN7b 217 
25 CUL2 62 CUL2 149 
26 CUL2 179 CUL2 96 
27 CUL2 179 CUL2 252 
28 CUL2 252 CUL2 244 
29 CUL2 261 CUL2 244 
30 CUL2 393 CUL2 404 
31 CUL2 608 CUL2 615 
32 CUL2 659 CUL2 404 
33 CUL2 244 CUL2 238 
34 CUL2 400 CUL2 404 
35 CUL2 22 CUL2 74 
36 CUL2 290 CUL2 291 
                                                        
s Indicates five cross-links omitted from projection onto the CSN-CRL2 structure in Supplementary Figure 




37 CUL2 244 CUL2 291 
38 CUL2 400 CUL2 401 
39 CUL2 677 CUL2 728 
40 CUL2 719 CUL2 728 
41t CUL2 252 CUL2 252 
42 ELOB 36 ELOB 46 
43 ELOB 11 ELOB 28 
44 ELOB 11 ELOB 36 
45 ELOB 11 ELOB 46 
46 ELOB 28 ELOB 36 
47 VHL 196 VHL 171 
Inter-subunit     
1 CSN1 422 CSN2 415 
2 CSN1 438 CSN2 426 
3 CSN1 438 CSN3 312 
4 s CSN1 467 CSN7b 257 
5 CSN2 303 CSN4 200 
6 CSN2 426 CSN3 243 
7 CSN2 361 CSN4 337 
8 CSN3 115 CSN8 58 
9 CSN3 115 CSN8 65 
10 CSN4 372 CSN6 75 
11 CSN5 180 CSN7b 199 
12 CSN5 309 CSN7b 199 
13 s CSN5 294 CSN7b 217 
14 CUL2 114 VHL 196 
15 CUL2 114 ELOC 43 
16 ELOB 19 ELOC 32 
17 ELOB 36 ELOC 20 
18 ELOB 19 ELOC 6 
Inter-complex     
1 CSN1 467 VHL 171 
2 CSN2 225 CUL2 462 
3 CSN2 263 CUL2 462 
4 CSN2 415 CUL2 692 
5 s CSN7b 218 CUL2 149 
6 s CSN7b 221 CUL2 291 
 
                                                        




Supplementary Data 6.3. Chemical cross-links of the CSN complex. 
Index Protein A Protein B Residue A Residue B 
Intra-subunit     
1 CSN1 136 CSN1 144 
2 CSN1 144 CSN1 137 
3 CSN1 183 CSN1 153 
4 CSN1 224 CSN1 97 
5 CSN1 422 CSN1 444 
6 CSN1 444 CSN1 451 
7 u CSN1 467 CSN1 467 
8 CSN2 48 CSN2 93 
9 CSN2 64 CSN2 48 
10 CSN2 64 CSN2 93 
11 CSN2 64 CSN2 143 
12 CSN2 93 CSN2 143 
13 CSN2 93 CSN2 157 
14 CSN2 110 CSN2 73 
15 CSN2 110 CSN2 93 
16 CSN2 110 CSN2 150 
17 CSN2 150 CSN2 143 
18 CSN2 150 CSN2 157 
19 CSN2 157 CSN2 150 
20 CSN2 157 CSN2 170 
21 CSN2 167 CSN2 157 
22 CSN2 170 CSN2 143 
23 CSN2 225 CSN2 253 
24 CSN2 253 CSN2 215 
25 CSN2 415 CSN2 361 
26 CSN2 415 CSN2 364 
27 CSN2 426 CSN2 364 
28 CSN2 426 CSN2 415 
29 u CSN3 115 CSN3 115 
30 CSN3 125 CSN3 115 
31 CSN3 254 CSN3 115 
32 CSN3 254 CSN3 237 
33 CSN3 254 CSN3 243 
34 CSN3 254 CSN3 281 
35 CSN3 281 CSN3 125 
36 CSN3 281 CSN3 305 
                                                        




37 v CSN4 32 CSN4 20 
38 v CSN4 32 CSN4 25 
39 v CSN4 116 CSN4 200 
40 v CSN4 137 CSN4 150 
41 v CSN4 137 CSN4 214 
42 v CSN4 144 CSN4 200 
43 v CSN4 150 CSN4 200 
44 u CSN4 200 CSN4 200 
45 v CSN4 214 CSN4 116 
46 v CSN4 214 CSN4 200 
47 v CSN4 251 CSN4 200 
48 v CSN4 290 CSN4 200 
49 CSN5 179 CSN5 301 
50 CSN5 229 CSN5 179 
51 CSN5 301 CSN5 294 
52 CSN6 75 CSN6 113 
53 CSN6 117 CSN6 75 
54 CSN7b 97 CSN7b 165 
55 CSN7b 144 CSN7b 199 
56 CSN7b 221 CSN7b 217 
Inter-subunit     
1 CSN1 467 CSN3 115 
2 CSN1 224 CSN5 294 
3 CSN1 467 CSN7b 257 
4 CSN2 415 CSN1 467 
5 CSN2 426 CSN1 262 
6 CSN2 426 CSN1 264 
7 CSN2 426 CSN1 438 
8 CSN2 415 CSN3 115 
9 CSN2 426 CSN3 243 
10 CSN2 441 CSN3 243 
11 v CSN2 253 CSN4 200 
12 v CSN2 300 CSN4 200 
13 v CSN2 361 CSN4 337 
14 v CSN2 415 CSN4 200 
15 CSN2 415 CSN5 179 
16 CSN3 243 CSN1 262 
17 CSN3 281 CSN1 467 
18 CSN3 312 CSN1 438 
                                                        




19 CSN3 254 CSN2 426 
20 CSN3 391 CSN7b 199 
21 v CSN4 214 CSN2 364 
22 CSN4 314 CSN6 75 
23 CSN5 179 CSN7b 199 
24 CSN6 75 CSN4 200 
25 CSN6 243 CSN7b 164 
26 CSN7b 217 CSN5 294 
27 CSN8 166 CSN1 250 
28 CSN8 58 CSN3 115 
29 CSN8 65 CSN3 243 
30 CSN8 65 CSN3 281 
 
